Tüm yayınlar

Toplam 612 yayın. DOI veya PubMed bağlantıları bulunan çalışmalar doğrudan açılabilir.

612 yayın gösteriliyor.

#1 2016 Proc Natl Acad Sci U S A

Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease

Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai WL, Kuehn HS, Wang H, Yang D, Park YH, Ombrello AK, Blake M, Romeo T, Remmers EF, Chae JJ, Mullikin JC, Güzel F, Milner JD, Boehm M, Rosenzweig SD, Gadina M, Welch SB, Özen S, Topaloglu R, Abinun M, Kastner DL, Aksentijevich I. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10127-32. doi: 10.1073/pnas.1612594113. Epub 2016 Aug 24. PMID: 27559085; PMCID: PMC5018768.

#2 2016 Nat Genet

Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL, Lyons JJ, Yu X, Ouyang C, Chen C, Chin DT, Zaal K, Chandrasekharappa SC, Hanson EP, Yu Z, Mullikin JC, Hasni SA, Wertz IE, Ombrello AK, Stone DL, Hoffmann P, Jones A, Barham BK, Leavis HL, van Royen-Kerkof A, Sibley C, Batu ED, Gül A, Siegel RM, Boehm M, Milner JD, Ozen S, Gadina M, Chae J, Laxer RM, Kastner DL, Aksentijevich I. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016 Jan;48(1):67-73. doi: 10.1038/ng.3459. Epub 2015 Dec 7. PMID: 26642243; PMCID: PMC4777523.

#3 2014 N Engl J Med

Early-onset stroke and vasculopathy associated with mutations in ADA2

Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19. PMID: 24552284; PMCID: PMC4193683.

#4 2026 Arthritis Rheumatol

EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis

Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, Aguiar CL, Akikusa JD, Akca UK, Almeida B, Appenzeller S, Balay-Dustrude E, Basaran O, Basiaga ML, Bilginer Y, Cabral DA, Capponi M, Donaldson N, Egeli BH, Fox EJ, Insalaco A, Iyer RS, Jansson AF, Kostik I, Kostik M, Kovalick LK, Kozu KT, Lapidus SK, Lee TC, Lenert A, Mahmood K, Marrani E, Mosa DM, Muse I, Mushkin A, Nowicki KD, Nuruzzaman F, Onel K, Pardeo M, Pham TS, Potts L, Ramanan AV, Ravelli A, Rogers ND, Grim AW, Romano M, Rosenwasser N, Sato TS, Simonini G, Soep JB, Stern SM, Strauss T, Kohli AT, Theos AC, Tucker LB, Vogel LF, Yasin S, Wong SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis. Arthritis Rheumatol. 2026 Mar;78(3):537-547. doi: 10.1002/art.43137. Epub 2025 May 8. PMID: 40342207.

#5 2025 Ann Rheum Dis

EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)

Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, Aguiar CL, Akikusa JD, Akca UK, Almeida B, Appenzeller S, Balay-Dustrude E, Basaran O, Basiaga ML, Bilginer Y, Cabral DA, Capponi M, Donaldson N, Egeli BH, Fox EJ, Insalaco A, Iyer RS, Jansson AF, Kostik I, Kostik M, Kovalick LK, Kozu KT, Lapidus SK, Lee TC, Lenert A, Mahmood K, Marrani E, Mosad Mosa D, Muse I, Mushkin A, Nowicki KD, Nuruzzaman F, Onel K, Pardeo M, Pham TS, Potts L, Ramanan AV, Ravelli A, Rogers ND, Grim AW, Romano M, Rosenwasser N, Sato TS, Simonini G, Soep JB, Stern SM, Strauss T, Kohli AT, Theos AC, Tucker LB, Vogel LF, Yasin S, Wong SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO). Ann Rheum Dis. 2025 Sep;84(9):1458-1468. doi: 10.1016/j.ard.2024.11.006. Epub 2025 Jan 30. PMID: 39966038.

#6 2018 Arthritis Care Res (Hoboken)

Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions

Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, Lee TC, Fox E, Amarilyo G, Stern SM, Dvergsten JA, Haines KA, Rouster-Stevens KA, Onel KB, Cherian J, Hausmann JS, Miettunen P, Cellucci T, Nuruzzaman F, Taneja A, Barron KS, Hollander MC, Lapidus SK, Li SC, Ozen S, Girschick H, Laxer RM, Dedeoglu F, Hedrich CM, Ferguson PJ; Chronic Nonbacterial Osteomyelitis/Chronic Recurrent Multifocal Osteomyelitis Study Group and the Childhood Arthritis and Rheumatology Research Alliance Scleroderma, Vasculitis, Autoinflammatory and Rare Diseases Subcommittee. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res (Hoboken). 2018 Aug;70(8):1228-1237. doi: 10.1002/acr.23462. Epub 2018 Jul 12. PMID: 29112802; PMCID: PMC5938153.

#7 2021 Lupus

Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus

Yuksel K, Sag E, Demir S, Özdel S, Kaya UA, Atalay E, Cuceoglu MK, Topaloglu R, Bilginer Y, Ozen S. Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus. Lupus. 2021 May;30(6):998-1004. doi: 10.1177/09612033211002275. Epub 2021 Mar 10. PMID: 33691516.

#8 2014 Rheumatology (Oxford)

Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events

Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T, Saglam M, Unal HU, Gok M, Polat A, Cetinkaya H, Eyileten T, Sari S, Yildirim AO, Sonmez A, Oguz Y, Vural A, Ozen S, Carrero JJ. Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. Rheumatology (Oxford). 2014 Nov;53(11):2002-8. doi: 10.1093/rheumatology/keu231. Epub 2014 Jun 6. PMID: 24907154.

#9 2003 Turk J Pediatr

Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients

Yilmaz E, Balci B, Kutlay S, Ozen S, Ertürk S, Oner A, Beşbaş N, Bakkaloğlu A. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr. 2003 Jul-Sep;45(3):198-202. PMID: 14696796.

#10 2013 The specificities of pediatric vasculitis classification

L16

Yildiz C, Ozen S. L16. The specificities of pediatric vasculitis classification. Presse Med. 2013 Apr;42(4 Pt 2):546-50. doi: 10.1016/j.lpm.2013.01.015. Epub 2013 Mar 1. PMID: 23453996.

#11 2024 Phys Occup Ther Pediatr

Examination of Physical Functions, Activity and Participation in Children with Juvenile Idiopathic Arthritis

Yildiz-Kabak V, Buran S, Karaca NB, Tufekci O, Aliyev E, Bayindir Y, Atasavun Uysal S, Bilginer Y, Unal E, Ozen S. Examination of Physical Functions, Activity and Participation in Children with Juvenile Idiopathic Arthritis. Phys Occup Ther Pediatr. 2024;44(6):798-811. doi: 10.1080/01942638.2024.2376058. Epub 2024 Jul 11. PMID: 38992979.

#12 2026 J Allergy Clin Immunol

Circulating extracellular vesicles drive innate immune dysregulation in MIS-C

Yildirim TC, Ozsurekci Y, Yildirim M, Yazar V, Evcili I, Gungor B, Yilmaz IC, Ozen S, Aykac K, Cengiz AB, Guler U, Salih B, Gursel M, Gursel I. Circulating extracellular vesicles drive innate immune dysregulation in MIS-C. J Allergy Clin Immunol. 2026 May 18:S0091-6749(26)00342-8. doi: 10.1016/j.jaci.2026.02.048. Epub ahead of print. PMID: 42155682.

#13 2015 Clin Exp Rheumatol

Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children

Yesilkaya S, Acikel C, Fidanci BE, Polat A, Sozeri B, Ayaz NA, Makay BB, Simsek D, Akinci N, Özçelik G, Kavukçu S, Emre S, Donmez O, Delibas A, Yüksel S, Berdeli A, Poyrazoglu H, Saldir M, Fidanci K, Çakar N, Peru H, Bakkaloglu S, Tabel Y, Sari O, Aydogan U, Ozenc S, Basbozkurt G, Unsal E, Kasapcopur Ö, Gok F, Ozen S, Demirkaya E; FMF Arthritis Vasculitis and Orphan disease Research in Paediatric Rheumatology (FAVOR). Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children. Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S156-62. Epub 2015 Sep 22. PMID: 26393894.

#14 2026 Arthritis Rheumatol

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

Yaz I, Ozen S, Bildik HN, Ipsir C, Unal D, Esenboga S, Cicek B, Seker ME, Aerts-Kaya F, Sener S, Erkan MO, Avci H, Cagdas D, Tezcan I. From Interferon Signature to the Clinical Landscape: Type I Interferonopathies. Arthritis Rheumatol. 2026 Jun 22. doi: 10.1002/art.70257. Epub ahead of print. PMID: 42328836.

#15 2014 Pediatr Nephrol

Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis

Yazici MU, Orhan D, Kale G, Besbas N, Ozen S. Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis. Pediatr Nephrol. 2014 May;29(5):853-62. doi: 10.1007/s00467-013-2695-1. Epub 2014 Jan 31. PMID: 24482023.

#16 2023 Neuropediatrics

Claude Syndrome in Childhood Associated with Probable Neuro-Behcet Disease

Yavuz P, Solmaz I, Kaya UA, Akgoz A, Oguz KK, Aytac S, Ozen S, Yalnizoglu D. Claude Syndrome in Childhood Associated with Probable Neuro-Behcet Disease. Neuropediatrics. 2023 Feb;54(1):82-87. doi: 10.1055/s-0042-1759794. Epub 2022 Dec 23. PMID: 36564024.

#17 2022 J Pediatr

New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children

Yavuz P, Demir OO, Ozsurekci Y, Ozen S, Anlar B, Haliloglu G. New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children. J Pediatr. 2022 Jun;245:213-216. doi: 10.1016/j.jpeds.2022.02.046. Epub 2022 Feb 26. PMID: 35231493; PMCID: PMC8882031.

#18 2026 bioRxiv [Preprint]

STING- STAT3-SOX18 Axis Drives EndMT and Epigenetic Reprogramming in SAVI Lung Fibrosis

Yang D, Chen G, Gaurav S, de Jesus AA, Mehta AK, McNinch C, Miranda AX, Wei J, Kedei N, Hernandez MO, Zou J, Linask K, Lee CC, Sukumar G, Zhang Y, Alehashemi S, Folio L, Yu Q, Lin B, Lang B, Buehring B, Dueckers G, Reinhardt A, Schulte G, Liptzin DR, Ozen S, Borzutzky A, Wong M, Tillo D, Dmitrieva NI, Mani H, Nathan SD, Kovacic JC, Dalgard C, Boehm M, Goldbach-Mansky R. STING- STAT3-SOX18 Axis Drives EndMT and Epigenetic Reprogramming in SAVI Lung Fibrosis. bioRxiv [Preprint]. 2026 Mar 24:2026.03.23.713256. doi: 10.64898/2026.03.23.713256. PMID: 42051306; PMCID: PMC13119299.

#19 2009 Rheumatology (Oxford)

A new set of criteria for the diagnosis of familial Mediterranean fever in childhood

Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, Kasapçopur O, Elhan AH, Doganay B, Ekim M, Kara N, Uncu N, Bakkaloglu A. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford). 2009 Apr;48(4):395-8. doi: 10.1093/rheumatology/ken509. Epub 2009 Feb 4. PMID: 19193696.

#20 2007 J Pediatr

Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa

Yalçinkaya F, Ozçakar ZB, Kasapçopur O, Oztürk A, Akar N, Bakkaloğlu A, Arisoy N, Ekim M, Ozen S. Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr. 2007 Dec;151(6):675-8. doi: 10.1016/j.jpeds.2007.04.062. Epub 2007 Aug 28. PMID: 18035151.

#21 2024 Diagnostics (Basel)

The Potential Role of Cell-Death Mechanisms in the Pathogenesis of Familial Mediterranean Fever Attacks: Granzyme A and Beyond

Yaglikara E, Boluk O, Bayindir Y, Bilginer Y, Tasar MA, Ozen S, Sag E. The Potential Role of Cell-Death Mechanisms in the Pathogenesis of Familial Mediterranean Fever Attacks: Granzyme A and Beyond. Diagnostics (Basel). 2024 Sep 13;14(18):2031. doi: 10.3390/diagnostics14182031. PMID: 39335710; PMCID: PMC11431255.

#22 2023 J Rheumatol

Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis

Wu EY, Oliver M, Scheck J, Lapidus S, Akca UK, Yasin S, Stern SM, Insalaco A, Pardeo M, Simonini G, Marrani E, Wang X, Huang B, Kovalick LK, Rosenwasser N, Casselman G, Liau A, Shao Y, Yang C, Mosa DM, Tucker L, Girschick H, Laxer RM, Akikusa JD, Hedrich CM, Onel K, Dedeoglu F, Twilt M, Ferguson PJ, Ozen S, Zhao Y. Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis. J Rheumatol. 2023 Oct;50(10):1333-1340. doi: 10.3899/jrheum.2022-1323. Epub 2023 Jul 1. PMID: 37399459; PMCID: PMC10543471.

#23 2017 Vaccine

IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data

Woerner A, Rudin C, Bonetto C, Santuccio C, Ozen S, Wise RP, Chandler R, Bonhoeffer J; Brighton Collaboration lgA Vasclitis (Henoch–Schönlein) Working Group. IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2017 Mar 13;35(11):1559-1566. doi: 10.1016/j.vaccine.2016.09.024. Epub 2016 Dec 26. PMID: 28034474.

#24 2024 Arthritis Rheumatol

Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis

Weiss PF, Brandon TG, Aggarwal A, Burgos-Vargas R, Colbert RA, Horneff G, Laxer RM, Minden K, Ravelli A, Ruperto N, Smith JA, Stoll ML, Tse SM, Van den Bosch F, Maksymowych WP, Lambert RG, Biko DM, Chauvin NA, Francavilla ML, Jaremko JL, Herregods N, Kasapcopur O, Yildiz M, Srinivasalu H, Lovell DJ, Nigrovic PA, Foeldvari I, Klein-Gitelman MS, Ozen S, Naden R, Hendry AM, Joos R. Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis. Arthritis Rheumatol. 2024 Dec;76(12):1797-1808. doi: 10.1002/art.42959. Epub 2024 Sep 8. PMID: 39039899; PMCID: PMC11606790.

#25 2026 Rheumatology (Oxford)

Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network

Vitale A, Caggiano V, Sbalchiero J, Tufan A, Ragab G, Lopalco G, Portincasa P, Rigante D, Al-Mayouf SM, Şahin A, Tekgöz N, Verrecchia E, Fotis L, Barone P, Sfikakis PP, Batu ED, Gaggiano C, Ozen S, Bes C, Akay N, Konte EK, Aslan E, Torunoglu Z, Karakaya B, Yildirim D, Kucuk H, Noto A, Khalil M, Sicignano LL, Alsaleem A, Alsonbul A, Babayiğit A, Semanur E, Kourtesi K, Papa S, Laskari K, Deniz R, Alemanno A, Maggio MC, Hernández-Rodríguez J, Gomez-Caverzaschi V, De Paulis A, Mormile I, Aragona E, Bronte F, Gallizzi R, Insalaco A, Olivieri AN, Bilgin E, Erdik N, Saad MA, Robles-Marhuenda Á, Lo Gullo A, Conforti A, Tornero Romero F, Ogunjimi B, Sener S, Frassi M, Conti G, Cauli A, Govoni M, Marzano AV, Moltrasio C, Więsik-Szewczyk E, Tharwat S, Moshrif A, Karamanakos A, Semanur E, Balistreri A, Frediani B, Fabiani C, Kasapçopur Ö, Cantarini L. Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network. Rheumatology (Oxford). 2026 Jul 13:keag361. doi: 10.1093/rheumatology/keag361. Epub ahead of print. PMID: 42444147.

#26 2026 Semin Arthritis Rheum

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry

Vitale A, Caggiano V, Sbalchiero J, Lopalco G, Tufan A, Ragab G, Sfikakis PP, Dagna L, Batu ED, Ozen S, Conti F, Maiolini F, Bugatti S, Frassi M, Ruscitti P, Cito A, Cakir IY, Akay N, Konte EK, Laskari K, Emreol HE, Priori R, Croce J, De Stefano L, Francesca C, Cipriani P, La Torre F, Maggio MC, Al-Mayouf SM, Fotis L, Rigante D, Verrecchia E, Guggino G, La Barbera L, Piga M, Emmi G, Gallizzi R, Conti G, Sfriso P, Bartoloni E, Giacomelli R, Barone P, Gicchino MF, Alemanno A, Lo Gullo A, Direskeneli H, Alibaz-Oner F, Karamanakos A, Prete M, Edrees A, Gavioli F, Parronchi P, Ciccia F, Cardamone C, Hernández-Rodríguez J, Hatemi G, Bes C, Almaghlouth IA, Marhuenda ÁR, Gonzáles-García A, Gaggiano C, Mormile I, Tezcan ME, Brucato AL, Feist E, Tornero-Romero F, Suzon B, Ogunjimi B, Thabet M, Conforti A, Pucino V, Boyarchuk O, Kovalchuk T, Govoni M, Iagnocco A, Chimenti MS, Moshrif A, Giudice ED, Carubbi F, Erten Ş, Tharwat S, Hegazy MT, Więsik-Szewczyk E, Torres-Ruiz J, Martín-Nares E, Balistreri A, Fabiani C, Frediani B, Hinojosa-Azaola A, Kasapçopur Ö, Cantarini L. Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry. Semin Arthritis Rheum. 2026 Jun 20;80:153030. doi: 10.1016/j.semarthrit.2026.153030. Epub ahead of print. PMID: 42364377.

#27 2026 Front Immunol

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry

Vitale A, Caggiano V, Sbalchiero J, Gavioli F, Lopalco G, Ragab G, Guerriero S, Almaglouth I, Tufan A, Giacomelli R, Direskeneli H, Ruscitti P, Hatemi G, Carubbi F, Batu ED, Ozen S, Sota J, Giardini HAM, Frassi M, Sfikakis PP, Morrone M, Gatti F, Maher A, Mahmoud AAA, Dammacco R, Kucuk H, Kardas RC, Cakir IY, Corcia LPD, Öner FA, Sevik G, Gentile M, Karakoc A, Alunno A, Emreol HE, Crisafulli F, Tektonidou M, Ciccia F, Thabet M, Bugatti S, Milanesi A, Chimenti MS, Monosi B, Piga M, Floris A, Hinojosa-Azaola A, Guaracha-Basañez GA, Chighizola CB, Hernández-Rodríguez J, Cattalini M, Govoni M, Viapiana O, Civino A, Opris-Belinski D, Gaggiano C, Talarico R, Giardina A, Emmi G, Puttini PS, Maggio MC, Parronchi P, Portincasa P, de-la-Torre A, Cardona-López J, Gentileschi S, Mauro A, Sebastiani GD, Gicchino MF, Şahin A, Rigante D, Bilgin E, Del Giudice E, Breda L, De Paulis A, Lo Gullo A, Erten Ş, Tharwat S, Fotis L, Armin M, Insalaco A, Karamanakos A, Conforti A, Gündüz ÖS, Moshrif A, Li Gobbi F, Costi S, Bartoloni E, Barone P, Guiducci S, González-García A, Rodriguez IH, Conti G, Iagnocco A, Önen F, Al-Mayouf SM, Hatemi Aİ, Balistreri A, Fabiani C, Cantarini L. Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry. Front Immunol. 2026 May 13;17:1778171. doi: 10.3389/fimmu.2026.1778171. PMID: 42212137; PMCID: PMC13212520.

#28 2026 Rheumatology (Oxford)

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry

Vitale A, Gavioli F, Caggiano V, Sbalchiero J, Lopalco G, Ragab G, Guerriero S, AlMaglouth I, Tufan A, Giacomelli R, Direskeneli H, Ruscitti P, Hatemi G, Carubbi F, Batu ED, Ozen S, Sota J, Giardini HAM, Frassi M, Sfikakis PP, Iannone F, Morrone M, Ghanema M, Saad MA, Dammacco R, Kucuk H, Kardas RC, Cakir IY, Navarini L, Alibaz Öner F, Sevik G, Gentile M, Karakoc A, Alunno A, Ercan Emreol H, Crisafulli F, Fragoulis G, Ciccia F, Thabet M, Bugatti S, Milanesi A, Chimenti MS, Monosi B, Piga M, Floris A, Hinojosa-Azaola A, Guaracha-Basañez GA, Chighizola CB, Hernández-Rodríguez J, Cattalini M, Govoni M, Viapiana O, Civino A, Opris-Belinski D, Gaggiano C, Talarico R, Giardina A, Emmi G, Sarzi Puttini P, Maggio MC, Parronchi P, Portincasa P, de-la-Torre A, Aguilar-Barrera B, Gentileschi S, Mauro A, Sebastiani GD, Olivieri AN, Şahin A, Rigante D, Bilgin E, Del Giudice E, Breda L, De Paulis A, Lo Gullo A, Erten Ş, Tharwat S, Fotis L, Maier A, Insalaco A, Karamanakos A, Conforti A, Soysal Gündüz Ö, Moshrif A, Li Gobbi F, Balistreri A, Bartoloni E, Barone P, Guiducci S, Gonzáles-García A, Hernanz Rodriguez I, Conti G, Iagnocco A, Önen F, Al-Mayouf SM, Ucar D, Frediani B, Fabiani C, Cantarini L; from the International AIDA (AutoInflammatory Diseases Alliance) Network. Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry. Rheumatology (Oxford). 2026 Feb 4;65(2):keaf613. doi: 10.1093/rheumatology/keaf613. PMID: 41259668.

#29 2026 Ophthalmol Ther

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry

Vitale A, Caggiano V, Sbalchiero J, Lopalco G, Ragab G, Guerriero S, AlMaglouth I, Tufan A, Giacomelli R, Direskeneli H, Ruscitti P, Hatemi G, Carubbi F, Batu ED, Ozen S, Sota J, Giardini HAM, Frassi M, Sfikakis PP, Gatti F, Ammoscato C, Maher A, Mahmoud AAA, Dammacco R, Kucuk H, Kardas RC, Cakir IY, Öner FA, Sevik G, Gentile M, Karakoc A, Alunno A, Emreol HE, Crisafulli F, Laskari K, Ciccia F, Thabet M, Feriel N, Bugatti S, Milanesi A, Chimenti MS, Monosi B, Piga M, Floris A, Gavioli F, Chighizola CB, Hernández-Rodríguez J, Cattalini M, Govoni M, Viapiana O, Civino A, Opris-Belinski D, Gaggiano C, Talarico R, Alemanno A, Giardina A, Emmi G, Puttini PS, Maggio MC, Parronchi P, Portincasa P, de-la-Torre A, Rodríguez-Camelo LD, Gentileschi S, Mauro A, Sebastiani GD, Olivieri AN, Şahin A, Rigante D, Bilgin E, Del Giudice E, Breda L, De Paulis A, Lo Gullo A, Erten Ş, Tharwat S, Fotis L, Maier A, Insalaco A, Karamanakos A, Conforti A, Gündüz ÖS, Moshrif A, Gobbi FL, Costi S, Bartoloni E, Barone P, Guiducci S, Gonzáles-García A, Rodriguez IH, Conti G, Iagnocco A, Önen F, Al-Mayouf SM, Uçar D, Balistreri A, Frediani B, Cantarini L, Fabiani C. The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry. Ophthalmol Ther. 2026 Jan;15(1):223-237. doi: 10.1007/s40123-025-01258-0. Epub 2025 Nov 8. PMID: 41205142; PMCID: PMC12882929.

#30 2025 Front Med (Lausanne)

Development and implementation of the International AIDA Network Castleman's disease registry

Vitale A, Sbalchiero J, Caggiano V, Lazzi S, Tharwat S, Fotis L, Lopalco G, Emmi G, Ruscitti P, Tufan A, Ragab G, Hissaria P, Dagna L, Wiesik-Szewczyk E, Hernández-Rodríguez J, González-Garcia A, Karamanakos A, Batu ED, Direskeneli H, Iannone F, Di Cola I, Kucuk H, Duran R, Saad MA, Ghanema M, Sikora M, Alibaz- Öner F, Beecher M, Ozen S, Cencini E, Bocchia M, Balistreri A, Fabiani C, Frediani B, Cantarini L, Zinzani P. Development and implementation of the International AIDA Network Castleman's disease registry. Front Med (Lausanne). 2025 Sep 3;12:1579182. doi: 10.3389/fmed.2025.1579182. PMID: 40969814; PMCID: PMC12441021.

#31 2025 Rheumatology (Oxford)

Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

Vitale A, Caggiano V, Sbalchiero J, Tufan A, Batu ED, Ragab G, Portincasa P, Conti G, Aragona E, Sota J, Gavioli F, Gaggiano C, De Paulis A, Şahin A, Maggio MC, Rigante D, Olivieri AN, Yildirim D, Kucuk H, Kardas RC, Vasi I, Ozen S, Bilginer Y, Sener S, Emreol HE, Mahmoud AAA, Ghanema M, Maher A, Saad MA, Jaber N, Khalil M, Di Ciaula A, De Palma L, Cuzzola R, Affronti A, Gambino F, Della Casa F, Mormile I, Babayiğit A, Çelik NÇ, Gicchino MF, Jahnz-Rozyk K, La Torre F, Insalaco A, Recke A, Del Giudice E, Barone P, Cattalini M, Brucato AL, Opris- Belinski D, Sfikakis PP, Li Gobbi F, Emmi G, Giardini HAM, Hernández-Rodríguez J, Parronchi P, Ruscitti P, Costi S, Tharwat S, Karamanakos A, Sfriso P, Conforti A, Verrecchia E, Lopalco G, Ogunjimi B, Wiesik-Szewczyk E, Balistreri A, Fabiani C, Frediani B, Cantarini L. Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry. Rheumatology (Oxford). 2025 Aug 1;64(8):4776-4787. doi: 10.1093/rheumatology/keaf181. PMID: 40175882.

#32 2025 Front Pharmacol

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry

Vitale A, Caggiano V, Leone F, Hinojosa-Azaola A, Martín-Nares E, Guaracha- Basañez GA, Torres-Ruiz J, Kawakami-Campos PA, Hissaria P, Callisto A, Beecher M, Dagna L, Campochiaro C, Tomelleri A, Frassi M, Franceschini F, Crisafulli F, Hernández-Rodríguez J, Gómez-Caverzaschi V, Araújo O, Sfriso P, Bindoli S, Baggio C, Sota J, Tufan A, Kucuk H, Piga M, Cauli A, D'Agostino MA, De Paulis A, Mormile I, Giardini HAM, Cordeiro RA, Lopalco G, Iannone F, Monti S, Montecucco C, Ruiz-Irastorza G, Soto-Peleteiro A, Triggianese P, Gurnari C, Viapiana O, Bixio R, Vitetta R, Rovera G, Conticini E, La Torre F, Portincasa P, Jaber N, Ragab G, Maher A, Batu ED, Ozen S, Wiesik-Szewczyk E, de-la-Torre A, Balistreri A, Frediani B, Fabiani C, Cantarini L. Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry. Front Pharmacol. 2025 Feb 19;16:1462254. doi: 10.3389/fphar.2025.1462254. PMID: 40046741; PMCID: PMC11879931.

#33 2024 Front Immunol

Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

Vitale A, Caggiano V, Tufan A, Ragab G, Batu ED, Portincasa P, Aragona E, Sota J, Conti G, De Paulis A, Rigante D, Olivieri AN, Şahin A, La Torre F, Lopalco G, Cattalini M, Maggio MC, Insalaco A, Sfikakis PP, Verrecchia E, Yildirim D, Kucuk H, Kardas RC, Laymouna AH, Ghanema M, Saad MA, Sener S, Ercan Emreol H, Ozen S, Jaber N, Khalil M, Di Ciaula A, Gaggiano C, Malizia G, Affronti A, Patroniti S, Romeo M, Sbalchiero J, Della Casa F, Mormile I, Silvaroli S, Gicchino MF, Çelik NÇ, Tarsia M, Karamanakos A, Hernández-Rodríguez J, Parronchi P, Opris-Belinski D, Barone P, Recke A, Costi S, Sfriso P, Giardini HAM, Gentileschi S, Wiesik-Szewczyk E, Vasi I, Loconte R, Jahnz-Różyk K, Martín- Nares E, Torres-Ruiz J, Cauli A, Conforti A, Emmi G, Li Gobbi F, Biasi GR, Terribili R, Ruscitti P, Del Giudice E, Tharwat S, Brucato AL, Ogunjimi B, Hinojosa-Azaola A, Balistreri A, Fabiani C, Frediani B, Cantarini L. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries. Front Immunol. 2024 May 10;15:1397890. doi: 10.3389/fimmu.2024.1397890. PMID: 38799474; PMCID: PMC11116561.

#34 2010 Ann Rheum Dis

Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial

Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, van Rossum MA, Hollingworth P, Cawkwell G, Martini A, Ruperto N; Pediatric Rheumatology International Trials Organisation (PRINTO). Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis. 2010 Aug;69(8):1479-83. doi: 10.1136/ard.2009.120840. Epub 2010 Jun 4. PMID: 20525842.

#35 2018 Pediatr Rheumatol Online J

Towards a new set of classification criteria for PFAPA syndrome

Vanoni F, Caorsi R, Aeby S, Cochard M, Antón J, Berg S, Brik R, Dolezalova P, Koné-Paut I, Neven B, Ozen S, Pillet P, Stojanov S, Wouters C, Gattorno M, Hofer M. Towards a new set of classification criteria for PFAPA syndrome. Pediatr Rheumatol Online J. 2018 Sep 21;16(1):60. doi: 10.1186/s12969-018-0277-2. PMID: 30241480; PMCID: PMC6151014.

#36 2009 Arthritis Rheum

Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis

Uz E, Mustafa C, Topaloglu R, Bilginer Y, Dursun A, Kasapcopur O, Ozen S, Bakkaloglu A, Ozcelik T. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum. 2009 Nov;60(11):3410-2. doi: 10.1002/art.24956. PMID: 19877028.

#37 2007 World J Gastroenterol

An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood

Usta Y, Gurakan F, Akcoren Z, Ozen S. An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood. World J Gastroenterol. 2007 May 21;13(19):2764-7. doi: 10.3748/wjg.v13.i19.2764. PMID: 17569152; PMCID: PMC4147132.

#38 2004 Pediatr Nephrol

Effects of pentoxifylline in adriamycin-induced renal disease in rats

Usta Y, Ismailoglu UB, Bakkaloglu A, Orhan D, Besbas N, Sahin-Erdemli I, Ozen S. Effects of pentoxifylline in adriamycin-induced renal disease in rats. Pediatr Nephrol. 2004 Aug;19(8):840-3. doi: 10.1007/s00467-004-1538-5. Epub 2004 Jun 16. PMID: 15206020.

#39 2010 Dig Dis Sci

The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children

Uslu N, Yüce A, Demir H, Saltik-Temizel IN, Usta Y, Yilmaz E, Beşbaş N, Gürakan F, Ozen H, Ozen S. The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children. Dig Dis Sci. 2010 Dec;55(12):3488-94. doi: 10.1007/s10620-010-1178-5. Epub 2010 Mar 21. PMID: 20306331.

#40 2013 J Pediatr Hematol Oncol

Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis

Unal S, Balta G, Okur H, Aytac S, Cetin M, Gumruk F, Ozen S, Gurgey A. Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis. J Pediatr Hematol Oncol. 2013 Jul;35(5):e205-8. doi: 10.1097/MPH.0b013e31827b4859. PMID: 23274377.

#41 2010 Pediatr Blood Cancer

Stanozolol treatment for successful prevention of attacks of severe primary cryofibrinogenemia

Unal S, Kara F, Ozen S, Orhan D, Tuncer M, Gumruk F. Stanozolol treatment for successful prevention of attacks of severe primary cryofibrinogenemia. Pediatr Blood Cancer. 2010 Jul 15;55(1):174-6. doi: 10.1002/pbc.22469. PMID: 20209649.

#42 2008 Am J Hematol

Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment

Unal S, Gücer S, Kale G, Besbas N, Ozen S, Gümrük F. Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment. Am J Hematol. 2008 Feb;83(2):165-6. doi: 10.1002/ajh.21052. PMID: 17712793.

#43 2005 J Child Neurol

Four-month-old infant with focal segmental glomerulosclerosis and mitochondrial DNA deletion

Unal S, Kalkanoğlu HS, Kocaefe C, Gucer S, Ozen S, Turanli G, Coskun T. Four-month-old infant with focal segmental glomerulosclerosis and mitochondrial DNA deletion. J Child Neurol. 2005 Jan;20(1):83-4. doi: 10.1177/08830738050200011304. PMID: 15791930.

#44 2018 Rheumatol Int

A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q

Unal E, Batu ED, Sonmez HE, Arici ZS, Arin G, Karaca NB, Sag E, Demir S, Hakli DA, Ozcadirci A, Oflaz FB, Alpar R, Bilginer Y, Ozen S. A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q. Rheumatol Int. 2018 Aug;38(8):1557-1564. doi: 10.1007/s00296-018-4075-4. Epub 2018 Jun 5. PMID: 29869009.

#45 2026 Pediatr Pulmonol

Systemic JIA- Associated Lung Disease: A Multicenter Analysis of Clinical Features, Treatment Challenges, and Outcomes

Unal D, Cam V, Konte EK, Celikel E, Ozdel S, Gurgoze MK, Sag E, Basaran O, Barut K, Oguz B, Bilginer Y, Kasapçopur O, Dogru D, Ozen S. Systemic JIA- Associated Lung Disease: A Multicenter Analysis of Clinical Features, Treatment Challenges, and Outcomes. Pediatr Pulmonol. 2026 Jun;61(6):e71690. doi: 10.1002/ppul.71690. PMID: 42261212.

#46 2025 Clin Rheumatol

Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort

Unal D, Yigit YD, Basaran O, Yildiz AE, Bayindir Y, Cam V, Emreol HE, Erkan MO, Banak ON, Sag E, Bilginer Y, Aydingoz U, Ozen S. Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort. Clin Rheumatol. 2025 Oct;44(10):4229-4236. doi: 10.1007/s10067-025-07653-z. Epub 2025 Aug 26. PMID: 40858879.

#47 2025 Rheumatology (Oxford)

Long-term clinical course and treatment response in two patients with OTULIN-related autoinflammatory syndrome

Unal D, Ercan Emreol H, Bilginer Y, Ozen S. Long-term clinical course and treatment response in two patients with OTULIN-related autoinflammatory syndrome. Rheumatology (Oxford). 2025 Nov 1;64(11):5995-5997. doi: 10.1093/rheumatology/keaf428. PMID: 40795218.

#48 2025 Diagnostics (Basel)

Validation of Axial Juvenile Spondyloarthropathy Criteria in Turkish Juvenile Spondyloarthropathy Patients

Unal D, Tatar CA, Sag E, Bayindir Y, Aliyev E, Cam V, Ercan Emreol H, Erkan MO, Basaran O, Bilginer Y, Ozen S. Validation of Axial Juvenile Spondyloarthropathy Criteria in Turkish Juvenile Spondyloarthropathy Patients. Diagnostics (Basel). 2025 Jun 12;15(12):1498. doi: 10.3390/diagnostics15121498. PMID: 40564817; PMCID: PMC12191953.

#49 2024 Paediatr Drugs

Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update

Unal D, Cam V, Emreol HE, Özen S. Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update. Paediatr Drugs. 2024 Jul;26(4):381-395. doi: 10.1007/s40272-024-00632-y. Epub 2024 May 28. PMID: 38805115.

#50 2024 Rheumatology (Oxford)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy

Ulu K, Aliyev E, Kılıç Könte E, Tanatar A, Türkmen Ş, Doğantan Ş, Kızıldağ Z, Kasap Demir B, Gezgin Yıldırım D, Otar Yener G, Öztürk K, Baba Ö, Açarı C, Kılbaş G, Taşkın SN, Haşlak F, Çağlayan Ş, Bağlan E, Dundar HA, Başaran Ö, Barut K, Karadağ ŞG, Coşkuner T, Sönmez HE, Yüksel S, Kalyoncu M, Bakkaloğlu SA, Ünsal E, Paç Kısaarslan A, Bilginer Y, Aktay Ayaz N, Kasapçopur Ö, Özen S, Sözeri B. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy. Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI167-SI172. doi: 10.1093/rheumatology/keae124. PMID: 38441301.

#51 2023 Turk J Pediatr

Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study

Türkuçar S, Kaya ÜA, Çakmak F, Haşlak F, Demir F, Karabulut E, Makay B, Bilginer Y, Ayaz NA, Sözeri B, Kasapçopur Ö, Karagöz T, Ünal N, Özen S, Ünsal E. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. Turk J Pediatr. 2023;65(1):64-72. doi: 10.24953/turkjped.2021.1132. PMID: 36866986.

#52 2023 2023 Feb;58(2):627-628

Immunoglobulin A vasculitis in a child: Secondary to COVID-19 or cystic fibrosis? Pediatr Pulmonol

Turker E, Sener S, Guzelkas I, Emiralioglu N, Basaran O, Ozsurekci Y, Ozen S. Immunoglobulin A vasculitis in a child: Secondary to COVID-19 or cystic fibrosis? Pediatr Pulmonol. 2023 Feb;58(2):627-628. doi: 10.1002/ppul.26233. Epub 2022 Dec 20. PMID: 36349411; PMCID: PMC9877689.

#53 2025 Rheumatology (Oxford)

Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal

Tunce E, Atamyıldız Uçar S, Polat MC, Altuğ Gücenmez Ö, Çakan M, Bozkaya Yücel B, Arslanoğlu Aydın E, Doğan Kuzuca T, Kılıç Könte E, Demirhan S, Küçük E, Arık SD, Vatansever G, Özkaya O, Tekcan D, Nalçacıoğlu H, Tanatar A, Karakaş HD, Açarı C, Doğantan Ş, Şener S, Kışla Ekinci RM, Garipçin P, Ercan Emreol H, Kurt T, Adıgüzel Dündar H, Girgeç A, Arif Tutuş A, Köker O, Cevizbaş S, Kutlar Tanıdır M, Tığrak SN, Sezer M, Kazanasmaz H, Öksel B, Taşkın RB, Gümüşsoy Ay E, Coşkuner T, Özomay Baykal G, Yiğit RE, Türkmen Ş, Ulu K, Taşkın SN, Otar Yener G, Demir F, Kilic SS, Gürgöze MK, Aksu G, Sönmez HE, Türkuçar S, Kalyoncu M, Bakkaloğlu S, Özkayın N, Kasap Demir B, Ünsal E, Yüksel S, Balat A, Bilginer Y, Paç Kısaarslan A, Dönmez O, Aktay Ayaz N, Öztürk K, Demir S, Bağlan E, Çelikel E, Kasapçopur Ö, Özen S, Sözeri B. Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal. Rheumatology (Oxford). 2025 Aug 1;64(8):4816-4824. doi: 10.1093/rheumatology/keaf221. PMID: 40257440.

#54 2023 Int Immunopharmacol

Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients

Tümerdem BŞ, Akbaba TH, Batu ED, Akkaya-Ulum YZ, Mutlu P, Ozen S, Balci- Peynircioğlu B. Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients. Int Immunopharmacol. 2023 Nov;124(Pt B):111011. doi: 10.1016/j.intimp.2023.111011. Epub 2023 Oct 14. PMID: 37844462.

#55 2026 Clin J Am Soc Nephrol

Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors

Trivioli G, Allinovi M, Di Marcantonio E, Jawa NA, Trivelli A, Yang J, Grenda R, Rubik J, Mohammad AJ, Testa S, Jahnukainen T, Gulhan B, Topaloglu R, Puéchal X, Kosałka-Węgiel J, Dursun I, Guzzo I, Pasini A, Kostik MM, Oni L, Buti E, Becherucci F, Palazzini G, Moroni G, Ozen S, Laurent A, Harambat J, Dossier C, Marks SD, Bruchfeld A, Lugli G, Bettiol A, Emmi G, Romagnani P, Saleem MA, Ware N, Zhou J, Teoh CW, Ghiggeri GM, Noone D, Vaglio A; CIBREO study group. Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors. Clin J Am Soc Nephrol. 2026 Mar 1;21(3):480-493. doi: 10.2215/CJN.0000000936. Epub 2026 Jan 8. PMID: 41505217; PMCID: PMC12959740.

#56 2007 Arthritis Rheum

Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever

Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalçinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnère D, Michelon C, Séguret F, Gershoni-Baruch R; International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007 May;56(5):1706-12. doi: 10.1002/art.22507. PMID: 17469185.

#57 2003 Blood

Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever

Touitou I, Ben-Chetrit E, Gershoni-Baruch R, Grateau G, Kastner DL, Kone- Paut I, Livneh A, Manna R, Mansour I, Ozdogan H, Ozen S, Sarkisian T, Tunca M, Yalcinkaya F. Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever. Blood. 2003 Jul 1;102(1):409. doi: 10.1182/blood-2003-04-1105. PMID: 12814918.

#58 2012 Ann Rheum Dis

An international registry on autoinflammatory diseases: the Eurofever experience

Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Koné-Paut I, De Benedetti F, Neven B, Hofer M, Dolezalova P, Kümmerle-Deschner J, Touitou I, Hentgen V, Simon A, Girschick H, Rose C, Wouters C, Vesely R, Arostegui J, Stojanov S, Ozgodan H, Martini A, Ruperto N, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO), Eurotraps and Eurofever Projects. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012 Jul;71(7):1177-82. doi: 10.1136/annrheumdis-2011-200549. Epub 2012 Feb 29. PMID: 22377804.

#59 2018 Int J Rheum Dis

Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease

Topaloglu R, Batu ED, Yıldız Ç, Korkmaz E, Özen S, Beşbaş N, Özaltın F. Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease. Int J Rheum Dis. 2018 Oct;21(10):1857-1862. doi: 10.1111/1756-185X.12929. Epub 2016 Jul 26. PMID: 27457448.

#60 2016 Pediatr Nephrol

Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases

Topaloglu R, Batu ED, Orhan D, Ozen S, Besbas N. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases. Pediatr Nephrol. 2016 Apr;31(4):633-40. doi: 10.1007/s00467-015-3249-5. Epub 2015 Nov 12. PMID: 26563115.

#61 2010 Turk J Pediatr

Neuroendocrine immune system in familial Mediterranean fever

Topaloğlu R, Bilginer Y, Alikaşifoğlu A, Ozaltin F, Beşbaş N, Ozen S, Bakkaloğlu A. Neuroendocrine immune system in familial Mediterranean fever. Turk J Pediatr. 2010 Nov-Dec;52(6):588-93. PMID: 21428190.

#62 2010 Pediatr Nephrol

Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children

Topaloglu R, Er I, Dogan BG, Bilginer Y, Ozaltin F, Besbas N, Ozen S, Bakkaloglu A, Gur D. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol. 2010 May;25(5):919-25. doi: 10.1007/s00467-009-1431-3. Epub 2010 Feb 12. PMID: 20151161.

#63 2013 Ann Rheum Dis

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

Ter Haar N, Lachmann H, Özen S, Woo P, Uziel Y, Modesto C, Koné-Paut I, Cantarini L, Insalaco A, Neven B, Hofer M, Rigante D, Al-Mayouf S, Touitou I, Gallizzi R, Papadopoulou-Alataki E, Martino S, Kuemmerle-Deschner J, Obici L, Iagaru N, Simon A, Nielsen S, Martini A, Ruperto N, Gattorno M, Frenkel J; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013 May;72(5):678-85. doi: 10.1136/annrheumdis-2011-201268. Epub 2012 Jun 29. PMID: 22753383.

#64 2018 Ann Rheum Dis

In silico validation of the Autoinflammatory Disease Damage Index

Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M, Frenkel J. In silico validation of the Autoinflammatory Disease Damage Index. Ann Rheum Dis. 2018 Nov;77(11):1599-1605. doi: 10.1136/annrheumdis-2018-213725. Epub 2018 Aug 4. PMID: 30077992; PMCID: PMC8411437.

#65 2017 Ann Rheum Dis

Development of the autoinflammatory disease damage index (ADDI)

Ter Haar NM, Annink KV, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler SM, Brogan PA, Cantarini L, Cattalini M, Cochino AV, De Benedetti F, Dedeoglu F, De Jesus AA, Della Casa Alberighi O, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Koné-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Ozen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Gattorno M, Frenkel J. Development of the autoinflammatory disease damage index (ADDI). Ann Rheum Dis. 2017 May;76(5):821-830. doi: 10.1136/annrheumdis-2016-210092. Epub 2016 Nov 3. PMID: 27811147.

#66 2015 Ann Rheum Dis

Recommendations for the management of autoinflammatory diseases

ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, Cantarini L, Galeotti C, Grateau G, Hentgen V, Hofer M, Kallinich T, Kone-Paut I, Lachmann HJ, Ozdogan H, Ozen S, Russo R, Simon A, Uziel Y, Wouters C, Feldman BM, Vastert SJ, Wulffraat NM, Benseler SM, Frenkel J, Gattorno M, Kuemmerle- Deschner JB. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015 Sep;74(9):1636-44. doi: 10.1136/annrheumdis-2015-207546. Epub 2015 Jun 24. PMID: 26109736.

#67 2024 Front Immunol

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

Temizoz B, Shibahara T, Hioki K, Hayashi T, Kobiyama K, Lee MSJ, Surucu N, Sag E, Kumanogoh A, Yamamoto M, Gursel M, Ozen S, Kuroda E, Coban C, Ishii KJ. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation. Front Immunol. 2024 Mar 12;15:1353336. doi: 10.3389/fimmu.2024.1353336. PMID: 38533502; PMCID: PMC10963404.

#68 2024 Nucleosides Nucleotides Nucleic Acids

Characterization of serum extracellular vesicles and their differential level of miR-197-3p in familial Mediterranean fever patients

Tavukcuoglu Z, Akkaya-Ulum YZ, Yersal N, Horzum U, Akbaba TH, Karadag O, Esendagli G, Korkusuz P, Ozen S, Balci-Peynircioglu B. Characterization of serum extracellular vesicles and their differential level of miR-197-3p in familial Mediterranean fever patients. Nucleosides Nucleotides Nucleic Acids. 2024;43(6):557-571. doi: 10.1080/15257770.2023.2283187. Epub 2023 Dec 2. PMID: 38041620.

#69 2025 Klin Padiatr

Renal Artery Involvement in Pediatric-Onset Takayasu Arteritis: Renal Characteristics and Mid-Term Follow-up Outcomes

Tastemel Ozturk T, Baltu D, Kurt-Sukur ED, Gulhan B, Bilginer Y, Ozen S, Oguz B, Volkan Salanci B, Duzova A, Ozaltin F, Topaloglu R. Renal Artery Involvement in Pediatric-Onset Takayasu Arteritis: Renal Characteristics and Mid-Term Follow-up Outcomes. Klin Padiatr. 2025 Aug 21. English. doi: 10.1055/a-2568-6472. Epub ahead of print. PMID: 40840498.

#70 2024 Pediatr Nephrol

Acute kidney injury in children with moderate-severe COVID-19 and multisystem inflammatory syndrome in children: a referral center experience

Tastemel Ozturk T, Düzova A, Oygar PD, Baltu D, Ozcilingir Hakverdi P, Lacinel Gurlevik S, Kurt-Sukur ED, Aykan HH, Ozen S, Ertugrul I, Kesici S, Gulhan B, Ozaltin F, Ozsurekci Y, Cengiz AB, Topaloglu R. Acute kidney injury in children with moderate-severe COVID-19 and multisystem inflammatory syndrome in children: a referral center experience. Pediatr Nephrol. 2024 Mar;39(3):867-877. doi: 10.1007/s00467-023-06125-3. Epub 2023 Sep 7. PMID: 37676500.

#71 2019 J Clin Immunol

A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet's Disease

Taskiran EZ, Sonmez HE, Kosukcu C, Tavukcuoglu E, Yazici G, Esendagli G, Batu ED, Kiper POS, Bilginer Y, Alikasifoglu M, Ozen S. A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet's Disease. J Clin Immunol. 2019 Jan;39(1):99-105. doi: 10.1007/s10875-018-0587-7. Epub 2019 Jan 8. PMID: 30617623.

#72 2018 Clin Immunol

Hypomorphic RAG1 defect in a child presented with pulmonary hemorrhage and digital necrosis

Taşkıran EZ, Sönmez HE, Ayvaz DÇ, Koşukcu C, Batu ED, Esenboğa S, Topaloğlu R, Orhan D, Bilginer Y, Alikaşifoğlu M, Özen S, Tezcan İ. Hypomorphic RAG1 defect in a child presented with pulmonary hemorrhage and digital necrosis. Clin Immunol. 2018 Feb;187:92-94. doi: 10.1016/j.clim.2017.10.010. Epub 2017 Nov 7. PMID: 29107076.

#73 2021 Sci Adv

Deubiquitination of proteasome subunits by OTULIN regulates type I IFN production

Tao P, Wang S, Ozen S, Lee PY, Zhang J, Wang J, Han H, Yang Z, Fang R, Tsai WL, Yang H, Sag E, Topaloglu R, Aksentijevich I, Yu X, Zhou Q. Deubiquitination of proteasome subunits by OTULIN regulates type I IFN production. Sci Adv. 2021 Nov 19;7(47):eabi6794. doi: 10.1126/sciadv.abi6794. Epub 2021 Nov 19. PMID: 34797715; PMCID: PMC8604410.

#74 2021 Cell

Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death

Taft J, Markson M, Legarda D, Patel R, Chan M, Malle L, Richardson A, Gruber C, Martín-Fernández M, Mancini GMS, van Laar JAM, van Pelt P, Buta S, Wokke BHA, Sabli IKD, Sancho-Shimizu V, Chavan PP, Schnappauf O, Khubchandani R, Cüceoğlu MK, Özen S, Kastner DL, Ting AT, Aksentijevich I, Hollink IHIM, Bogunovic D. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell. 2021 Aug 19;184(17):4447-4463.e20. doi: 10.1016/j.cell.2021.07.026. Epub 2021 Aug 6. PMID: 34363755; PMCID: PMC8380741.

#75 2022 Science

Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin

Spaan AN, Neehus AL, Laplantine E, Staels F, Ogishi M, Seeleuthner Y, Rapaport F, Lacey KA, Van Nieuwenhove E, Chrabieh M, Hum D, Migaud M, Izmiryan A, Lorenzo L, Kochetkov T, Heesterbeek DAC, Bardoel BW, DuMont AL, Dobbs K, Chardonnet S, Heissel S, Baslan T, Zhang P, Yang R, Bogunovic D, Wunderink HF, Haas PA, Molina H, Van Buggenhout G, Lyonnet S, Notarangelo LD, Seppänen MRJ, Weil R, Seminario G, Gomez-Tello H, Wouters C, Mesdaghi M, Shahrooei M, Bossuyt X, Sag E, Topaloglu R, Ozen S, Leavis HL, van Eijk MMJ, Bezrodnik L, Blancas Galicia L, Hovnanian A, Nassif A, Bader-Meunier B, Neven B, Meyts I, Schrijvers R, Puel A, Bustamante J, Aksentijevich I, Kastner DL, Torres VJ, Humblet-Baron S, Liston A, Abel L, Boisson B, Casanova JL. Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin. Science. 2022 Jun 17;376(6599):eabm6380. doi: 10.1126/science.abm6380. Epub 2022 Jun 17. PMID: 35587511; PMCID: PMC9233084.

#76 2024 Pediatr Rheumatol Online J

Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

Sözeri B, Şahin N, Açarı C, Avar Aydın PO, Baba O, Bağlan E, Bakkaloğlu S, Bakırcı S, Bilginer Y, Bozkaya BY, Çağlayan Ş, Çakan M, Çakmak F, Coşkuner T, Demir F, Demirkan FG, Doğantan Ş, Adıgüzel Dündar H, Ersözlü ED, Gücenmez S, Gürler O, İşgüder R, Küçük A, Kalyoncu M, Kılıç L, Kılıç SŞ, Kısaoğlu H, Paç Kısaarslan A, Kızıldağ Z, Kurtuluş D, Özdel S, Öztürk K, Şenol P, Tanatar A, Taşkın SN, Tuncer Kuru F, Türkuçar S, Ulu K, Ünsal E, Yazıcı A, Gezgin Yıldırım D, Yüksel S, Kasapçopur Ö, Özen S, Aktay Ayaz N, Sönmez HE. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study. Pediatr Rheumatol Online J. 2024 Jan 2;22(1):7. doi: 10.1186/s12969-023-00943-3. PMID: 38167070; PMCID: PMC10762787.

#77 2024 Clin Exp Rheumatol

Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study

Sozeri B, Demir F, Barut K, Atalay E, Pac Kisaarslan A, Özdel S, Altuğ Gücenmez Ö, Makay B, Aktay Ayaz N, Haşlak F, Sağ E, Yıldız M, Kaya Akça Ü, Adroviç A, Bilginer Y, Poyrazoğlu H, Ünsal E, Kasapçopur Ö, Özen S. Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study. Clin Exp Rheumatol. 2024 Jan;42(1):194-201. doi: 10.55563/clinexprheumatol/j611kr. Epub 2023 Jul 24. PMID: 37497697.

#78 2022 Rheumatol Int

The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

Sozeri B, Ulu K, Kaya-Akça U, Haslak F, Pac-Kisaarslan A, Otar-Yener G, Baba O, Altug-Gucenmez O, Sahin N, Bağlan E, Sönmez HE, Cakmak F, Ozturk K, Gezgin- Yıldırım D, Şener S, Barut K, Batu ED, Yıldız M, Basaran O, Adrovic A, Sahin S, Ozdel S, Bilginer Y, Poyrazoglu MH, Demir F, Yuksel S, Kalyoncu M, Kasapcopur O, Ozen S, Aktay-Ayaz N. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study. Rheumatol Int. 2022 Mar;42(3):469-475. doi: 10.1007/s00296-021-05008-w. Epub 2021 Sep 27. PMID: 34570263; PMCID: PMC8475421.

#79 2019 Pediatr Allergy Immunol

Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases

Soyer O, Demir S, Bilginer Y, Batu ED, Sonmez HE, Arıcı ZS, Şahiner ÜM, Sekerel BE, Ozen S. Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases. Pediatr Allergy Immunol. 2019 Dec;30(8):833-840. doi: 10.1111/pai.13114. Epub 2019 Sep 8. PMID: 31419311.

#80 2026 Ophthalmol Ther

Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis Registry

Sota J, Hinojosa-Azaola A, de-la-Torre A, Giardini HAM, Guerriero S, Kawakami-Campos PA, Martín-Nares E, Guaracha-Basañez GA, Ragab G, Chimenti MS, Lopalco G, Hissaria P, Cattalini M, Ruscitti P, Tharwat S, Ruiz-Irastorza G, García-Madero JJ, Tierradentro-Alape R, Hegazy MT, Afifi K, Emmi G, Parronchi P, Paroli MP, Hernández-Rodríguez J, Sainz-de-la-Maza M, Caggiano V, Sbalchiero J, Bugatti S, Gaggiano C, Breda L, Dammacco R, Monosi B, Capodiferro M, Beecher M, Olivieri AN, Batu ED, Ozen S, Frediani B, Thabet M, Balistreri A, Gupta V, Fonollosa A, Vitale A, Cantarini L, Fabiani C; Study Group of Systemic Autoinflammatory Disease of SIR (Italian Society of Rheumatology). Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis Registry. Ophthalmol Ther. 2026 Jun;15(6):2081-2093. doi: 10.1007/s40123-026-01390-5. Epub 2026 May 9. PMID: 42105127; PMCID: PMC13250021.

#81 2025 Joint Bone Spine

Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry

Sota J, Ragab G, AlMaglouth I, Lopalco G, Tufan A, Direskeneli H, Hinojosa- Azaola A, Mayrink Giardini HA, Guerriero S, Triggianese P, Sfikakis PP, Piga M, Ruscitti P, Govoni M, Iagnocco A, Carubbi F, Hernández-Rodríguez J, Laymouna AH, Mahmoud AAA, Ghanema M, Aboabat AA, Asfina KN, Alanazi F, Morrone M, Spedicato V, Kucuk H, Kardas R, Alibaz Öner F, Sevik G, Torres-Ruiz J, Kawakami-Campos PA, Parente de Brito Antonelli I, Dammacco R, Chimenti MS, Arida K, Floris A, Gentile M, Ruffilli F, Bellis E, Alunno A, Espinosa G, Gentileschi S, Gaggiano C, Vitale A, Caggiano V, Lopez R, Tarsia M, Monti S, Hatemi G, Karakoç A, Frassi M, Giacomelli R, Tharwat S, Thabet M, Ciccia F, Emmi G, Viapiana O, Şahin A, Sebastiani GD, Batu ED, Ozen S, Sener S, Opris-Belinski D, Costi S, Conforti A, Cattalini M, Bartoloni E, Akkoç N, Gunduz OS, Conti G, Maier A, Giardina A, Li Gobbi F, Parronchi P, Sarzi Puttini P, Breda L, De Paulis A, Carreño E, La Torre F, Więsik-Scewczyk E, de-la Torre A, Mejía-Salgado G, Shahram F, Guiducci S, Maggio MC, Aragona E, Rigante D, Ciavarro A, Önen F, Erten Ş, Insalaco A, Del Giudice E, Barone P, Gicchino F, Brucato A, Lo Gullo A, Mauro A, Karamanakos A, Balistreri A, Mazzei MA, Frediani B, Fabiani C, Cantarini L. Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry. Joint Bone Spine. 2025 Mar;92(2):105819. doi: 10.1016/j.jbspin.2024.105819. Epub 2024 Nov 15. PMID: 39549971.

#82 2025 Ocul Immunol Inflamm

Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

Sota J, Guerriero S, Lopalco G, Tufan A, Ragab G, AlMaglouth I, Govoni M, Sfikakis PP, Frassi M, Vitale A, Kardas RC, Triggianese P, Chimenti MS, Aboabat AA, Piga M, Monti S, Sebastiani GD, Yildirim D, Conforti A, Gentileschi S, Dammacco R, Hinojosa-Azaola A, Kawakami-Campos PA, Ruffilli F, Torres-Ruiz J, Thabet M, Atig A, Ruscitti P, Cataldi G, Viapiana O, Hatemi G, Karakoç A, Costi S, Iagnocco A, Crisafulli F, Fragoulis G, Del Giudice E, Hegazy MT, Paroli MP, Şahin A, Morrone M, Iannone F, Opris-Belinski D, Asfina KN, Barone P, Gaggiano C, Kucuk H, Gicchino MF, Carubbi F, Caggiano V, Laskari K, Tharwat S, Direskeneli H, Alibaz-Oner F, Sevik G, Maier A, Laymouna AH, Emmi G, Akkoç N, Tarsia M, Sbalchiero J, Conti G, Spinella R, La Torre F, Tombetti E, Amin RH, Mauro A, Karamanakos A, Carreño E, Fonollosa A, Cattalini M, Breda L, de-la- Torre A, Wiesik-Szewczyk E, Cifuentes-González C, Ozen S, Mazzei MA, Tosi GM, Frediani B, Balistreri A, Batu ED, Gupta V, Cantarini L, Fabiani C. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders. Ocul Immunol Inflamm. 2025 Jan;33(1):48-55. doi: 10.1080/09273948.2024.2346815. Epub 2024 May 17. PMID: 38759215.

#83 2024 Lupus

Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study

Sönmez HE, Batu ED, İşgüder R, Şahin N, Aliyev E, Aslan E, Çoban S, Güngörer V, Karadağ ŞG, Karaçayır N, Kısaoğlu H, Yekedüz Bülbül A, Garip S, Karalı Y, Ayduran S, Demir S, Kaya Akça Ü, Başaran Ö, Şahin S, Kasap B, Kilic SS, Kışla Ekinci RM, Kısaarslan AP, Kalyoncu M, Bakkaloğlu S, Yüksel S, Aktay Ayaz N, Çelikel Acar B, Sözeri B, Kasapçopur Ö, Ünsal E, Özen S. Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study. Lupus. 2024 Oct;33(12):1358-1364. doi: 10.1177/09612033241279071. Epub 2024 Aug 26. PMID: 39186467.

#84 2020 Pediatr Res

A clinical score to guide in decision making for monogenic type I IFNopathies

Sönmez HE, Karaaslan C, de Jesus AA, Batu ED, Anlar B, Sözeri B, Bilginer Y, Karaguzel D, Cagdas Ayvaz D, Tezcan I, Goldbach-Mansky R, Ozen S. A clinical score to guide in decision making for monogenic type I IFNopathies. Pediatr Res. 2020 Mar;87(4):745-752. doi: 10.1038/s41390-019-0614-2. Epub 2019 Oct 22. PMID: 31641281; PMCID: PMC8425764.

#85 2019 Clin Exp Rheumatol

Polyarteritis nodosa: lessons from 25 years of experience

Sönmez HE, Armağan B, Ayan G, Barut K, Batu ED, Erden A, Uğurlu S, Bilginer Y, Kasapçopur Ö, Karadağ Ö, Bilgen SA, Özdoğan H, Ozen S. Polyarteritis nodosa: lessons from 25 years of experience. Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):52-56. Epub 2018 Oct 30. PMID: 30418125.

#86 2018 2018 Nov;26(11):1563-1565

Genetic testing for DADA2: How can we avoid missing patients? Eur J Hum Genet

Sönmez HE, Batu ED, Taşkıran EZ, Alikaşifoğlu M, Bilginer Y, Özen S. Genetic testing for DADA2: How can we avoid missing patients? Eur J Hum Genet. 2018 Nov;26(11):1563-1565. doi: 10.1038/s41431-018-0240-1. Epub 2018 Sep 11. PMID: 30206352; PMCID: PMC6189089.

#87 2019 2019 Jan;39(1):83-87

Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever? Rheumatol Int

Sönmez HE, Esmeray P, Batu ED, Arıcı ZS, Demir S, Sağ E, Özen S, Bilginer Y. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever? Rheumatol Int. 2019 Jan;39(1):83-87. doi: 10.1007/s00296-018-4123-0. Epub 2018 Aug 7. PMID: 30088045.

#88 2018 Clin Rheumatol

Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature

Sönmez HE, Demir S, Bilginer Y, Özen S. Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol. 2018 Dec;37(12):3329-3335. doi: 10.1007/s10067-018-4095-1. Epub 2018 Apr 16. PMID: 29663156.

#89 2017 Clin Exp Rheumatol

Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy

Sönmez HE, Batu ED, Demir S, Bilginer Y, Özen S. Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):124-127. Epub 2017 Sep 26. PMID: 28980897.

#90 2017 Int Immunol

A clinical update on inflammasomopathies

Sönmez HE, Özen S. A clinical update on inflammasomopathies. Int Immunol. 2017 Nov 1;29(9):393-400. doi: 10.1093/intimm/dxx020. PMID: 28387826.

#91 2017 Clin Rheumatol

Gastrointestinal system manifestations in juvenile systemic lupus erythematosus

Sönmez HE, Karhan AN, Batu ED, Bilginer Y, Gümüş E, Demir H, Yüce A, Özen S. Gastrointestinal system manifestations in juvenile systemic lupus erythematosus. Clin Rheumatol. 2017 Jul;36(7):1521-1526. doi: 10.1007/s10067-017-3571-3. Epub 2017 Feb 16. PMID: 28204893.

#92 2017 Clin Rheumatol

Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants

Sönmez HE, Batu ED, Bilginer Y, Özen S. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants. Clin Rheumatol. 2017 Feb;36(2):421-425. doi: 10.1007/s10067-016-3421-8. Epub 2016 Sep 27. PMID: 27679472.

#93 2016 J Inflamm Res

Familial Mediterranean fever: current perspectives

Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res. 2016 Mar 17;9:13-20. doi: 10.2147/JIR.S91352. PMID: 27051312; PMCID: PMC4803250.

#94 2007 Turk J Pediatr

Septated pericarditis associated with Kawasaki disease: a brief case report

Sonçaği A, Devrim I, Karagöz T, Dilber E, Celiker A, Ozen S, Seçmeer G. Septated pericarditis associated with Kawasaki disease: a brief case report. Turk J Pediatr. 2007 Jul-Sep;49(3):312-4. PMID: 17990588.

#95 2023 Ann Rheum Dis

Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force

Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, Burnham J, Ciurtin C, Hedrich CM, Kamphuis S, Levy DM, Lewandowski LB, Maxwell N, Morand EF, Ozen S, Pain CE, Ravelli A, Saad Magalhaes C, Pilkington CA, Schonenberg- Meinema D, Scott C, Tullus K, Beresford MW; cSLE T2T International Task Force. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. Ann Rheum Dis. 2023 Jun;82(6):788-798. doi: 10.1136/ard-2022-223328. Epub 2023 Jan 10. PMID: 36627168; PMCID: PMC10314055.

#96 2023 Dig Dis Sci

Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children

Şimşek-Onat P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, Özen H, Demir H, Özen S, Saltık-Temizel İN. Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children. Dig Dis Sci. 2023 Jan;68(1):233-239. doi: 10.1007/s10620-022-07547-z. Epub 2022 May 17. PMID: 35579794.

#97 2020 Clin Chem

ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era

Shinar Y, Ceccherini I, Rowczenio D, Aksentijevich I, Arostegui J, Ben- Chétrit E, Boursier G, Gattorno M, Hayrapetyan H, Ida H, Kanazawa N, Lachmann HJ, Mensa-Vilaro A, Nishikomori R, Oberkanins C, Obici L, Ohara O, Ozen S, Sarkisian T, Sheils K, Wolstenholme N, Zonneveld-Huijssoon E, van Gijn ME, Touitou I. ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era. Clin Chem. 2020 Apr 1;66(4):525-536. doi: 10.1093/clinchem/hvaa024. PMID: 32176780.

#98 2025 J Autoimmun

Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides

Shibahara T, Temizoz B, Egashira S, Hosomi K, Park J, Surucu N, Björk A, Sag E, Doi T, Kisla Ekinci RM, Balci S, Versnel MA, Kunisawa J, Yamamoto M, Hayashi T, Ito S, Kamiyama Y, Kobiyama K, Katsikis PD, Coban C, Gursel M, Ozen S, Nishida S, Kumanogoh A, Ishii KJ. Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides. J Autoimmun. 2025 Jun;154:103434. doi: 10.1016/j.jaut.2025.103434. Epub 2025 May 6. PMID: 40334619.

#99 2023 Semin Arthritis Rheum

Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study

Sestan M, Kifer N, Sozeri B, Demir F, Ulu K, Silva CA, Campos RT, Batu ED, Koker O, Sapina M, Srsen S, Held M, Gagro A, Fonseca AR, Rodrigues M, Rigante D, Filocamo G, Baldo F, Heshin-Bekenstein M, Giani T, Kataja J, Frkovic M, Ruperto N, Ozen S, Jelusic M; Vasculitis Working Party of the Pediatric Rheumatology European Society (PReS). Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study. Semin Arthritis Rheum. 2023 Aug;61:152209. doi: 10.1016/j.semarthrit.2023.152209. Epub 2023 Apr 26. PMID: 37126983.

#100 2025 Turk J Med Sci

Evaluation of rheumatic causes underlying childhood-onset arthritis

Şener S, Atalay E, Batu ED, Tatar CA, Başaran Ö, Bilginer Y, Özen S. Evaluation of rheumatic causes underlying childhood-onset arthritis. Turk J Med Sci. 2025 Jun 14;55(4):826-836. doi: 10.55730/1300-0144.6034. PMID: 40933983; PMCID: PMC12419053.

#101 2025 Turk Arch Pediatr

Subclinical Enthesitis in Children with Chronic Nonbacterial Osteomyelitis

Sener S, Yildiz AE, Batu ED, Atalay E, Basaran O, Bilginer Y, Ozen S. Subclinical Enthesitis in Children with Chronic Nonbacterial Osteomyelitis. Turk Arch Pediatr. 2025 May 2;60(2):289-293. doi: 10.5152/TurkArchPediatr.2025.24300. PMID: 40353601; PMCID: PMC12093391.

#102 2025 Turk J Pediatr

Treatment of systemic juvenile idiopathic arthritis: conventional treatment versus biologics

Şener S, Batu ED, Başaran Ö, Balık Z, Aliyev E, Bayındır Y, Çam V, Bilginer Y, Özen S. Treatment of systemic juvenile idiopathic arthritis: conventional treatment versus biologics. Turk J Pediatr. 2025 Feb 27;67(1):61-68. doi: 10.24953/turkjpediatr.2025.5482. PMID: 40084723.

#103 2025 Mod Rheumatol

Antinuclear antibodies staining patterns and titres in juvenile idiopathic arthritis

Sener S, Batu ED, Aliyev E, Basaran O, Saribas Z, Bilginer Y, Sener B, Ozen S. Antinuclear antibodies staining patterns and titres in juvenile idiopathic arthritis. Mod Rheumatol. 2025 Jul 5;35(4):762-766. doi: 10.1093/mr/roaf011. PMID: 39901832.

#104 2025 Int J Rheum Dis

Differences and Similarities Between Children and Adults With Rhupus Syndrome

Sener S, Unal D, Batu ED, Kart Bayram GS, Firlatan B, Kilic L, Sahin S, Gezgin Yildirim D, Kisla Ekinci M, Kisaoglu H, Karali Y, Demir S, Kaya Akca U, Gunalp A, Turkmen S, Kavrul Kayaalp G, Arslanoglu C, Torun R, Ercan Emreol H, Basaran O, Pac Kisaarslan A, Sozeri B, Aktay Ayaz N, Bakkaloglu SA, Kilic SS, Kalyoncu M, Bilginer Y, Unsal E, Kasapcopur O, Apras Bilgen S, Ozen S. Differences and Similarities Between Children and Adults With Rhupus Syndrome. Int J Rheum Dis. 2025 Jan;28(1):e70082. doi: 10.1111/1756-185X.70082. PMID: 39835506.

#105 2024 Turk J Med Sci

Transition of patients with systemic lupus erythematosus from pediatric to adult-oriented rheumatology care

Şener S, Yardimci GK, Batu ED, Kiliç L, Akça ÜK, Cüceoğlu MK, Balik Z, Başaran Ö, Bilginer Y, Apraş Bilgen Ş, Özen S. Transition of patients with systemic lupus erythematosus from pediatric to adult-oriented rheumatology care. Turk J Med Sci. 2024 Nov 5;54(6):1198-1204. doi: 10.55730/1300-0144.5900. PMID: 39734331; PMCID: PMC11673664.

#106 2024 Expert Rev Cardiovasc Ther

Evaluation of cardiac function using echocardiography in childhood-onset systemic lupus erythematosus patients treated with hydroxychloroquine

Sener S, Sener YZ, Batu ED, Ertugrul I, Basaran O, Bilginer Y, Karagoz T, Ozen S. Evaluation of cardiac function using echocardiography in childhood-onset systemic lupus erythematosus patients treated with hydroxychloroquine. Expert Rev Cardiovasc Ther. 2024 Dec 21:1-5. doi: 10.1080/14779072.2024.2445800. Epub ahead of print. PMID: 39699079.

#107 2025 Lupus

Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus

Sener S, Batu ED, Unal D, Basaran O, Saribas Z, Bilginer Y, Sener B, Ozen S. Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus. Lupus. 2025 Jan;34(1):71-78. doi: 10.1177/09612033241305198. Epub 2024 Nov 27. PMID: 39603714.

#108 2024 Lupus

Detection of genetic mutations underlying early-onset systemic lupus erythematosus

Sener S, Sag E, Han X, Bilginer Y, Zhou Q, Ozen S. Detection of genetic mutations underlying early-onset systemic lupus erythematosus. Lupus. 2024 Aug;33(9):998-1003. doi: 10.1177/09612033241255011. Epub 2024 May 13. PMID: 38739464.

#109 2024 Clin Rheumatol

Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis

Sener S, Aliyev E, Batu ED, Balik Z, Bayindir Y, Cam V, Basaran O, Bilginer Y, Ozen S. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis. Clin Rheumatol. 2024 Jun;43(6):2021-2026. doi: 10.1007/s10067-024-06925-4. Epub 2024 Apr 29. PMID: 38683443.

#110 2024 Turk Arch Pediatr

Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

Şener S, Batu ED, Kaya Akca Ü, Atalay E, Kasap Cüceoğlu M, Balık Z, Başaran Ö, Karagöz T, Özsürekçi Y, Bilginer Y, Özen S. Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic. Turk Arch Pediatr. 2024 Mar;59(2):150-156. doi: 10.5152/TurkArchPediatr.2024.23192. PMID: 38454223; PMCID: PMC11059258.

#111 2024 Semin Arthritis Rheum

Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature

Sener S, Cam V, Ozen S, Batu ED. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature. Semin Arthritis Rheum. 2024 Jun;66:152426. doi: 10.1016/j.semarthrit.2024.152426. Epub 2024 Mar 1. PMID: 38442462.

#112 2024 Lupus

Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

Sener S, Batu ED, Sahin S, Yildirim DG, Ekinci MK, Kisaoglu H, Karali Y, Demir S, Kaya Akca U, Gunalp A, Turkmen S, Kavrul Kayaalp G, Arslanoglu C, Torun R, Basaran O, Pac Kisaarslan A, Sozeri B, Aktay Ayaz N, Bakkaloglu SA, Kilic SS, Kalyoncu M, Bilginer Y, Unsal E, Kasapcopur O, Ozen S. Rhupus syndrome in children: A multi-center retrospective cohort study and literature review. Lupus. 2024 Mar;33(3):273-281. doi: 10.1177/09612033231226353. Epub 2024 Jan 16. PMID: 38226485.

#113 2023 Turk J Pediatr

Choice and switch of biologic drugs in juvenile idiopathic arthritis

Şener S, Başaran Ö, Batu ED, Cüceoğlu MK, Balık Z, Aliyev E, Bayındır Y, Bilginer Y, Özen S. Choice and switch of biologic drugs in juvenile idiopathic arthritis. Turk J Pediatr. 2023;65(6):980-989. doi: 10.24953/turkjped.2023.22. PMID: 38204313.

#114 2023 Turk Arch Pediatr

Comparison of Biopsychosocial Characteristics of Children with Juvenile Idiopathic Arthritis According to Common Disease Subtypes

Şener S, Karaca NB, Kaşlı K, Özçadırcı A, Batu ED, Başaran Ö, Bilginer Y, Özen S, Ünal E. Comparison of Biopsychosocial Characteristics of Children with Juvenile Idiopathic Arthritis According to Common Disease Subtypes. Turk Arch Pediatr. 2023 Nov;58(6):625-630. doi: 10.5152/TurkArchPediatr.2023.23087. PMID: 37850665; PMCID: PMC10724840.

#115 2024 Clin Rheumatol

Biologic drugs in the treatment of juvenile dermatomyositis: a literature review

Sener S, Cam V, Ozen S, Batu ED. Biologic drugs in the treatment of juvenile dermatomyositis: a literature review. Clin Rheumatol. 2024 Feb;43(2):591-602. doi: 10.1007/s10067-023-06740-3. Epub 2023 Aug 16. PMID: 37582998.

#116 2024 Mod Rheumatol

Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever

Sener S, Atalay E, Yildiz AE, Kasap Cuceoglu M, Basaran O, Batu ED, Bilginer Y, Ozen S. Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever. Mod Rheumatol. 2024 Mar 28;34(3):607-613. doi: 10.1093/mr/road053. PMID: 37267199.

#117 2023 Rheumatology (Oxford)

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

Sener S, Cam V, Batu ED, Kasap Cuceoglu M, Balik Z, Aliyev E, Bayindir Y, Basaran O, Bilginer Y, Ozen S. Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever. Rheumatology (Oxford). 2023 Nov 2;62(11):3700-3705. doi: 10.1093/rheumatology/kead128. PMID: 36961326; PMCID: PMC10629778.

#118 2023 J Neuromuscul Dis

A Child with Refractory and Relapsing Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Myopathy: Case-Based Review

Sener S, Batu ED, Sari S, Kasap Cuceoglu M, Yildiz AE, Talim B, Aydingoz U, Ozen S, Haliloglu G. A Child with Refractory and Relapsing Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Myopathy: Case-Based Review. J Neuromuscul Dis. 2023;10(2):279-291. doi: 10.3233/JND-221557. PMID: 36617789.

#119 2023 Semin Arthritis Rheum

Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature

Sener S, Basaran O, Batu ED, Sag E, Oz S, Talim B, Bilginer Y, Haliloglu G, Ozen S. Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature. Semin Arthritis Rheum. 2023 Feb;58:152133. doi: 10.1016/j.semarthrit.2022.152133. Epub 2022 Nov 19. PMID: 36434896.

#120 2022 Clin Rheumatol

Childhood-onset Takayasu arteritis and immunodeficiency: case-based review

Sener S, Basaran O, Batu ED, Atalay E, Esenboga S, Cagdas D, Kuskonmaz BB, Bilginer Y, Ozaltin F, Oguz B, Duzova A, Tezcan I, Ozen S. Childhood-onset Takayasu arteritis and immunodeficiency: case-based review. Clin Rheumatol. 2022 Sep;41(9):2883-2892. doi: 10.1007/s10067-022-06295-9. Epub 2022 Jul 20. PMID: 35854168.

#121 2023 Mod Rheumatol

Rice bodies in children with rheumatic disorders: A case series and systematic literature review

Sener S, Tanali G, Ergen FB, Kasap Cuceoglu M, Balik Z, Bayindir Y, Aliyev E, Basaran O, Bilginer Y, Ozen S, Batu ED. Rice bodies in children with rheumatic disorders: A case series and systematic literature review. Mod Rheumatol. 2023 Jul 4;33(4):811-816. doi: 10.1093/mr/roac075. PMID: 35819010.

#122 2022 Pediatr Pulmonol

Bradypnea in a child taking tumor necrosis factor-alpha inhibitors

Sener S, Basaran O, Bilginer Y, Kiper N, Ozen S. Bradypnea in a child taking tumor necrosis factor-alpha inhibitors. Pediatr Pulmonol. 2022 Sep;57(9):2267-2268. doi: 10.1002/ppul.25985. Epub 2022 May 25. PMID: 35604108.

#123 2022 Rheumatology (Oxford)

Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents

Sener S, Basaran O, Kaya Akca U, Atalay E, Kasap Cuceoglu M, Balik Z, Aliyev E, Bayindir Y, Batu ED, Hazirolan T, Bilginer Y, Ozen S. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents. Rheumatology (Oxford). 2022 Nov 28;61(12):4885-4891. doi: 10.1093/rheumatology/keac149. PMID: 35262635.

#124 2022 Mod Rheumatol

Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease

Sener S, Basaran O, Lacinel Gurlevik S, Kaya Akca U, Atalay E, Kasap Cuceoglu M, Balik Z, Batu ED, Bilginer Y, Ozsurekci Y, Ozen S. Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease. Mod Rheumatol. 2022 Oct 15;32(6):1108-1113. doi: 10.1093/mr/roab112. PMID: 34850910; PMCID: PMC8690254.

#125 2021 Curr Rheumatol Rep

Wind of Change in the Treatment of Childhood- Onset Takayasu Arteritis: a Systematic Review

Sener S, Basaran O, Ozen S. Wind of Change in the Treatment of Childhood- Onset Takayasu Arteritis: a Systematic Review. Curr Rheumatol Rep. 2021 Jul 3;23(8):68. doi: 10.1007/s11926-021-01032-8. PMID: 34218346.

#126 2004 Pediatr Dermatol

Fatal cytophagic histiocytic panniculitis

Seçmeer G, Sakalli H, Gök F, Ozen S, Kara A, Cengiz AB, Ceyhan M, Gürgey A, Gögüs S, Kanra G. Fatal cytophagic histiocytic panniculitis. Pediatr Dermatol. 2004 May-Jun;21(3):246-9. doi: 10.1111/j.0736-8046.2004.21312.x. PMID: 15165205.

#127 2025 Clin Exp Rheumatol

Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study

Satiş H, Gül A, Ayan G, Babaoğlu H, Armağan B, Erden A, Bilgin E, Karabulut E, Kiliç L, Tecer D, Sari A, Küçükşahin O, Uğurlu S, Kasapçopur Ö, Özen S, Ayvali MO, Fidanci AA, Ülgü MM, Ata N, Birinci Ş, Kalyoncu U. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study. Clin Exp Rheumatol. 2025 Oct;43(10):1709-1714. doi: 10.55563/clinexprheumatol/pzbg88. Epub 2025 Oct 1. PMID: 41031678.

#128 2018 Am J Ophthalmol

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series

Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series. Am J Ophthalmol. 2018 Mar;187:158-166. doi: 10.1016/j.ajo.2017.08.017. Epub 2017 Sep 6. PMID: 28887115.

#129 2024 J Allergy Clin Immunol Pract

Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses

Saper VE, Tian L, Verstegen RHJ, Conrad CK, Cidon M, Hopper RK, Kuo CS, Osoegawa K, Baszis K, Bingham CA, Ferguson I, Hahn T, Horne A, Isupova EA, Jones JT, Kasapcopur Ö, Klein-Gitelman MS, Kostik MM, Ozen S, Phadke O, Prahalad S, Randell RL, Sener S, Stingl C, Abdul-Aziz R, Akoghlanian S, Al Julandani D, Alvarez MB, Bader-Meunier B, Balay-Dustrude EE, Balboni I, Baxter SK, Berard RA, Bhattad S, Bolaria R, Boneparth A, Cassidy EA, Co DO, Collins KP, Dancey P, Dickinson AM, Edelheit BS, Espada G, Flanagan ER, Imundo LF, Jindal AK, Kim HA, Klaus G, Lake C, Lapin WB, Lawson EF, Marmor I, Mombourquette J, Ogunjimi B, Olveda R, Ombrello MJ, Onel K, Poholek C, Ramanan AV, Ravelli A, Reinhardt A, Robinson AD, Rouster-Stevens K, Saad N, Schneider R, Selmanovic V, Sefic Pasic I, Shenoi S, Shilo NR, Soep JB, Sura A, Taber SF, Tesher M, Tibaldi J, Torok KS, Tsin CM, Vasquez-Canizares N, Villacis Nunez DS, Way EE, Whitehead B, Zemel LS, Sharma S, Fernández-Viña MA, Mellins ED; CARRA Registry Investigators. Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2996-3013.e7. doi: 10.1016/j.jaip.2024.07.002. Epub 2024 Aug 15. PMID: 39002722; PMCID: PMC11560592.

#130 2022 Ann Rheum Dis

Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA- DRB1*15 alleles

Saper VE, Ombrello MJ, Tremoulet AH, Montero-Martin G, Prahalad S, Canna S, Shimizu C, Deutsch G, Tan SY, Remmers EF, Monos D, Hahn T, Phadke OK, Cassidy E, Ferguson I, Mallajosyula V, Xu J, Rosa Duque JS, Chua GT, Ghosh D, Szymanski AM, Rubin D, Burns JC, Tian L, Fernandez-Vina MA, Mellins ED, Hollenbach JA; Drug Hypersensitivity Consortium; INCHARGE Consortium. Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA- DRB1*15 alleles. Ann Rheum Dis. 2022 Mar;81(3):406-415. doi: 10.1136/annrheumdis-2021-220578. Epub 2021 Nov 17. PMID: 34789453; PMCID: PMC10564446.

#131 2019 Ann Rheum Dis

Emergent high fatality lung disease in systemic juvenile arthritis

Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, Canna S, Schulert G, Deterding R, Xu J, Leung AN, Bouzoubaa L, Abulaban K, Baszis K, Behrens EM, Birmingham J, Casey A, Cidon M, Cron RQ, De A, De Benedetti F, Ferguson I, Fishman MP, Goodman SI, Graham TB, Grom AA, Haines K, Hazen M, Henderson LA, Ho A, Ibarra M, Inman CJ, Jerath R, Khawaja K, Kingsbury DJ, Klein-Gitelman M, Lai K, Lapidus S, Lin C, Lin J, Liptzin DR, Milojevic D, Mombourquette J, Onel K, Ozen S, Perez M, Phillippi K, Prahalad S, Radhakrishna S, Reinhardt A, Riskalla M, Rosenwasser N, Roth J, Schneider R, Schonenberg- Meinema D, Shenoi S, Smith JA, Sönmez HE, Stoll ML, Towe C, Vargas SO, Vehe RK, Young LR, Yang J, Desai T, Balise R, Lu Y, Tian L, Bejerano G, Davis MM, Khatri P, Mellins ED; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019 Dec;78(12):1722-1731. doi: 10.1136/annrheumdis-2019-216040. Epub 2019 Sep 27. Erratum in: Ann Rheum Dis. 2022 Feb;81(2):e35. doi: 10.1136/annrheumdis-2019-216040corr1. PMID: 31562126; PMCID: PMC7065839.

#132 2018 J Clin Invest

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11. PMID: 29649002; PMCID: PMC6026004.

#133 2006 Curr Opin Rheumatol

Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever

Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol. 2006 Jan;18(1):108-17. doi: 10.1097/01.bor.0000198006.65697.5b. PMID: 16344627.

#134 2019 Int J Pediatr Otorhinolaryngol

Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack- free period

Salimov A, Akyol U, Cildir B, Batu ED, Ozen S. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack- free period. Int J Pediatr Otorhinolaryngol. 2019 Apr;119:185-192. doi: 10.1016/j.ijporl.2019.01.042. Epub 2019 Feb 1. PMID: 30743166.

#135 2021 Pediatr Rheumatol Online J

Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER

Sahin S, Acari C, Sonmez HE, Kilic FZ, Sag E, Dundar HA, Adrovic A, Demir S, Barut K, Bilginer Y, Sozeri B, Unsal E, Ozen S, Kasapcopur O. Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER. Pediatr Rheumatol Online J. 2021 Aug 23;19(1):134. doi: 10.1186/s12969-021-00613-2. PMID: 34425847; PMCID: PMC8383412.

#136 2024 Pediatr Rheumatol Online J

Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals

Şahin N, Baykal GÖ, Açarı C, Aydın PÖA, Baba Ö, Bağlan E, Bakkaloğlu S, Bakırcı S, Bilginer Y, Bozkaya BY, Çağlayan Ş, Çakan M, Çakmak F, Coşkuner T, Demir F, Demirkan FG, Doğantan Ş, Dündar HA, Ersözlü ED, Gücenmez S, Gürler O, İşgüder R, Küçük A, Kalyoncu M, Kılıç L, Kılıç SŞ, Kısaoğlu H, Kısaarslan AP, Kızıldağ Z, Kurtuluş D, Özdel S, Öztürk K, Şenol P, Tanatar A, Taşkın SN, Kuru FT, Türkuçar S, Ulu K, Ünsal E, Yazıcı A, Cefle A, Yıldırım DG, Yüksel S, Kasapçopur Ö, Özen S, Ayaz NA, Sönmez HE, Sözeri B. Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals. Pediatr Rheumatol Online J. 2024 Dec 18;22(1):105. doi: 10.1186/s12969-024-01047-2. PMID: 39695685; PMCID: PMC11654283.

#137 2025 Ann Rheum Dis

Transcriptome analysis of unmedicated heterozygous familial Mediterranean fever patients reveals a type I interferon signature driving increasing Pyrin expression

Sag E, Imren G, Walle LV, Aydin EA, Bayindir Y, Cam V, Unal D, Emreol HE, Kısaarslan AP, Ozdel S, Basaran O, Karaosmanoglu B, Alikasifoglu M, Bilginer Y, Lamkanfi M, Taskiran EZ, Ozen S. Transcriptome analysis of unmedicated heterozygous familial Mediterranean fever patients reveals a type I interferon signature driving increasing Pyrin expression. Ann Rheum Dis. 2025 Nov;84(11):1928-1937. doi: 10.1016/j.ard.2025.08.001. Epub 2025 Aug 28. PMID: 40883219.

#138 2025 Ann Rheum Dis

Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR/PReS recommendations for familial Mediterranean fever

Sag E, Otón T, Carmona L, Ozen S. Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR/PReS recommendations for familial Mediterranean fever. Ann Rheum Dis. 2025 Nov;84(11):1909-1927. doi: 10.1016/j.ard.2025.05.020. Epub 2025 Jun 24. PMID: 40562663.

#139 2025 Rheumatology (Oxford)

Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile

Sag E, Balik Z, Demir S, Akca Kaya U, Sener S, Kasap Cuceoglu M, Atalay E, Bocutcu S, Vural T, Tasdemir NK, Aydin B, Bilginer Y, Deleuran B, Ozen S. Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile. Rheumatology (Oxford). 2025 Mar 1;64(3):1424-1430. doi: 10.1093/rheumatology/keae306. PMID: 38781517.

#140 2021 Pediatr Res

Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes

Sag E, Demir S, Aspari M, Nielsen MA, Skejø C, Hvid M, Turhan E, Bilginer Y, Greisen S, Ozen S, Deleuran B. Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes. Pediatr Res. 2021 Oct;90(4):744-751. doi: 10.1038/s41390-021-01588-2. Epub 2021 May 24. PMID: 34031570.

#141 2021 Semin Arthritis Rheum

Clinical features, muscle biopsy scores, myositis specific antibody profiles and outcome in juvenile dermatomyositis

Sag E, Demir S, Bilginer Y, Talim B, Haliloglu G, Topaloglu H, Ozen S. Clinical features, muscle biopsy scores, myositis specific antibody profiles and outcome in juvenile dermatomyositis. Semin Arthritis Rheum. 2021 Feb;51(1):95-100. doi: 10.1016/j.semarthrit.2020.10.007. Epub 2020 Dec 22. PMID: 33360233.

#142 2021 Clin Exp Rheumatol

Validation of the EULAR/ACR 2017 idiopathic inflammatory myopathy classification criteria in juvenile dermatomyositis patients

Sag E, Demir S, Bilginer Y, Talim B, Haliloglu G, Ozen S. Validation of the EULAR/ACR 2017 idiopathic inflammatory myopathy classification criteria in juvenile dermatomyositis patients. Clin Exp Rheumatol. 2021 May- Jun;39(3):688-694. doi: 10.55563/clinexprheumatol/4tz6ci. Epub 2020 Dec 4. PMID: 33337999.

#143 2021 Rheumatol Int

Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients

Sag E, Keskin A, Atalay E, Demir S, Cuceoglu MK, Akca UK, Batu ED, Bilginer Y, Ozen S. Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients. Rheumatol Int. 2021 Jan;41(1):87-93. doi: 10.1007/s00296-020-04750-x. Epub 2020 Nov 19. PMID: 33215249.

#144 2021 Rheumatol Int

Inflammatory milieu of muscle biopsies in juvenile dermatomyositis

Sag E, Kale G, Haliloglu G, Bilginer Y, Akcoren Z, Orhan D, Gucer S, Topaloglu H, Ozen S, Talim B. Inflammatory milieu of muscle biopsies in juvenile dermatomyositis. Rheumatol Int. 2021 Jan;41(1):77-85. doi: 10.1007/s00296-020-04735-w. Epub 2020 Oct 26. PMID: 33106894.

#145 2020 Curr Rheumatol Rep

Clusters in Pediatric Rheumatic Diseases

Sag E, Demir S, Ozen S. Clusters in Pediatric Rheumatic Diseases. Curr Rheumatol Rep. 2020 May 20;22(7):28. doi: 10.1007/s11926-020-00908-5. PMID: 32436006.

#146 2020 J Pediatr

Colchicine and Leukopenia: Clinical Implications

Sag E, Bayindir Y, Adiguzel A, Demir S, Bilginer Y, Aytac S, Ozen S. Colchicine and Leukopenia: Clinical Implications. J Pediatr. 2020 Sep;224:166-170.e1. doi: 10.1016/j.jpeds.2020.03.065. Epub 2020 May 13. Erratum in: J Pediatr. 2022 Jan;240:322. doi: 10.1016/j.jpeds.2020.09.063. Erratum in: J Pediatr. 2020 Oct 23:S0022-3476(20)31128-8. doi: 10.1016/j.jpeds.2020.09.003. PMID: 32417084.

#147 2020 Semin Arthritis Rheum

Response to letter to the editor

Sag E, Ozen S. Response to letter to the editor. Semin Arthritis Rheum. 2020 Dec;50(6):1553. doi: 10.1016/j.semarthrit.2020.03.021. Epub 2020 May 5. PMID: 32408986.

#148 2020 Rheumatology (Oxford)

Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry

Sag E, Akal F, Atalay E, Akca UK, Demir S, Demirel D, Batu ED, Bilginer Y, Ozen S. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry. Rheumatology (Oxford). 2020 Nov 1;59(11):3324-3329. doi: 10.1093/rheumatology/keaa121. PMID: 32306038.

#149 2019 Turk J Pediatr

Systemic onset juvenile idiopathic arthritis: a single center experience

Sağ E, Uzunoğlu B, Bal F, Sönmez HE, Demir S, Bilginer Y, Özen S. Systemic onset juvenile idiopathic arthritis: a single center experience. Turk J Pediatr. 2019;61(6):852-858. doi: 10.24953/turkjped.2019.06.005. PMID: 32134578.

#150 2019 Turk J Pediatr

Chronic recurrent multifocal osteomyelitis in children: a single center experience over five years

Sağ E, Sönmez HE, Demir S, Bilginer Y, Ergen FB, Aydıngöz Ü, Özen S. Chronic recurrent multifocal osteomyelitis in children: a single center experience over five years. Turk J Pediatr. 2019;61(3):386-391. doi: 10.24953/turkjped.2019.03.010. PMID: 31916716.

#151 2020 Semin Arthritis Rheum

Performance of the new 'Eurofever/PRINTO classification criteria' in FMF patients

Sag E, Demirel D, Demir S, Atalay E, Akca U, Bilginer Y, Ozen S. Performance of the new 'Eurofever/PRINTO classification criteria' in FMF patients. Semin Arthritis Rheum. 2020 Feb;50(1):172-175. doi: 10.1016/j.semarthrit.2019.08.004. Epub 2019 Aug 7. PMID: 31471011.

#152 2017 Best Pract Res Clin Rheumatol

Childhood systemic vasculitis

Sag E, Batu ED, Ozen S. Childhood systemic vasculitis. Best Pract Res Clin Rheumatol. 2017 Aug;31(4):558-575. doi: 10.1016/j.berh.2017.11.009. Epub 2017 Dec 23. PMID: 29773273.

#153 2017 Curr Rheumatol Rep

Autoinflammatory Diseases with Periodic Fevers

Sag E, Bilginer Y, Ozen S. Autoinflammatory Diseases with Periodic Fevers. Curr Rheumatol Rep. 2017 Jul;19(7):41. doi: 10.1007/s11926-017-0670-8. PMID: 28631068.

#154 2025 Ann Rheum Dis

Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research

Sadun RE, Cooper JC, Belot A, Avcin T, Aggarwal A, Ainsworth J, Akinsete A, Ardoin SP, Beresford MW, Bortey L, Brunner HI, Chang JC, Ciurtin C, Daftary A, Eberhard B, Feldman CH, Hedrich CM, Hersh AO, Hiraki LT, Isenberg DA, Kamphuis S, Knight AM, Lambert L, Levy DM, Marks SD, Maxwell N, Migowa A, Moore K, Ozen S, Ramsey-Goldman R, Ravelli A, Reeve BB, Rubinstein TB, Saad-Magalhaes C, Sawhney S, Schanberg LE, von Scheven E, Scott C, Son MB, Tony G, Weitzman ER, Wenderfer SE, Woodside A, Lewandowski LB, Smith EM; CARRA SLE Committee and PReS Lupus Working Party. Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Ann Rheum Dis. 2025 Feb;84(2):158-168. doi: 10.1136/ard-2024-226528. Epub 2025 Jan 2. PMID: 39919891; PMCID: PMC12345348.

#155 2002 Nephrol Dial Transplant

Pulmonary hydatid disease associated with nephrotic syndrome in a paediatric patient

Saçkesen C, Atasoy H, Kiper N, Ozen S. Pulmonary hydatid disease associated with nephrotic syndrome in a paediatric patient. Nephrol Dial Transplant. 2002 Mar;17(3):523-4. doi: 10.1093/ndt/17.3.523. PMID: 11865111.

#156 2026 Front Immunol

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry

Ruscitti P, Masedu F, Vitale A, Caggiano V, Di Cola I, Atzeni F, Sbalchiero J, Lopalco G, Iannone F, Morrone M, Iacono D, Riccio F, Visconti M, Gaggiano C, Caso F, Emmi G, Hinojosa-Azaola A, Torres-Ruiz J, Martín-Nares E, Guggino G, La Barbera L, Batu ED, Ozen S, Sfikakis PP, Navarini L, Costa L, Tufan A, Cakir IY, Perosa F, Hernández-Rodríguez J, Prete M, Dagna L, Campochiaro C, Ursini F, Sfriso P, Bindoli S, Giardini HAM, Fotis L, Kourtesi K, Ragab G, Ghanema M, Saad MA, Direskeneli H, Karamanakos A, Conforti A, La Torre F, Frassi M, Govoni M, Parronchi P, Sarzi-Puttini P, Maggio MC, Bugatti S, De Stefano L, Pelizza J, Bartoloni E, Rigante D, Iagnocco A, Viapiana O, Wiesik-Szewczyk E, Makowska J, Gündüz ÖS, Erten Ş, Ogunjimi B, Sebastiani GD, Del Giudice E, Biancalana E, Conti G, AlMaghlouth IA, Breda L, Gidaro A, Barone P, Olivieri AN, Carubbi F, De Paulis A, Chimenti MS, Lo Gullo A, Tharwat S, Thabet M, Moshrif A, Alessio M, Mauro A, Suzon B, Pucino V, Boyarchuk O, Kovalchuk T, Bes C, Deniz R, Al-Mayouf SM, Cipriani P, Valenti M, Balistreri A, Fabiani C, Ciccia F, Montecucco C, Giacomelli R, Frediani B, Cantarini L. Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry. Front Immunol. 2026 Apr 14;17:1811317. doi: 10.3389/fimmu.2026.1811317. PMID: 42058206; PMCID: PMC13121312.

#157 2025 J Rheumatol

Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry

Ruscitti P, Di Cola I, Vitale A, Caggiano V, Palumbo P, Di Cesare E, Torres-Ruiz J, Guaracha-Basañez GA, Martín-Nares E, Ciccia F, Iacono D, Riccio F, Maggio MC, Tharwat S, Hashad S, Rigante D, Ortolan A, Mayrink Giardini HA, de Brito Antonelli IP, Cordeiro RA, Giacomelli R, Navarini L, Berardicurti O, Conforti A, Opris-Belinski D, Sota J, Gaggiano C, Lopalco G, Iannone F, La Torre F, Mastrorilli V, Govoni M, Ruffilli F, Emmi G, Biancalana E, Sfikakis PP, Tektonidou M, Hernández-Rodríguez J, Gómez-Caverzaschi V, Gündüz ÖS, Conti G, Patroniti S, Gidaro A, Bartoli A, Olivieri AN, Gicchino MF, Brucato AL, Dagna L, Tomelleri A, Campochiaro C, De Paulis A, Mormile I, Della Casa F, Direskeneli H, Alibaz-Oner F, Karamanakos A, Dimouli A, Ragab G, Mahmoud AAA, Tufan A, Kucuk H, Kardas R, Batu ED, Ozen S, Wiesik-Szewczyk E, Hinojosa-Azaola A, Balistreri A, Fabiani C, Frediani B, Cantarini L; International AIDA Network and the Autoinflammatory Diseases Working Group of the Italian Society of Rheumatology. Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry. J Rheumatol. 2025 Mar 1;52(3):226-233. doi: 10.3899/jrheum.2024-0683. PMID: 39547690.

#158 2012 N Engl J Med

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099. PMID: 23252526.

#159 2010 Part I: Overall methodology and clinical characterisation

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008

Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O'Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhães CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Kone-Paut I, Zulian F, Barone P, Bircan Z, Maldonado Mdel R, Russo R, Vilca I, Tullus K, Cimaz R, Horneff G, Anton J, Garay S, Nielsen S, Barbano G, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis. 2010 May;69(5):790-7. doi: 10.1136/ard.2009.116624. Epub 2010 Apr 13. Erratum in: Ann Rheum Dis. 2011 Feb;70(2):397. Paut, Isabelle Kone [corrected to Kone-Paut, Isabella]. PMID: 20388738.

#160 2005 Arthritis Rheum

The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set

Ruperto N, Ravelli A, Cuttica R, Espada G, Ozen S, Porras O, Sztajnbok F, Falcini F, Kasapcopur O, Venning H, Bica B, Merino R, Coto C, Ros J, Susic G, Gamir ML, Minden K, See Y, Uziel Y, Mukamel M, Riley P, Zulian F, Olivieri AN, Cimaz R, Girschick H, Rumba I, Cavuto S, Pistorio A, Lovell DJ, Martini A; Pediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG). The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum. 2005 Sep;52(9):2854-64. doi: 10.1002/art.21230. PMID: 16142708.

#161 2019 Kidney Int

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 Feb;95(2):281-295. doi: 10.1016/j.kint.2018.11.008. PMID: 30665569.

#162 2002 J Am Soc Nephrol

The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease

Rossetti S, Burton S, Strmecki L, Pond GR, San Millán JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol. 2002 May;13(5):1230-7. doi: 10.1097/01.asn.0000013300.11876.37. PMID: 11961010.

#163 2024 Arthritis Rheumatol

Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score

Rosina S, Rebollo-Giménez AI, Tarantola L, Pistorio A, Vyzhga Y, El Miedany Y, Lotfy HM, Abu-Shady H, Eissa M, Osman NS, Hassan W, Mahgoub MY, Fouad NA, Mosa DM, Adel Y, Mohamed SEM, Radwan AR, Abu-Zaid MH, Tabra SAA, Shalaby RH, Nasef SI, Khubchandani R, Khan A, Maldar NP, Ozen S, Bayindir Y, Alsuweiti M, Alzyoud R, Almaaitah H, Vilaiyuk S, Lerkvaleekul B, Alexeeva E, Dvoryakovskaya T, Kriulin I, Bracaglia C, Pardeo M, De Benedetti F, Licciardi F, Montin D, Robasto F, Minoia F, Filocamo G, Rossano M, Simonini G, Marrani E, Abu-Rumeileh S, Kostik MM, Belozerov KE, Pal P, Bathia JN, Katsicas MM, Villarreal G, Marino A, Costi S, Sztajnbok F, Silva RM, Maggio MC, El-Ghoneimy DH, El Owaidy R, Civino A, Diomeda F, Al-Mayouf SM, Al-Sofyani F, Dāvidsone Z, Patrone E, Saad- Magalhães C, Consolaro A, Ravelli A. Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score. Arthritis Rheumatol. 2024 Sep;76(9):1446-1454. doi: 10.1002/art.42865. Epub 2024 Jun 11. PMID: 38682570.

#164 2022 Ann Rheum Dis

The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist

Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron KS, Benseler S, Berard R, Broderick L, Dedeoglu F, Diebold M, Durrant KL, Ferguson P, Foell D, Hausmann J, Jones OY, Kastner DL, Lachmann HJ, Laxer RM, Rivera D, Ruperto N, Simon A, Twilt M, Frenkel J, Hoffman H, de Jesus AA, Kuemmerle-Deschner JB, Ozen S, Gattorno M, Goldbach-Mansky R, Demirkaya E. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022 Jul;81(7):907-921. doi: 10.1136/annrheumdis-2021-221801. Epub 2022 May 27. PMID: 35623638.

#165 2022 Arthritis Rheumatol

The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin- Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist

Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron K, Benseler S, Berard RA, Broderick L, Dedeoglu F, Diebold M, Durrant K, Ferguson P, Foell D, Hausmann JS, Jones OY, Kastner D, Lachmann HJ, Laxer RM, Rivera D, Ruperto N, Simon A, Twilt M, Frenkel J, Hoffman HM, de Jesus AA, Kuemmerle-Deschner JB, Ozen S, Gattorno M, Goldbach-Mansky R, Demirkaya E. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin- Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. Arthritis Rheumatol. 2022 Jul;74(7):1102-1121. doi: 10.1002/art.42139. Epub 2022 May 27. PMID: 35621220; PMCID: PMC9531906.

#166 2013 Rheum Dis Clin North Am

Rheumatic inflammatory eye diseases of childhood

Reiff A, Kadayifcilar S, Özen S. Rheumatic inflammatory eye diseases of childhood. Rheum Dis Clin North Am. 2013 Nov;39(4):801-32. doi: 10.1016/j.rdc.2013.05.005. Epub 2013 Jul 13. PMID: 24182856.

#167 2024 J Clin Med

Patient Experiences and Challenges in the Management of Autoinflammatory Diseases-Data from the International FMF & AID Global Association Survey

Rech J, Schett G, Tufan A, Kuemmerle-Deschner JB, Özen S, Tascilar K, Geck L, Krickau T, Cohen E, Welzel T, Kuehn M, Vetterli M. Patient Experiences and Challenges in the Management of Autoinflammatory Diseases-Data from the International FMF & AID Global Association Survey. J Clin Med. 2024 Feb 20;13(5):1199. doi: 10.3390/jcm13051199. PMID: 38592017; PMCID: PMC10931825.

#168 2016 Ann Rheum Dis

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016 Mar;75(3):481-9. doi: 10.1136/annrheumdis-2015-208982. PMID: 26865703.

#169 2016 RMD Open

Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic A, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open. 2016 Jan 19;2(1):e000161. doi: 10.1136/rmdopen-2015-000161. PMID: 26848401; PMCID: PMC4731834.

#170 2016 Arthritis Rheumatol

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016 Mar;68(3):566-76. doi: 10.1002/art.39332. Epub 2016 Feb 9. PMID: 26314788.

#171 2016 Arthritis Res Ther

Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial

Polat A, Acikel C, Sozeri B, Dursun I, Kasapcopur O, Gulez N, Simsek D, Saldir M, Dokurel I, Poyrazoglu H, Bakkaloglu S, Delibas A, Ekinci Z, Ayaz NA, Kandur Y, Peru H, Kurt YG, Polat SR, Unsal E, Makay B, Gok F, Ozen S, Demirkaya E; FMF Arthritis Vasculitis and Orphan Disease Research in Pediatric Rheumatology (FAVOR). Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial. Arthritis Res Ther. 2016 Apr 7;18:85. doi: 10.1186/s13075-016-0980-7. PMID: 27055417; PMCID: PMC4823910.

#172 2014 Ann Rheum Dis

Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes

Piram M, Koné-Paut I, Lachmann HJ, Frenkel J, Ozen S, Kuemmerle-Deschner J, Stojanov S, Simon A, Finetti M, Sormani MP, Martini A, Gattorno M, Ruperto N; EUROFEVER, EUROTRAPS and the Paediatric Rheumatology International Trials Organisation (PRINTO) networks. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. 2014 Dec;73(12):2168-73. doi: 10.1136/annrheumdis-2013-203666. Epub 2013 Sep 11. PMID: 24026675; PMCID: PMC4251184.

#173 2011 Ann Rheum Dis

A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto- Inflammatory Diseases Activity Index) Consensus Conference

Piram M, Frenkel J, Gattorno M, Ozen S, Lachmann HJ, Goldbach-Mansky R, Hentgen V, Neven B, Stojanovic KS, Simon A, Kuemmerle-Deschner J, Hoffman H, Stojanov S, Duquesne A, Pillet P, Martini A, Pouchot J, Koné-Paut I; EUROFEVER and EUROTRAPS networks. A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto- Inflammatory Diseases Activity Index) Consensus Conference. Ann Rheum Dis. 2011 Feb;70(2):309-14. doi: 10.1136/ard.2010.132613. Epub 2010 Nov 15. PMID: 21081528; PMCID: PMC3463866.

#174 2008 Turk J Pediatr

A child with Behçet's disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis

Pektaş A, Devrim I, Beşbaş N, Bilginer Y, Cengiz AB, Ozen S. A child with Behçet's disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis. Turk J Pediatr. 2008 Jan-Feb;50(1):78-80. PMID: 18365598.

#175 2006 Clin Rheumatol

A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis

Pay S, Türkçapar N, Kalyoncu M, Simşek I, Beyan E, Ertenli I, Oztürk MA, Düzgün N, Erdem H, Ozbalkan Z, Kiraz S, Kinikli G, Besbas N, Dinç A, Ateş A, Olmez U, Calgüneri M, Aydintuğ OT, Bakkaloğlu A, Turan M, Turgay M, Karaaslan Y, Topaloğlu R, Duman M, Ozen S; Ankara Rheumatology Study Group. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006 Sep;25(5):639-44. doi: 10.1007/s10067-005-0138-5. Epub 2005 Dec 20. PMID: 16365690.

#176 2009 Arthritis Rheum

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients

Parodi A, Davì S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, Miettunen P, Bader-Meunier B, Espada G, Sterba G, Ozen S, Wright D, Magalhães CS, Khubchandani R, Michels H, Woo P, Iglesias A, Guseinova D, Bracaglia C, Hayward K, Wouters C, Grom A, Vivarelli M, Fischer A, Breda L, Martini A, Ravelli A; Lupus Working Group of the Paediatric Rheumatology European Society. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009 Nov;60(11):3388-99. doi: 10.1002/art.24883. PMID: 19877067.

#177 2020 Nat Immunol

Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis

Park YH, Remmers EF, Lee W, Ombrello AK, Chung LK, Shilei Z, Stone DL, Ivanov MI, Loeven NA, Barron KS, Hoffmann P, Nehrebecky M, Akkaya-Ulum YZ, Sag E, Balci-Peynircioglu B, Aksentijevich I, Gül A, Rotimi CN, Chen H, Bliska JB, Ozen S, Kastner DL, Shriner D, Chae JJ. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nat Immunol. 2020 Aug;21(8):857-867. doi: 10.1038/s41590-020-0705-6. Epub 2020 Jun 29. PMID: 32601469; PMCID: PMC7381377.

#178 2026 Arthritis Rheumatol

Decision Tree Analysis as a Preliminary Evidence-Based Tool for Identifying the Syndrome of Undifferentiated Recurrent Fever in Children Compared With Hereditary Recurrent Fevers and Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome

Papa R, Bovis F, Federici S, Palmeri S, Bustaffa M, Recchi G, Bertelli R, Caorsi R, Volpi S, Fuehner S, Cam V, Kozáková A, Fingerhutová ŠH, Insalaco A, Foell D, Ozen S, Ceccherini I, Gattorno M; Eurofever study group for the classification criteria of recurrent fevers and PerSAID project. Decision Tree Analysis as a Preliminary Evidence-Based Tool for Identifying the Syndrome of Undifferentiated Recurrent Fever in Children Compared With Hereditary Recurrent Fevers and Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome. Arthritis Rheumatol. 2026 May;78(5):1166-1175. doi: 10.1002/art.70019. Epub 2026 Feb 17. PMID: 41423343.

#179 2017 Orphanet J Rare Dis

A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry

Papa R, Doglio M, Lachmann HJ, Ozen S, Frenkel J, Simon A, Neven B, Kuemmerle-Deschner J, Ozgodan H, Caorsi R, Federici S, Finetti M, Trachana M, Brunner J, Bezrodnik L, Pinedo Gago MC, Maggio MC, Tsitsami E, Al Suwairi W, Espada G, Shcherbina A, Aksu G, Ruperto N, Martini A, Ceccherini I, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever Project. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry. Orphanet J Rare Dis. 2017 Oct 18;12(1):167. doi: 10.1186/s13023-017-0720-3. PMID: 29047407; PMCID: PMC5648458.

#180 2005 J Child Neurol

Reversible posterior leukoencephalopathy syndrome: report of three cases

Ozyurek H, Oguz G, Ozen S, Akyuz C, Karli Oguz K, Anlar B, Aysun S. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005 Dec;20(12):990-3. doi: 10.1177/08830738050200121201. PMID: 16417849.

#181 2021 2021 Nov;36(11):3771-3776

Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr Nephrol

Ozsurekci Y, Oygar PD, Gürlevik SL, Kesici S, Ozen S, Kurt Sukur ED, Gülhan B, Topaloglu R, Bayrakci B, Cengiz AB. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr Nephrol. 2021 Nov;36(11):3771-3776. doi: 10.1007/s00467-021-05111-x. Epub 2021 May 22. PMID: 34021797; PMCID: PMC8140325.

#182 2021 Clin Rheumatol

Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

Ozsurekci Y, Gürlevik S, Kesici S, Akca UK, Oygar PD, Aykac K, Karacanoglu D, Nakip OS, Ilbay S, Katlan B, Ertugrul İ, Cengiz AB, Basaran O, Yayla BCC, Karakaya J, Bilginer Y, Bayrakci B, Ceyhan M, Ozen S. Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean. Clin Rheumatol. 2021 Jun;40(6):2523. doi: 10.1007/s10067-021-05692-w. Erratum for: Clin Rheumatol. 2021 Aug;40(8):3227-3237. doi: 10.1007/s10067-021-05631-9. PMID: 33738688; PMCID: PMC7972943.

#183 2021 Clin Rheumatol

Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

Ozsurekci Y, Gürlevik S, Kesici S, Akca UK, Oygar PD, Aykac K, Karacanoglu D, Sarıtas Nakip O, Ilbay S, Katlan B, Ertugrul İ, Cengiz AB, Basaran O, Cura Yayla BC, Karakaya J, Bilginer Y, Bayrakci B, Ceyhan M, Ozen S. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean. Clin Rheumatol. 2021 Aug;40(8):3227-3237. doi: 10.1007/s10067-021-05631-9. Epub 2021 Feb 12. Erratum in: Clin Rheumatol. 2021 Jun;40(6):2523. doi: 10.1007/s10067-021-05692-w. PMID: 33576926; PMCID: PMC7879406.

#184 2026 Ann Rheum Dis

Reply to "Correspondence on: EULAR/PRES endorsed recommendations for the management of FMF: 2024 update"

Ozen S, Gül A, Santos CS, Sağ E, Lachmann HJ, Deschner JK, Gattorno M, Aktay-Ayaz N, Karadağ Ö, Kivity S, Georgin-Lavialle S, Sarkisian T, Oton T, Kallinich T, Hentgen V, Uziel Y. Reply to "Correspondence on: EULAR/PRES endorsed recommendations for the management of FMF: 2024 update". Ann Rheum Dis. 2026 Mar;85(3):e33-e35. doi: 10.1016/j.ard.2025.12.009. PMID: 41771618.

#185 2025 Ann Rheum Dis

EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update

Ozen S, Sağ E, Oton T, Gül A, Sieiro Santos C, Bayraktar D, Proft FN, Lachmann HJ, Kuemmerle Deschner J, Gattorno M, Ayaz NA, Karadağ Ö, Yüce S, Kivity S, Georgin-Lavialle S, Sarkisian T, Kallinich T, Hentgen V, Prior Y, Uziel Y, Yardeni Z, Carmona L. EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Ann Rheum Dis. 2025 Jun;84(6):899-909. doi: 10.1016/j.ard.2025.01.028. Epub 2025 Apr 9. PMID: 40234174.

#186 2024 Nat Rev Rheumatol

The past 25 years in paediatric rheumatology: insights from monogenic diseases

Ozen S, Aksentijevich I. The past 25 years in paediatric rheumatology: insights from monogenic diseases. Nat Rev Rheumatol. 2024 Sep;20(9):585-593. doi: 10.1038/s41584-024-01145-1. Epub 2024 Aug 7. PMID: 39112602.

#187 2021 Curr Opin Rheumatol

Update in familial Mediterranean fever

Ozen S. Update in familial Mediterranean fever. Curr Opin Rheumatol. 2021 Sep 1;33(5):398-402. doi: 10.1097/BOR.0000000000000821. PMID: 34397603.

#188 2021 Clin Exp Rheumatol

Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children

Ozen S, Lutz HL, Rivera VM, Reiff A, Batu ED, Anderson E, Salas Garcia M, Aldrovandi G, Akbaba TH, Pazarbasi İ, Bilginer Y, Balat A, Balci-Peynircioglu B, Gilbert JA, Dedeoglu F, Hausmann JS. Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children. Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):102-108. doi: 10.55563/clinexprheumatol/olvbyd. Epub 2021 Jul 5. PMID: 34251310.

#189 2021 Rheumatology (Oxford)

Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach

Özen S, Sag E, Ben-Chetrit E, Gattorno M, Gül A, Hashkes PJ, Kone-Paut I, Lachmann HJ, Tsitsami E, Twilt M, Benedetti F, Kuemmerle-Deschner JB. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach. Rheumatology (Oxford). 2021 Aug 2;60(8):3799-3808. doi: 10.1093/rheumatology/keaa863. PMID: 33331943.

#190 2022 Ann Rheum Dis

Response to: 'Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'' by Satis <i>et al</i>

Ozen S, De Benedetti F. Response to: 'Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'' by Satis <i>et al</i>. Ann Rheum Dis. 2022 Dec;81(12):e257. doi: 10.1136/annrheumdis-2020-218942. Epub 2020 Sep 28. PMID: 32988842.

#191 2020 Ann Rheum Dis

Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial

Ozen S, Ben-Cherit E, Foeldvari I, Amarilyo G, Ozdogan H, Vanderschueren S, Marzan K, Kahlenberg JM, Dekker E, De Benedetti F, Koné-Paut I. Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial. Ann Rheum Dis. 2020 Oct;79(10):1362-1369. doi: 10.1136/annrheumdis-2020-217419. Epub 2020 Jun 22. PMID: 32571870; PMCID: PMC7509527.

#192 2020 Rheumatology (Oxford)

Childhood vasculitis

Ozen S, Sag E. Childhood vasculitis. Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii95-iii100. doi: 10.1093/rheumatology/kez599. PMID: 32348513.

#193 2019 J Rheumatol

Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis

Ozen S, Demir S, Batu ED. Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis. J Rheumatol. 2019 Oct;46(10):1422-1424. doi: 10.3899/jrheum.190238. Epub 2019 Jun 15. PMID: 31203219.

#194 2020 J Rheumatol

A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2

Özen S, Batu ED, Taşkıran EZ, Özkara HA, Ünal Ş, Güleray N, Erden A, Karadağ Ö, Gümrük F, Çetin M, Sönmez HE, Bilginer Y, Ayvaz DÇ, Tezcan I. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2. J Rheumatol. 2020 Jan;47(1):117-125. doi: 10.3899/jrheum.181384. Epub 2019 May 1. PMID: 31043544.

#195 2019 Rheumatology (Oxford)

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative

Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019 Sep 1;58(9):1607-1616. doi: 10.1093/rheumatology/kez041. PMID: 30879080.

#196 2019 2019 Dec;34(12):2449-2456

What's new in autoinflammation? Pediatr Nephrol

Ozen S. What's new in autoinflammation? Pediatr Nephrol. 2019 Dec;34(12):2449-2456. doi: 10.1007/s00467-018-4155-4. Epub 2018 Dec 14. PMID: 30552566.

#197 2018 Best Pract Res Clin Rheumatol

Update on the epidemiology and disease outcome of Familial Mediterranean fever

Özen S. Update on the epidemiology and disease outcome of Familial Mediterranean fever. Best Pract Res Clin Rheumatol. 2018 Apr;32(2):254-260. doi: 10.1016/j.berh.2018.09.003. Epub 2018 Sep 29. PMID: 30527430.

#198 2018 Best Pract Res Clin Rheumatol

Pediatric forms of vasculitis

Özen S, Sönmez HE, Demir S. Pediatric forms of vasculitis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):137-147. doi: 10.1016/j.berh.2018.09.007. Epub 2018 Oct 10. PMID: 30526893.

#199 2018 2018 Aug 14;9:1892

Vasculitis Pathogenesis: Can We Talk About Precision Medicine? Front Immunol

Ozen S, Batu ED. Vasculitis Pathogenesis: Can We Talk About Precision Medicine? Front Immunol. 2018 Aug 14;9:1892. doi: 10.3389/fimmu.2018.01892. PMID: 30154798; PMCID: PMC6102378.

#200 2017 Curr Opin Rheumatol

Recent advances in childhood vasculitis

Ozen S, Acar-Ozen NP. Recent advances in childhood vasculitis. Curr Opin Rheumatol. 2017 Sep;29(5):530-534. doi: 10.1097/BOR.0000000000000424. PMID: 28582318.

#201 2017 Paediatr Drugs

Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient

Ozen S, Demir S. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient. Paediatr Drugs. 2017 Aug;19(4):303-311. doi: 10.1007/s40272-017-0232-6. PMID: 28497352.

#202 2017 Nat Rev Rheumatol

The changing face of polyarteritis nodosa and necrotizing vasculitis

Ozen S. The changing face of polyarteritis nodosa and necrotizing vasculitis. Nat Rev Rheumatol. 2017 Jun;13(6):381-386. doi: 10.1038/nrrheum.2017.68. Epub 2017 May 11. PMID: 28490787.

#203 2017 Semin Arthritis Rheum

Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments

Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017 Aug;47(1):115-120. doi: 10.1016/j.semarthrit.2017.03.006. Epub 2017 Mar 20. PMID: 28413100.

#204 2017 Front Immunol

Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management

Özen S, Batu ED, Demir S. Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management. Front Immunol. 2017 Mar 23;8:253. doi: 10.3389/fimmu.2017.00253. PMID: 28386255; PMCID: PMC5362626.

#205 2017 Arthritis Care Res (Hoboken)

International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome

Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I, Zeft A, Spalding S, Gul A, Hentgen V, Savic S, Foeldvari I, Frenkel J, Cantarini L, Patel D, Weiss J, Marinsek N, Degun R, Lomax KG, Lachmann HJ. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome. Arthritis Care Res (Hoboken). 2017 Apr;69(4):578-586. doi: 10.1002/acr.23120. Epub 2017 Mar 3. PMID: 27723279.

#206 2016 Ann Rheum Dis

EULAR recommendations for the management of familial Mediterranean fever

Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016 Apr;75(4):644-51. doi: 10.1136/annrheumdis-2015-208690. Epub 2016 Jan 22. PMID: 26802180.

#207 2015 Nat Rev Rheumatol

Decade in review-paediatric rheumatology: A field on the move

Ozen S. Decade in review-paediatric rheumatology: A field on the move. Nat Rev Rheumatol. 2015 Nov;11(11):625-6. doi: 10.1038/nrrheum.2015.130. Epub 2015 Sep 22. PMID: 26390845.

#208 2015 2015 Jul;37(4):363-9

The myths we believed in familial Mediterranean fever: what have we learned in the past years? Semin Immunopathol

Ozen S, Batu ED. The myths we believed in familial Mediterranean fever: what have we learned in the past years? Semin Immunopathol. 2015 Jul;37(4):363-9. doi: 10.1007/s00281-015-0484-6. Epub 2015 Apr 2. PMID: 25832989.

#209 2014 Ann Rheum Dis

FMF50: a score for assessing outcome in familial Mediterranean fever

Ozen S, Demirkaya E, Duzova A, Erdogan O, Erken E, Gul A, Kasapcopur O, Kasifoglu T, Kisacik B, Ozdogan H, Tunca M, Acikel C; FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR) and Turkish FMF study group. FMF50: a score for assessing outcome in familial Mediterranean fever. Ann Rheum Dis. 2014 May;73(5):897-901. doi: 10.1136/annrheumdis-2013-204719. Epub 2014 Feb 25. PMID: 24570027.

#210 2014 Nat Rev Rheumatol

A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin

Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. 2014 Mar;10(3):135-47. doi: 10.1038/nrrheum.2013.174. Epub 2013 Nov 19. PMID: 24247370.

#211 2013 Curr Opin Rheumatol

Pediatric-onset Behçet disease

Ozen S, Eroglu FK. Pediatric-onset Behçet disease. Curr Opin Rheumatol. 2013 Sep;25(5):636-42. doi: 10.1097/BOR.0b013e328363ea8b. PMID: 23872902.

#212 2014 Ann Rheum Dis

Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children

Ozen S, Demirkaya E, Amaryan G, Koné-Paut I, Polat A, Woo P, Uziel Y, Modesto C, Finetti M, Quartier P, Papadopoulou-Alataki E, Al-Mayouf SM, Fabio G, Gallizzi R, Cantarini L, Frenkel J, Nielsen S, Hofer M, Insalaco A, Acikel C, Ozdogan H, Martini A, Ruperto N, Gattorno M; Paediatric Rheumatology International Trials Organisation; Eurofever Project. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. 2014 Apr;73(4):662-7. doi: 10.1136/annrheumdis-2012-202708. Epub 2013 Mar 5. PMID: 23463692.

#213 2011 Eur J Pediatr

The Eurofever Project: towards better care for autoinflammatory diseases

Ozen S, Frenkel J, Ruperto N, Gattorno M; Eurofever Project. The Eurofever Project: towards better care for autoinflammatory diseases. Eur J Pediatr. 2011 Apr;170(4):445-52. doi: 10.1007/s00431-011-1411-z. Epub 2011 Mar 1. PMID: 21360011.

#214 2011 J Rheumatol

Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine

Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. J Rheumatol. 2011 Mar;38(3):516-8. doi: 10.3899/jrheum.100718. Epub 2010 Dec 15. PMID: 21159830.

#215 2010 Curr Opin Rheumatol

Pediatric onset Behçet disease

Ozen S. Pediatric onset Behçet disease. Curr Opin Rheumatol. 2010 Sep;22(5):585-9. doi: 10.1097/BOR.0b013e32833cc9b7. PMID: 20616738.

#216 2010 Part II: Final classification criteria

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008

Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010 May;69(5):798-806. doi: 10.1136/ard.2009.116657. PMID: 20413568.

#217 2010 Pediatr Nephrol

The "other" vasculitis syndromes and kidney involvement

Ozen S. The "other" vasculitis syndromes and kidney involvement. Pediatr Nephrol. 2010 Sep;25(9):1633-9. doi: 10.1007/s00467-009-1327-2. Epub 2009 Nov 7. PMID: 19898878; PMCID: PMC2908464.

#218 2009 Best Pract Res Clin Rheumatol

Update in paediatric vasculitis

Ozen S, Fuhlbrigge RC. Update in paediatric vasculitis. Best Pract Res Clin Rheumatol. 2009 Oct;23(5):679-88. doi: 10.1016/j.berh.2009.07.004. PMID: 19853832.

#219 2010 Eur J Pediatr

Behçet disease: treatment of vascular involvement in children

Ozen S, Bilginer Y, Besbas N, Ayaz NA, Bakkaloglu A. Behçet disease: treatment of vascular involvement in children. Eur J Pediatr. 2010 Apr;169(4):427-30. doi: 10.1007/s00431-009-1040-y. Epub 2009 Sep 13. PMID: 19756733.

#220 2009 2009 Jun;60(6):1575-7

Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum

Ozen S. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum. 2009 Jun;60(6):1575-7. doi: 10.1002/art.24565. PMID: 19479854.

#221 2008 Arthritis Rheum

A view from the Eastern Mediterranean

Ozen S. A view from the Eastern Mediterranean. Arthritis Rheum. 2008 Feb;58(2 Suppl):S143-4. doi: 10.1002/art.22949. PMID: 18240206.

#222 2007 J Pediatr

Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate

Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, Davin JC, Bakkaloğlu M. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. 2007 Jan;150(1):72-6. doi: 10.1016/j.jpeds.2006.10.059. PMID: 17188618.

#223 2006 J Rheumatol

Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease

Ozen S, Berdeli A, Türel B, Kutlay S, Yalcinkaya F, Arici M, Besbas N, Bakkaloglu A, Yilmaz E. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol. 2006 Dec;33(12):2498-500. Epub 2006 Oct 1. PMID: 17013994.

#224 2007 Clin Rheumatol

Childhood vasculitides in Turkey: a nationwide survey

Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, Kasapcopur O, Ozkaya O, Yalcinkaya F, Balat A, Kural N, Donmez O, Alpay H, Anarat A, Mir S, Gur-Guven A, Sonmez F, Gok F; Turkish Pediatric Vasculitis Study Group. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol. 2007 Feb;26(2):196-200. doi: 10.1007/s10067-006-0266-6. Epub 2006 Apr 4. PMID: 16586044.

#225 2005 Pediatr Nephrol

Problems in classifying vasculitis in children

Ozen S. Problems in classifying vasculitis in children. Pediatr Nephrol. 2005 Sep;20(9):1214-8. doi: 10.1007/s00467-005-1911-z. Epub 2005 May 7. PMID: 15880268.

#226 2004 J Pediatr

Juvenile polyarteritis: results of a multicenter survey of 110 children

Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, García- Consuegra J, Dolezalova P, Dressler F, Duzova A, Ferriani VP, Hilário MO, Ibáñez-Rubio M, Kasapcopur O, Kuis W, Lehman TJ, Nemcova D, Nielsen S, Oliveira SK, Schikler K, Sztajnbok F, Terreri MT, Zulian F, Woo P. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004 Oct;145(4):517-22. doi: 10.1016/j.jpeds.2004.06.046. PMID: 15480378.

#227 2004 2004 Apr;31(4):831-2

Juvenile polyarteritis: is it a different disease? J Rheumatol

Ozen S. Juvenile polyarteritis: is it a different disease? J Rheumatol. 2004 Apr;31(4):831-2. PMID: 15095751.

#228 2004 Kidney Int

Renal amyloidosis in familial Mediterranean fever

Ozen S. Renal amyloidosis in familial Mediterranean fever. Kidney Int. 2004 Mar;65(3):1118-27. doi: 10.1111/j.1523-1755.2004.00485.x. PMID: 14871446.

#229 2003 2003 Sep;30(9):2014-8

Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol

Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol. 2003 Sep;30(9):2014-8. PMID: 12966608.

#230 2003 Eur J Pediatr

Familial mediterranean fever: revisiting an ancient disease

Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003 Jul;162(7-8):449-454. doi: 10.1007/s00431-003-1223-x. Epub 2003 May 16. PMID: 12751000.

#231 2019 Pediatr Nephrol

Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis

Özçelik G, Sönmez HE, Şahin S, Özağarı A, Bayram MT, Çiçek RY, Çakıcı EK, Çomak E, Barut K, Şahin N, Bakkaloğlu S, Gökçe İ, Düzova A, Bilginer Y, Açarı C, Melek E, Kılıç BD, Özdel S, Adroviç A, Kasapçopur Ö, Ünsal E, Alpay H, Orhan D, Topaloğlu R, Düşünsel R, Özen S. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis. Pediatr Nephrol. 2019 May;34(5):847-854. doi: 10.1007/s00467-018-4162-5. Epub 2019 Jan 4. PMID: 30607566.

#232 2014 Clin Rheumatol

Diagnostic validity of colchicine in patients with Familial Mediterranean fever

Ozaltin F, Bilginer Y, Gülhan B, Bajin I, Erdogan O, Hayran M, Yılmaz E, Ozen S. Diagnostic validity of colchicine in patients with Familial Mediterranean fever. Clin Rheumatol. 2014 Jul;33(7):969-74. doi: 10.1007/s10067-014-2598-y. Epub 2014 Apr 17. PMID: 24740462.

#233 2013 J Am Soc Nephrol

DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN

Ozaltin F, Li B, Rauhauser A, An SW, Soylemezoglu O, Gonul II, Taskiran EZ, Ibsirlioglu T, Korkmaz E, Bilginer Y, Duzova A, Ozen S, Topaloglu R, Besbas N, Ashraf S, Du Y, Liang C, Chen P, Lu D, Vadnagara K, Arbuckle S, Lewis D, Wakeland B, Quigg RJ, Ransom RF, Wakeland EK, Topham MK, Bazan NG, Mohan C, Hildebrandt F, Bakkaloglu A, Huang CL, Attanasio M. DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol. 2013 Feb;24(3):377-84. doi: 10.1681/ASN.2012090903. Epub 2012 Dec 28. PMID: 23274426; PMCID: PMC3582208.

#234 2008 Pediatr Nephrol

Eye involvement in children with primary focal segmental glomerulosclerosis

Ozaltin F, Heeringa S, Poyraz CE, Bilginer Y, Kadayifcilar S, Besbas N, Topaloglu R, Ozen S, Hildebrandt F, Bakkaloglu A. Eye involvement in children with primary focal segmental glomerulosclerosis. Pediatr Nephrol. 2008 Mar;23(3):421-7. doi: 10.1007/s00467-007-0695-8. Epub 2007 Dec 5. PMID: 18058136.

#235 2005 Pediatr Nephrol

Apoptosis and proliferation in childhood acute proliferative glomerulonephritis

Ozaltin F, Besbas N, Bakkaloglu A, Gucer S, Topaloglu R, Ozen S, Kale G, Caglar M. Apoptosis and proliferation in childhood acute proliferative glomerulonephritis. Pediatr Nephrol. 2005 Nov;20(11):1572-7. doi: 10.1007/s00467-005-1985-7. Epub 2005 Jun 18. PMID: 15965768.

#236 2004 Clin Rheumatol

The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schönlein purpura

Ozaltin F, Bakkaloglu A, Ozen S, Topaloglu R, Kavak U, Kalyoncu M, Besbas N. The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schönlein purpura. Clin Rheumatol. 2004 Oct;23(5):426-9. doi: 10.1007/s10067-004-0910-y. Epub 2004 Jun 18. PMID: 15278754.

#237 2004 2004 Apr;23(2):186-7

Helicobacter pylori infection in Turkish children with familial Mediterranean fever: is it a cause of persistent inflammation? Clin Rheumatol

Ozaltin F, Bakkaloglu A, Saltik IN, Demir H, Duzova A, Bulun A, Besbas N, Topaloglu R, Ozen S. Helicobacter pylori infection in Turkish children with familial Mediterranean fever: is it a cause of persistent inflammation? Clin Rheumatol. 2004 Apr;23(2):186-7. doi: 10.1007/s10067-003-0839-6. Epub 2004 Feb 24. PMID: 15045642.

#238 2025 Ann Rheum Dis

Safety of colchicine on fertility, pregnancy, and lactation: a systematic review and meta-analysis informing the EULAR/PReS recommendations for familial Mediterranean fever

Otón T, Sağ E, Carmona L, Ozen S. Safety of colchicine on fertility, pregnancy, and lactation: a systematic review and meta-analysis informing the EULAR/PReS recommendations for familial Mediterranean fever. Ann Rheum Dis. 2025 Jun;84(6):1045-1051. doi: 10.1016/j.ard.2025.02.005. Epub 2025 Feb 28. PMID: 40023732.

#239 2022 Rheumatol Int

Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study

Otar Yener G, Paç Kısaarslan A, Ulu K, Atalay E, Haşlak F, Özdel S, Bozkaya Yücel B, Gezgin Yıldırım D, Çakmak F, Öztürk K, Çakan M, Balık Z, Hasbal Akkuş C, Yıldız M, Erat T, Çetin BŞ, Yılmaz M, Bağlan E, Laçinel Gürlevik S, Atasayan V, Karadağ ŞG, Adrovic A, Çağlayan Ş, Tanatar A, Demirkan FG, Coşkuner T, Akgün Ö, Kasap Cüceoğlu M, Kavrul Kayaalp G, Şahin S, Başaran Ö, Demir F, Barut K, Çiftel M, Gürses D, Baykan A, Özsürekçi Y, Karagöz T, Sönmez HE, Bilginer Y, Aktay Ayaz N, Aydoğ Ö, Yüksel S, Sözeri B, Kasapçopur Ö, Özen S. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study. Rheumatol Int. 2022 May;42(5):879-889. doi: 10.1007/s00296-021-04980-7. Epub 2021 Sep 7. PMID: 34491393; PMCID: PMC8421714.

#240 2025 Kidney Int Rep

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop

Oni L, Smith R, Ozen S, Williams C, Davies E, King C, Brogan P, Haas M, Barratt J, Hafkin J, Eleftheriou D, Keat K, Smith E, Ding W, Cheung C, Platt C, Pillebout E, Chetwynd A, Alladin A, Vaglio A, Jones C, Pain C, Sunderkötter C, Peipert J, Barnes E, Trivioli G, Hardwick H, Morgan H, Bajema I, Wason J, Wade J, Sanchez-Manubens J, Vernon K, Willcocks L, Harper L, Lindsay L, Beldie MA, Marlais M, O'Shaughnessy M, Gkargkoula P, Hamilton P, Bakry R, Bogos R, Demir S, Brix S, Appenzeller S, Bansal T, Anastasa Z, Marks SD, Audemard-Verger A, Renson T, Jelusic M, Jayne D, Salama A. A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop. Kidney Int Rep. 2025 Dec 16;11(3):103729. doi: 10.1016/j.ekir.2025.103729. PMID: 41568275; PMCID: PMC12816797.

#241 2026 Clin Rheumatol

Cutaneous manifestations of autoinflammatory bone diseases: a retrospective multicenter study

Öner N, Cüceoğlu MK, Könte EK, Kayhan E, Çakan M, Demir S, Baba Ö, Kılbaş G, Karaçayır N, Kaplan MM, Batu ED, Yıldız M, Bülbül AY, Tekin ZE, Haşlak F, Kısaarslan AP, Bilginer Y, Bakkaloğlu SA, Yüksel S, Kalyoncu M, Kasapçopur Ö, Özen S, Acar BÇ. Cutaneous manifestations of autoinflammatory bone diseases: a retrospective multicenter study. Clin Rheumatol. 2026 Feb;45(2):1245-1256. doi: 10.1007/s10067-025-07870-6. Epub 2025 Dec 10. PMID: 41372712.

#242 2017 Ann Rheum Dis

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group; Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. Epub 2016 Dec 7. PMID: 27927641; PMCID: PMC5530341.

#243 2015 Proc Natl Acad Sci U S A

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Mellins ED, Ilowite NT, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg A, Wedderburn LR, Anton J, Schwarz T, Hinks A, Bilginer Y, Park J, Cobb J, Satorius CL, Han B, Baskin E, Signa S, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group; Childhood Arthritis Prospective Study (CAPS) Group; Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators; Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group; Biologically Based Outcome Predictors in JIA (BBOP) Group; de Bakker PI, Raychaudhuri S, Langefeld CD, Thompson S, Zeggini E, Thomson W, Kastner DL, Woo P; International Childhood Arthritis Genetics (INCHARGE) Consortium. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15970-5. doi: 10.1073/pnas.1520779112. Epub 2015 Nov 23. PMID: 26598658; PMCID: PMC4702958.

#244 2025 Semin Arthritis Rheum

Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group

Oliver M, Nuruzzaman F, Lenert A, Jayatilleke A, Theos A, Palmou-Fontana N, Skinner A, Twilt M, Wu EY, Aguiar C, Shah S, Romano M, Li S, Lapidus S, King J, Gerber S, Welc B, Bergstrom L, Fox E, Hollander M, Simonini G, Alsaleem A, Chan KK, Laxer R, Onel K, Ozen S, Dedeoglu F, Ferguson P, Helliwell P, Shea B, Hedrich C, Akikusa J, Mease P, Zhao Y. Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group. Semin Arthritis Rheum. 2025 Dec;75:152862. doi: 10.1016/j.semarthrit.2025.152862. Epub 2025 Nov 13. PMID: 41270570.

#245 2021 Semin Arthritis Rheum

Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group

Oliver M, Jayatilleke A, Wu E, Nuruzzaman F, Aguiar C, Lenert A, Romano M, Simonini G, Shah S, Hollander M, Alsaleem A, Fox E, Theos A, Ramanan AV, Schnabel A, Lapidus S, Tucker L, Onel K, Ozen S, Dedeoglu F, Ferguson PJ, Shea B, Akikusa J, Hedrich C, Mease P, Zhao Y. Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group. Semin Arthritis Rheum. 2021 Aug;51(4):957-961. doi: 10.1016/j.semarthrit.2021.05.015. Epub 2021 Jun 7. PMID: 34176644.

#246 2014 J Pharm Sci

Characterization and evaluation of triamcinolone, raloxifene, and their dual-loaded microspheres as prospective local treatment system in rheumatic rat joints

Ocal Y, Kurum B, Karahan S, Tezcaner A, Ozen S, Keskin D. Characterization and evaluation of triamcinolone, raloxifene, and their dual-loaded microspheres as prospective local treatment system in rheumatic rat joints. J Pharm Sci. 2014 Aug;103(8):2396-405. doi: 10.1002/jps.24058. Epub 2014 Jun 17. PMID: 24939720.

#247 2021 Nat Rev Rheumatol

Publisher Correction: Biological classification of childhood arthritis: roadmap to a molecular nomenclature

Nigrovic PA, Colbert RA, Holers VM, Ozen S, Ruperto N, Thompson SD, Wedderburn LR, Yeung RSM, Martini A. Publisher Correction: Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol. 2021 May;17(5):306. doi: 10.1038/s41584-021-00610-5. Erratum for: Nat Rev Rheumatol. 2021 May;17(5):257-269. doi: 10.1038/s41584-021-00590-6. PMID: 33782593.

#248 2021 Nat Rev Rheumatol

Biological classification of childhood arthritis: roadmap to a molecular nomenclature

Nigrovic PA, Colbert RA, Holers VM, Ozen S, Ruperto N, Thompson SD, Wedderburn LR, Yeung RSM, Martini A. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol. 2021 May;17(5):257-269. doi: 10.1038/s41584-021-00590-6. Epub 2021 Mar 17. Erratum in: Nat Rev Rheumatol. 2021 May;17(5):306. doi: 10.1038/s41584-021-00610-5. PMID: 33731872; PMCID: PMC10355214.

#249 2023 Pediatr Pulmonol

Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature

Nayir Buyuksahin H, Basaran O, Balık Z, Bilginer Y, Ozen S, Dogru D. Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature. Pediatr Pulmonol. 2023 Feb;58(2):367-373. doi: 10.1002/ppul.26220. Epub 2022 Nov 7. PMID: 36314652.

#250 2022 Mol Med

Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever

Mughrabi IT, Ochani M, Tanovic M, Wang P, Diamond B, Sherry B, Pavlov VA, Ozen S, Kastner DL, Chae JJ, Al-Abed Y. Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever. Mol Med. 2022 Dec 9;28(1):148. doi: 10.1186/s10020-022-00571-9. PMID: 36494621; PMCID: PMC9733251.

#251 2014 Pediatr Rheumatol Online J

Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration

Moorthy LN, Roy E, Kurra V, Peterson MG, Hassett AL, Lehman TJ, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, de Almeida RG, de Jesus AA, de Arruda Campos LM, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatr Rheumatol Online J. 2014 Nov 25;12:49. doi: 10.1186/1546-0096-12-49. PMID: 25705138; PMCID: PMC4334772.

#252 2017 J Pediatr

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao YJ, Anton J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ, Ravelli A, Horne A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome. J Pediatr. 2017 Oct;189:72-78.e3. doi: 10.1016/j.jpeds.2017.06.005. Epub 2017 Aug 12. PMID: 28807357.

#253 2014 Arthritis Rheumatol

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients

Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014 Nov;66(11):3160-9. doi: 10.1002/art.38802. PMID: 25077692.

#254 2023 Rheumatology (Oxford)

Infantile Takayasu: clinical features and long-term outcome

Miller-Barmak A, Sztajnbok F, Balik Z, Borzutzky A, Fogel LA, Goldzweig O, Ozen S, Butbul Aviel Y. Infantile Takayasu: clinical features and long-term outcome. Rheumatology (Oxford). 2023 Sep 1;62(9):3126-3132. doi: 10.1093/rheumatology/keac691. PMID: 36495199.

#255 2013 Ann Rheum Dis

Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study

Miettunen PM, Pistorio A, Palmisani E, Ravelli A, Silverman E, Oliveira S, Alessio M, Cuttica R, Mihaylova D, Espada G, Pasic S, Insalaco A, Ozen S, Porras O, Sztajnbok F, Lazarevic D, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study. Ann Rheum Dis. 2013 Sep 1;72(9):1503-9. doi: 10.1136/annrheumdis-2012-201937. Epub 2012 Oct 25. PMID: 23100607.

#256 2026 Rheumatology (Oxford)

Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis

Mayer AS, Xiao R, Brandon TG, Weiss PF; Juvenile Axial Spondyloarthritis Research Taskforce (JAxSpRT). Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis. Rheumatology (Oxford). 2026 Mar 5;65(3):keaf611. doi: 10.1093/rheumatology/keaf611. PMID: 41776826; PMCID: PMC13007742.

#257 2025 Clin Exp Rheumatol

Data from a multicentric international study unveils a neglected association between chronic non-bacterial osteomyelitis and inflammatory bowel diseases

Matucci-Cerinic C, Bayindir Y, Longo C, Mori F, Alessi F, Vergani M, Rosina S, Consolaro A, Volpi S, Caorsi R, Arrigo S, Gattorno M, Ozen S, Malattia C. Data from a multicentric international study unveils a neglected association between chronic non-bacterial osteomyelitis and inflammatory bowel diseases. Clin Exp Rheumatol. 2025 Nov;43(11):1992-2000. doi: 10.55563/clinexprheumatol/2pobji. Epub 2025 Sep 25. PMID: 41004323.

#258 2024 Rheumatology (Oxford)

Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach

Matucci-Cerinic C, Palluy H, Al-Mayouf SM, Brogan PA, Cantarini L, Gul A, Kasapcopur O, Kuemmerle-Deschner J, Ozen S, Saadoun D, Shahram F, Bovis F, Mosci E, Ruperto N, Gattorno M, Kone-Paut I. Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach. Rheumatology (Oxford). 2024 Dec 1;63(12):3422-3431. doi: 10.1093/rheumatology/kead609. Erratum in: Rheumatology (Oxford). 2024 Dec 1;63(12):3496. doi: 10.1093/rheumatology/keae147. PMID: 37991850; PMCID: PMC11636558.

#259 2026 EClinicalMedicine

Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study

Mastrolia MV, Pandiarajan V, Cattalini M, Taddio A, Vergnano S, Anton J, Sontichai W, Sozeri B, Ozen S, Rosina S, Sánchez-Manubens J, Haviv R, Pal P, Fonseca AR, Gagro A, Bagri NK, Verdoni L, Montin D, Maggio MC, Thangaraj A, Pilania R, Mosquera M, Calzada J, Sittiwangkul R, Ulu K, Balik Z, Bilginer Y, Garrone M, Patrone E, Barbi E, Ciacci G, Barucci A, Ruperto N, Simonini G. Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study. EClinicalMedicine. 2026 Mar 4;93:103813. doi: 10.1016/j.eclinm.2026.103813. PMID: 41809203; PMCID: PMC12969337.

#260 2024 Semin Arthritis Rheum

Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry

Mastrolia MV, Matucci-Cerinic C, Ozen S, Kasapcopur O, Gaggiano C, Koné- Paut I, Cantarini L, Dusser P, Kaya-Akça Ü, Yildiz M, Brunner J, Filocamo G, Gallizzi R, Insalaco A, Pastore S, Rigante D, Sanchez-Manubens J, Tsitsami E, Ruperto N, Gattorno M, Simonini G; EUROFEVER REGISTRY and Pediatric Rheumatology International trial organization (PRINTO). Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry. Semin Arthritis Rheum. 2024 Jun;66:152454. doi: 10.1016/j.semarthrit.2024.152454. Epub 2024 Apr 23. PMID: 38678817.

#261 2024 medRxiv [Preprint]

Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis

Marques MC, Rubin D, Shuldiner E, Datta M, Schmitz E, Cruz GG, Patt A, Bennett E, Grom A, Foell D, Gattorno M, Bohnsack J, Yeung RSM, Prahalad S, Mellins E, Anton J, Len CA, Oliveira S, Woo P, Ozen S; INCHARGE Consortium; Deng Z, Ombrello MJ. Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis. medRxiv [Preprint]. 2024 Mar 15:2024.03.13.24304215. doi: 10.1101/2024.03.13.24304215. Update in: Arthritis Rheumatol. 2024 Oct;76(10):1566-1572. doi: 10.1002/art.42938. PMID: 38529491; PMCID: PMC10962746.

#262 2026 Rheumatology (Oxford)

Diagnostic approaches to Kawasaki disease worldwide: the results from the JIR- CliPS network

Marčiulynaitė J, Gorczyca D, Šnipaitienė A, Pateras K, Giani T, Ganeva M, Balik Z, Hofer F, Frank M, Ilisson J, Postepski J, Sánchez-Manubens J, Ramanauskienė A, Lanna CCD, Yan J, Dey D, Ozen S, Hofer M, Uziel Y, Kallinich T. Diagnostic approaches to Kawasaki disease worldwide: the results from the JIR- CliPS network. Rheumatology (Oxford). 2026 Jun 30;65(7):keag340. doi: 10.1093/rheumatology/keag340. PMID: 42360778; PMCID: PMC13378453.

#263 2020 Proc Natl Acad Sci U S A

Common genetic susceptibility loci link PFAPA syndrome, Behçet's disease, and recurrent aphthous stomatitis

Manthiram K, Preite S, Dedeoglu F, Demir S, Ozen S, Edwards KM, Lapidus S, Katz AE; Genomic Ascertainment Cohort; Feder HM Jr, Lawton M, Licameli GR, Wright PF, Le J, Barron KS, Ombrello AK, Barham B, Romeo T, Jones A, Srinivasalu H, Mudd PA, DeBiasi RL, Gül A, Marshall GS, Jones OY, Chandrasekharappa SC, Stepanovskiy Y, Ferguson PJ, Schwartzberg PL, Remmers EF, Kastner DL. Common genetic susceptibility loci link PFAPA syndrome, Behçet's disease, and recurrent aphthous stomatitis. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14405-14411. doi: 10.1073/pnas.2002051117. Epub 2020 Jun 9. PMID: 32518111; PMCID: PMC7322016.

#264 2005 Arthritis Rheum

Women in academic rheumatology

Lundberg IE, Ozen S, Gunes-Ayata A, Kaplan MJ. Women in academic rheumatology. Arthritis Rheum. 2005 Mar;52(3):697-706. doi: 10.1002/art.20881. PMID: 15751096.

#265 2024 Front Immunol

Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations

Lengvári L, Takács K, Lengyel A, Pálinkás A, Wouters CH, Koné-Paut I, Kuemmerle-Deschner J, Jeyaratnam J, Anton J, Lachmann HJ, Gattorno M, Hofer M, Toplak N, Weiser P, Kallinich T, Ozen S, Hentgen V, Uziel Y, Horváth Z, Szabados M, Brogan P, Constantin T, Frenkel J. Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations. Front Immunol. 2024 Nov 12;15:1466844. doi: 10.3389/fimmu.2024.1466844. PMID: 39600705; PMCID: PMC11590122.

#266 2023 JAMA Netw Open

Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement

Lee PY, Davidson BA, Abraham RS, Alter B, Arostegui JI, Bell K, Belot A, Bergerson JRE, Bernard TJ, Brogan PA, Berkun Y, Deuitch NT, Dimitrova D, Georgin-Lavialle SA, Gattorno M, Grimbacher B, Hashem H, Hershfield MS, Ichord RN, Izawa K, Kanakry JA, Khubchandani RP, Klouwer FCC, Luton EA, Man AW, Meyts I, Van Montfrans JM, Ozen S, Saarela J, Santo GC, Sharma A, Soldatos A, Sparks R, Torgerson TR, Uriarte IL, Youngstein TAB, Zhou Q, Aksentijevich I, Kastner DL, Chambers EP, Ombrello AK; DADA2 Foundation. Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement. JAMA Netw Open. 2023 May 1;6(5):e2315894. doi: 10.1001/jamanetworkopen.2023.15894. PMID: 37256629.

#267 2022 Front Immunol

Editorial: DADA2 and other monogenic vasculitides

Lee PY, Batu ED, Ozen S. Editorial: DADA2 and other monogenic vasculitides. Front Immunol. 2022 Dec 8;13:1108853. doi: 10.3389/fimmu.2022.1108853. PMID: 36569902; PMCID: PMC9773834.

#268 2022 Eur J Paediatr Neurol

Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review

Laçinel Gürlevik S, Günbey C, Ozsurekci Y, Oygar PD, Kesici S, Gocmen R, Aydin O, Temucin Ç, Tufan E, Terzi K, Baltu D, Ozturk TT, Teksam O, Ozen S, Oguz KK, Cengiz AB, Yalnızoglu D. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review. Eur J Paediatr Neurol. 2022 Mar;37:139-154. doi: 10.1016/j.ejpn.2022.02.003. Epub 2022 Feb 18. PMID: 35287009; PMCID: PMC8853984.

#269 2021 Pediatr Blood Cancer

Hemophagocytosis in bone marrow aspirates in multisystem inflammatory syndrome in children

Lacinel Gurlevik S, Aksu T, Ozen S, Kesici S, Gumruk F, Ozsurekci Y. Hemophagocytosis in bone marrow aspirates in multisystem inflammatory syndrome in children. Pediatr Blood Cancer. 2021 Jun;68(6):e28931. doi: 10.1002/pbc.28931. Epub 2021 Feb 22. PMID: 33619863.

#270 2025 Pediatr Rheumatol Online J

Neurological involvement in children with familial Mediterranean fever: a systematic review

La Bella S, Corsello A, Bayraktar D, Di Ludovico A, Scorrano G, Rinaldi M, Bayindir Y, Ozen S, Milani GP, Gattorno M, Caorsi R. Neurological involvement in children with familial Mediterranean fever: a systematic review. Pediatr Rheumatol Online J. 2025 Sep 2;23(1):90. doi: 10.1186/s12969-025-01137-9. PMID: 40898210; PMCID: PMC12403484.

#271 2025 Rheumatology (Oxford)

Global variations in artificial intelligence-generated information on juvenile idiopathic arthritis

La Bella S, Bayraktar D, Porreca A, Li LC, Attanasi M, Aliyev E, Migowa AN, Scott C, Thakare DR, Bayindir Y, Consolaro A, Feldman BM, Ozen S. Global variations in artificial intelligence-generated information on juvenile idiopathic arthritis. Rheumatology (Oxford). 2025 Nov 1;64(11):5687-5697. doi: 10.1093/rheumatology/keaf329. PMID: 40504018.

#272 2025 Rheumatol Int

Pediatric rheumatology on social media: experts ensure accuracy, public drives engagement - a comparative analysis

La Bella S, Attanasi M, Di Ludovico A, Mainieri F, Lauriola F, Silvestrini L, Ciarelli F, Osmelli J, Girlando V, Rinaldi M, Chiarelli F, Ozen S, Gattorno M, Breda L. Pediatric rheumatology on social media: experts ensure accuracy, public drives engagement - a comparative analysis. Rheumatol Int. 2025 Feb 19;45(3):53. doi: 10.1007/s00296-025-05809-3. PMID: 39969649.

#273 2024 Front Immunol

The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases

La Bella S, Di Ludovico A, Di Donato G, Basaran O, Ozen S, Gattorno M, Chiarelli F, Breda L. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases. Front Immunol. 2024 Jan 5;14:1341680. doi: 10.3389/fimmu.2023.1341680. PMID: 38250061; PMCID: PMC10796709.

#274 2007 Turk J Pediatr

Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association

Kuyucu S, Argin A, Kuyucu N, Ozen S. Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association. Turk J Pediatr. 2007 Jan-Mar;49(1):98-101. PMID: 17479654.

#275 2020 Clin Exp Rheumatol

Burden of illness in hereditary periodic fevers: a multinational observational patient diary study

Kuemmerle-Deschner JB, Quartier P, Kone-Paut I, Hentgen V, Marzan KA, Dedeoglu F, Lachmann HJ, Kallinich T, Blank N, Ozen S, Bilginer Y, Hausmann JS, Diaz A, Perrinjaquet M, Marinsek N, Lomax KG, Hur P, Dekker EL, Livneh A. Burden of illness in hereditary periodic fevers: a multinational observational patient diary study. Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):26-34. Epub 2020 Sep 30. PMID: 33025894.

#276 2018 Ann Rheum Dis

Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative

Kuemmerle-Deschner JB, Hansmann S, Wulffraat NM, Vastert SJ, Hens K, Anton J, Avcin T, Martini A, Koné-Paut I, Uziel Y, Ravelli A, Wouters C, Shaw D, Özen S, Eikelberg A, Prakken BJ, Ruperto N, Horneff G, Constantin T, Beresford MW, Sikken M, Foster HE, Haug I, Schuller S, Jägle C, Benseler SM. Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative. Ann Rheum Dis. 2018 Mar;77(3):319-327. doi: 10.1136/annrheumdis-2017-211904. Epub 2017 Oct 11. PMID: 29021237.

#277 2017 Ann Rheum Dis

Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)

Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, Blank N, Hoffman HM, Weissbarth-Riedel E, Hugle B, Kallinich T, Gattorno M, Gul A, Ter Haar N, Oswald M, Dedeoglu F, Cantarini L, Benseler SM. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). Ann Rheum Dis. 2017 Jun;76(6):942-947. doi: 10.1136/annrheumdis-2016-209686. Epub 2016 Oct 4. PMID: 27707729.

#278 2011 J Rheumatol

Pediatric Behcet's disease and thromboses

Krupa B, Cimaz R, Ozen S, Fischbach M, Cochat P, Koné-Paut I. Pediatric Behcet's disease and thromboses. J Rheumatol. 2011 Feb;38(2):387-90. doi: 10.3899/jrheum.100257. Epub 2010 Nov 15. PMID: 21078724.

#279 2019 Nucleic Acids Res

EPIC-TABSAT: analysis tool for targeted bisulfite sequencing experiments and array-based methylation studies

Krainer J, Weinhäusel A, Hanak K, Pulverer W, Özen S, Vierlinger K, Pabinger S. EPIC-TABSAT: analysis tool for targeted bisulfite sequencing experiments and array-based methylation studies. Nucleic Acids Res. 2019 Jul 2;47(W1):W166-W170. doi: 10.1093/nar/gkz398. PMID: 31106358; PMCID: PMC6602470.

#280 2021 2021 Feb 1;60(2):607-616

Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline? Rheumatology (Oxford)

Kosukcu C, Taskiran EZ, Batu ED, Sag E, Bilginer Y, Alikasifoglu M, Ozen S. Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline? Rheumatology (Oxford). 2021 Feb 1;60(2):607-616. doi: 10.1093/rheumatology/keaa165. PMID: 32447396.

#281 2022 Turk Arch Pediatr

The Comparison of Pediatric Patients with Familial Mediterranean Fever Originated from Turkey and Crimea

Kostik M, Akca Kaya U, Zhogova OV, Sag E, Suspitsin EN, Nizhnik VI, Tumakova AV, Ivanovskiy SV, Lagunova NV, Bilginer Y, Ozen S. The Comparison of Pediatric Patients with Familial Mediterranean Fever Originated from Turkey and Crimea. Turk Arch Pediatr. 2022 Sep;57(5):551-557. doi: 10.5152/TurkArchPediatr.2022.22106. PMID: 36062443; PMCID: PMC9524423.

#282 2020 Pediatr Res

Rheumatological manifestations in inborn errors of immunity

Köstel Bal S, Pazmandi J, Boztug K, Özen S. Rheumatological manifestations in inborn errors of immunity. Pediatr Res. 2020 Jan;87(2):293-299. doi: 10.1038/s41390-019-0600-8. Epub 2019 Oct 3. PMID: 31581173.

#283 2016 Clin Exp Rheumatol

A novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment report

Konukbay D, Gattorno M, Yildiz D, Frenkel J, Acikel C, Sozeri B, Makay B, Aktay Ayaz N, Barut K, Kisaarslan A, Bilginer Y, Karaman D, Peru H, Simsek D, Aydog O, Unsal E, Gunduz Z, Fidanci BE, Kone-Paut I, Kasapcopur O, Ravelli A, Ozen S, Demirkaya E; and the FMF Arthritis Vasculitis and Orphan disease Research in Paediatric Rheumatology.. A novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment report. Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):129-135. Epub 2016 Oct 25. PMID: 27791950.

#284 2016 Ann Rheum Dis

Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD

Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton J, Hofer M, Chkirate B, Bouayed K, Tugal-Tutkun I, Kuemmerle-Deschner J, Agostini H, Federici S, Arnoux A, Piedvache C, Ozen S; PEDBD group. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016 Jun;75(6):958-64. doi: 10.1136/annrheumdis-2015-208491. Epub 2015 Dec 23. PMID: 26698843.

#285 2011 Paediatric Behçet's disease: an international cohort study of 110 patients

Registries in rheumatological and musculoskeletal conditions

Koné-Paut I, Darce-Bello M, Shahram F, Gattorno M, Cimaz R, Ozen S, Cantarini L, Tugal-Tutktun I, Assaad-Khalil S, Hofer M, Kuemmerle-Deschner J, Benamour S, Al Mayouf S, Pajot C, Anton J, Faye A, Bono W, Nielsen S, Letierce A, Tran TA; PED-BD International Expert Committee. Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford). 2011 Jan;50(1):184-8. doi: 10.1093/rheumatology/keq324. Epub 2010 Oct 29. PMID: 21036877.

#286 2026 Curr Rheumatol Rep

Thrombo- inflammation and Rethinking the Role of Aspirin in Kawasaki Disease

Kocatürk B, Berberoğulları B, Aliyev E, Sağ E, Özen S, Arditi M. Thrombo- inflammation and Rethinking the Role of Aspirin in Kawasaki Disease. Curr Rheumatol Rep. 2026 Feb 6;28(1):4. doi: 10.1007/s11926-026-01211-5. PMID: 41649640; PMCID: PMC12881031.

#287 2023 Front Pediatr

Editorial: Recent advances in pediatric inflammatory diseases

Kocatürk B, Özmen F, Arditi M, Özen S. Editorial: Recent advances in pediatric inflammatory diseases. Front Pediatr. 2023 Jul 27;11:1237625. doi: 10.3389/fped.2023.1237625. PMID: 37576145; PMCID: PMC10421723.

#288 2022 Front Pediatr

Spondyloarthritides: Theories and beyond

Kocatürk B, Balık Z, Pişiren G, Kalyoncu U, Özmen F, Özen S. Spondyloarthritides: Theories and beyond. Front Pediatr. 2022 Dec 23;10:1074239. doi: 10.3389/fped.2022.1074239. PMID: 36619518; PMCID: PMC9816396.

#289 2025 Rheumatology (Oxford)

Severe haematological involvement in children with systemic lupus erythematosus and clinical associations

Kisaoglu H, Sener S, Demirbas KC, Demir Yigit Y, Garipcin P, Coşkun S, Kacmaz HM, Kisla Ekinci RM, Ozturk K, Koker O, Ucak K, Tuncez S, Kilbas G, Karacayir N, Baykal GO, Taskın SN, Bozkaya B, Baba O, Demir S, Basaran O, Sahin S, Baglan E, Sahin N, Gungorer V, Pac Kısaarslan A, Sozeri B, Yuksel S, Bakkaloglu S, Balat A, Gurgoze MK, Kasapcopur O, Ozen S, Kalyoncu M. Severe haematological involvement in children with systemic lupus erythematosus and clinical associations. Rheumatology (Oxford). 2025 Apr 1;64(4):2153-2161. doi: 10.1093/rheumatology/keae414. PMID: 39093021.

#290 2024 Rheumatology (Oxford)

Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus

Kisaoglu H, Sener S, Aslan E, Baba O, Sahin S, Bilginer Y, Kasapcopur O, Ozen S, Kalyoncu M. Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI114-SI121. doi: 10.1093/rheumatology/kead647. PMID: 38048608.

#291 2023 Joint Bone Spine

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

Kısaarslan AP, Çiçek SÖ, Batu ED, Şahin S, Gürgöze MK, Çetinkaya SB, Ekinci MK, Atmış B, Barut K, Adrovic A, Ağar BE, Şahin N, Demir F, Bağlan E, Kara MA, Selçuk ŞZ, Özdel S, Çomak E, Akkoyunlu B, Yener GO, Yıldırım DG, Öztürk K, Yıldız M, Haşlak F, Şener S, Kısaoğlu H, Baba Ö, Kızıldağ Z, İşgüder R, Çağlayan Ş, Bilgin RBG, Aytaç G, Yücel BB, Tanatar A, Sönmez HE, Çakan M, Kara A, Elmas AT, Kılıç BD, Ayaz NA, Kasap B, Acar BÇ, Ozkaya O, Yüksel S, Bakkaloğlu S, Aydoğ Ö, Aksu G, Akman S, Dönmez O, Bülbül M, Büyükçelik M, Tabel Y, Sözeri B, Kalyoncu M, Bilginer Y, Poyrazoğlu MH, Ünsal E, Kasapçopur Ö, Özen S, Düşünsel R. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study. Joint Bone Spine. 2023 Jul;90(4):105559. doi: 10.1016/j.jbspin.2023.105559. Epub 2023 Feb 28. PMID: 36858168.

#292 2025 J Rheumatol

Results of a Nationwide Multicenter Study in Childhood Sjögren Disease

Kılbaş G, Ayduran S, Şener S, Coşkuner T, Ulu K, Kısaoğlu H, Aslan E, Könte EK, Arslanaoğlu C, Aydın T, Oğuzkaya YŞ, Çakmak F, Yıldırım DG, Kaplan MM, Tığrak SN, Türkuçar S, Sönmez HE, Ekinci MK, Öztürk K, Demir F, Bağlan E, Bozkaya B, Taşkın SN, Demir S, Sağ E, Batu ED, Şahin S, Bakkaloğlu SA, Kilic SS, Kısaarslan AP, Acar BÇ, Kalyoncu M, Ayaz NA, Sözeri B, Ünsal E, Kasapçopur Ö, Özen S, Yüksel S. Results of a Nationwide Multicenter Study in Childhood Sjögren Disease. J Rheumatol. 2025 Nov 1;52(11):1141-1150. doi: 10.3899/jrheum.2024-1048. PMID: 40664482.

#293 2007 2007 Jun;27(8):691-4

Is the CD14 C159T polymorphism effective in the development of secondary amyloidosis in Familial Mediterranean fever? Rheumatol Int

Keskin O, Yilmaz E, Kutlay S, Bakkaloglu A, Topaloglu R, Arici M, Kalayci O, Ozen S. Is the CD14 C159T polymorphism effective in the development of secondary amyloidosis in Familial Mediterranean fever? Rheumatol Int. 2007 Jun;27(8):691-4. doi: 10.1007/s00296-006-0286-1. Epub 2006 Dec 23. PMID: 17187267.

#294 2015 2015 Sep;79(9):1566-70

Cochlear functions in children with familial Mediterranean fever: any role of the severity of the disease? Int J Pediatr Otorhinolaryngol

Keskindemirci G, Ayaz NA, Batıoğlu-Karaaltın A, Dönmez Z, Yiğit Ö, Aydoğan G, Özen S. Cochlear functions in children with familial Mediterranean fever: any role of the severity of the disease? Int J Pediatr Otorhinolaryngol. 2015 Sep;79(9):1566-70. doi: 10.1016/j.ijporl.2015.07.020. Epub 2015 Jul 23. PMID: 26231741.

#295 2025 Cytokine

Cord blood chemokine levels as a predictor of oxidative stress and morbidities of prematurity

Kayki G, Sag E, Aliyev F, Ozen S, Yigit S. Cord blood chemokine levels as a predictor of oxidative stress and morbidities of prematurity. Cytokine. 2025 Oct;194:157006. doi: 10.1016/j.cyto.2025.157006. Epub 2025 Aug 4. PMID: 40752454.

#296 2022 Turk J Pediatr

Glomerulonephritis with crescents in childhood; etiologies and significance of M2 macrophages

Kaykı G, Orhan D, Gülhan B, Topaloğlu R, Akçören Z, Düzova A, Özaltın F, Özen S, Bilginer Y, Güçer Ş. Glomerulonephritis with crescents in childhood; etiologies and significance of M2 macrophages. Turk J Pediatr. 2022;64(1):59-68. doi: 10.24953/turkjped.2020.2172. PMID: 35286031.

#297 2025 RMD Open

Clusters in paediatric Behçet's disease: a multicentre international study

Kaya Akca U, Shahram F, Karabulut E, Akhlaghi M, Faezi ST, Akgun O, Çakan M, Esen E, Matucci-Cerinic C, Torun R, Unsal E, Gattorno M, Aktay Ayaz N, Paç Kısaarslan A, Sozeri B, Batu ED, Koné-Paut I, Ozen S. Clusters in paediatric Behçet's disease: a multicentre international study. RMD Open. 2025 Jul 5;11(3):e005335. doi: 10.1136/rmdopen-2024-005335. PMID: 40617583; PMCID: PMC12228434.

#298 2025 Rheumatology (Oxford)

A rare disease with many faces: a multicentre registry of IgG4-related disease in children

Kaya Akca U, Kose H, Kurt T, Ulu K, Guliyeva V, Kılbas G, Arslanoglu C, Yildirim DG, Demir S, Sahin S, Kısaarslan AP, Kasap Demir B, Sonmez HE, Koker O, Yardimci GK, Ekici M, Kilic SS, Celikel Acar B, Sozeri B, Aktay Ayaz N, Yuksel S, Bakkaloglu SA, Kasapcopur O, Saglam EA, Karadag O, Ozen S, Bilginer Y. A rare disease with many faces: a multicentre registry of IgG4-related disease in children. Rheumatology (Oxford). 2025 Apr 1;64(4):2185-2192. doi: 10.1093/rheumatology/keae497. PMID: 39298509.

#299 2024 Lupus

Drug-induced lupus erythematosus in childhood: Case-based review

Kaya Akca U, Sener S, Batu ED, Balik Z, Basaran O, Bilginer Y, Ozen S. Drug-induced lupus erythematosus in childhood: Case-based review. Lupus. 2024 Jun;33(7):737-748. doi: 10.1177/09612033241245078. Epub 2024 Apr 5. PMID: 38580326.

#300 2024 Rheumatology (Oxford)

Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children

Kaya Akca U, Batu ED, Jelusic M, Calatroni M, Bakry R, Frkovic M, Vinšová N, Campos RT, Horne A, Caglayan S, Vaglio A, Moroni G, Emmi G, Ghiggeri GM, Koker O, Sinico RA, Kim S, Gagro A, Matucci-Cerinic C, Çomak E, Ekici Tekin Z, Arslanoglu Aydin E, Heshin-Bekenstein M, Acar BC, Gattorno M, Akman S, Sozeri B, Palmblad K, Al-Mayouf SM, Silva CA, Doležalová P, Merkel PA, Ozen S. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children. Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI122-SI128. doi: 10.1093/rheumatology/kead693. PMID: 38135503.

#301 2024 Clin Rheumatol

Chronic non-bacterial osteomyelitis and immune checkpoint molecules

Kaya Akca U, Sag E, Aydın B, Tasdemir NK, Kasap Cuceoglu M, Basaran O, Batu ED, Bilginer Y, Ozen S. Chronic non-bacterial osteomyelitis and immune checkpoint molecules. Clin Rheumatol. 2024 Jan;43(1):553-560. doi: 10.1007/s10067-023-06761-y. Epub 2023 Sep 7. PMID: 37676588.

#302 2023 Turk Arch Pediatr

Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods

Kaya Akca Ü, Batu ED, Tanalı G, Atalay E, Kasap Cüceoğlu M, Sener S, Balık Z, Bayındır Y, Aliyev E, Başaran Ö, Bilginer Y, Özen S. Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turk Arch Pediatr. 2023 Jan;58(1):49-55. doi: 10.5152/TurkArchPediatr.2022.22192. PMID: 36598211; PMCID: PMC9885826.

#303 2022 Clin Exp Rheumatol

Poor performance of IgG4-related disease responder index in children

Kaya Akca U, Yardimci GK, Bilginer Y, Ozen S, Karadag O. Poor performance of IgG4-related disease responder index in children. Clin Exp Rheumatol. 2022 Dec;40(12):2463. doi: 10.55563/clinexprheumatol/c195fr. Epub 2022 Jun 15. PMID: 35766010.

#304 2022 Clin Rheumatol

The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study

Kaya Akca U, Batu ED, Sener S, Balik Z, Kasap Cuceoglu M, Atalay E, Basaran O, Bilginer Y, Ozen S. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study. Clin Rheumatol. 2022 Jun;41(6):1785-1792. doi: 10.1007/s10067-022-06080-8. Epub 2022 Jan 29. PMID: 35091782.

#305 2022 Mod Rheumatol

Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients

Kaya Akca U, Sener S, Balık Z, Gurlevik S, Oygar PD, Atalay E, Cuceoglu MK, Basaran O, Batu ED, Teksam O, Bilginer Y, Ozsurekci Y, Ozen S. Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients. Mod Rheumatol. 2022 Feb 28;32(2):467-472. doi: 10.1093/mr/roab056. PMID: 34897503.

#306 2022 Rheumatol Int

Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases

Kaya Akca U, Atalay E, Cuceoglu MK, Balik Z, Sener S, Ozsurekci Y, Basaran O, Batu ED, Bilginer Y, Ozen S. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases. Rheumatol Int. 2022 Jan;42(1):51-57. doi: 10.1007/s00296-021-05027-7. Epub 2021 Nov 2. PMID: 34727197; PMCID: PMC8561687.

#307 2021 Clin Rheumatol

Real-world data on MTX tolerance with regimens used in children versus adults

Kaya Akca U, Farisogullari B, Yardimci GK, Sag E, Atalay E, Kasap Cuceoglu M, Basaran O, Kilic L, Ozen S, Bilginer Y. Real-world data on MTX tolerance with regimens used in children versus adults. Clin Rheumatol. 2021 Dec;40(12):5095-5102. doi: 10.1007/s10067-021-05802-8. Epub 2021 Jul 4. PMID: 34218394.

#308 2021 Semin Arthritis Rheum

The role of vascular inflammation markers in deficiency of adenosine deaminase 2

Kaya Akca U, Sag E, Unal S, Kasap Cuceoglu M, Bilginer Y, Ozen S. The role of vascular inflammation markers in deficiency of adenosine deaminase 2. Semin Arthritis Rheum. 2021 Aug;51(4):839-844. doi: 10.1016/j.semarthrit.2021.04.013. Epub 2021 Apr 28. PMID: 34157579.

#309 2022 Rheumatol Int

IgG4-related disease in pediatric patients: a single-center experience

Kaya Akca Ü, Atalay E, Kasap Cüceoğlu M, Şener S, Balık Z, Başaran Ö, Batu ED, Karadağ Ö, Özen S, Bilginer Y. IgG4-related disease in pediatric patients: a single-center experience. Rheumatol Int. 2022 Jul;42(7):1177-1185. doi: 10.1007/s00296-021-04885-5. Epub 2021 May 12. PMID: 33978820.

#310 2022 Pediatr Res

Comparison of IVIG resistance predictive models in Kawasaki disease

Kaya Akca U, Arslanoglu Aydin E, Aykan HH, Serin O, Sag E, Demir S, Atalay E, Kasap M, Batu ED, Karagoz T, Bilginer Y, Ozen S. Comparison of IVIG resistance predictive models in Kawasaki disease. Pediatr Res. 2022 Feb;91(3):621-626. doi: 10.1038/s41390-021-01459-w. Epub 2021 Mar 22. PMID: 33753891.

#311 2021 Eur J Med Genet

Genetic disorders with symptoms mimicking rheumatologic diseases: A single-center retrospective study

Kaya Akca U, Simsek Kiper PO, Urel Demir G, Sag E, Atalay E, Utine GE, Alikasifoglu M, Boduroglu K, Bilginer Y, Ozen S. Genetic disorders with symptoms mimicking rheumatologic diseases: A single-center retrospective study. Eur J Med Genet. 2021 Apr;64(4):104185. doi: 10.1016/j.ejmg.2021.104185. Epub 2021 Mar 2. PMID: 33662637.

#312 2021 J Pediatr Urol

Penile involvement of immunoglobulin a vasculitis/Henoch-Schönlein purpura

Kaya Akca U, Batu ED, Serin O, Ipek OF, Aydin O, Teksam O, Bilginer Y, Ozen S. Penile involvement of immunoglobulin a vasculitis/Henoch-Schönlein purpura. J Pediatr Urol. 2021 Jun;17(3):409.e1-409.e8. doi: 10.1016/j.jpurol.2021.01.012. Epub 2021 Jan 22. PMID: 33558175.

#313 2024 Lupus

Childhood- onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations

Kavrul Kayaalp G, Esencan D, Guliyeva V, Arık SD, Türkmen Ş, Şahin S, Bilginer Y, Kasapçopur Ö, Sözeri B, Özen S, Aktay Ayaz N, Sawalha AH. Childhood- onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations. Lupus. 2024 Sep;33(10):1130-1138. doi: 10.1177/09612033241265975. Epub 2024 Jul 22. PMID: 39037381; PMCID: PMC11405132.

#314 2022 J Clin Apher

Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children

Katlan B, Kesici S, Karacanoğlu D, Oygar PD, Ünal Yüksekgönül A, Şener S, Aykan HH, Özsurekçi Y, Özen S, Bayrakci B. Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children. J Clin Apher. 2022 Jun;37(3):281-291. doi: 10.1002/jca.21971. Epub 2022 Feb 17. PMID: 35174897.

#315 2018 Int J Nephrol

Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study

Kaspar CDW, Sanderson K, Ozen S, Verghese PS, Lo M, Bunchman TE, Wenderfer SE, Kidd J. Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study. Int J Nephrol. 2018 Aug 5;2018:8413096. doi: 10.1155/2018/8413096. PMID: 30155302; PMCID: PMC6098870.

#316 2022 Arch Rheumatol

Two siblings with Majeed syndrome and neutropenia

Kasap Cuceoglu M, Batu ED, Yildiz AE, Kaya Akca U, Atalay E, Sener S, Balik Z, Basaran O, Bilginer Y, Ozen S. Two siblings with Majeed syndrome and neutropenia. Arch Rheumatol. 2022 Sep 20;37(4):638-640. doi: 10.46497/ArchRheumatol.2022.9437. PMID: 36879569; PMCID: PMC9985377.

#317 2022 2022 Dec 8;11(24):7291

Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed? J Clin Med

Kasap Cuceoglu M, Basaran O, Soyer O, Ozen S. Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed? J Clin Med. 2022 Dec 8;11(24):7291. doi: 10.3390/jcm11247291. PMID: 36555908; PMCID: PMC9785630.

#318 2023 Int J Rheum Dis

Report of 2 pediatric cases with atypical Cogan's syndrome and a systematic review

Kasap Cuceoglu M, Basaran O, Batu ED, Kaya Akca U, Atalay E, Sener S, Balik Z, Bayindir Y, Aliyev E, Gocmen R, Kadayifcilar S, Akyol U, Bilginer Y, Ozen S. Report of 2 pediatric cases with atypical Cogan's syndrome and a systematic review. Int J Rheum Dis. 2023 Mar;26(3):544-550. doi: 10.1111/1756-185X.14531. Epub 2022 Dec 11. PMID: 36502531.

#319 2021 Semin Arthritis Rheum

Systematic review of childhood-onset polyarteritis nodosa and DADA2

Kasap Cuceoglu M, Sener S, Batu ED, Kaya Akca U, Demir S, Sag E, Atalay E, Balık Z, Basaran O, Bilginer Y, Ozen S. Systematic review of childhood-onset polyarteritis nodosa and DADA2. Semin Arthritis Rheum. 2021 Jun;51(3):559-564. doi: 10.1016/j.semarthrit.2021.04.009. Epub 2021 Apr 19. PMID: 33901990.

#320 2021 Ann Rheum Dis

COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study

Kasap Cuceoglu M, Batu ED, Bilginer Y, Özen S. COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study. Ann Rheum Dis. 2021 Jun;80(6):e95. doi: 10.1136/annrheumdis-2020-218341. Epub 2020 Jul 6. PMID: 32632034.

#321 2024 Arthritis Rheumatol

Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study

Karadag O, Bolek EC, Ayan G, Mohammad AJ, Grayson PC, Pagnoux C, Martín- Nares E, Monti S, Abe Y, Alberici F, Alibaz-Oner F, Cuthbertson D, Dagna L, Direskeneli H, Khalidi NA, Koening C, Langford CA, McAlear CA, Monach PA, Moroni L, Padoan R, Seo P, Warrington KJ, Hocevar A, Hinojosa-Azaola A, Furuta S, Emmi G, Ozen S, Jayne D, Merkel PA; GLOBAL‐PAN Collaborators. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study. Arthritis Rheumatol. 2024 Jul;76(7):1120-1129. doi: 10.1002/art.42817. Epub 2024 Feb 22. PMID: 38343337; PMCID: PMC11213674.

#322 2018 Rheumatol Int

A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts

Karadag O, Erden A, Bilginer Y, Gopaluni S, Sari A, Armagan B, Ertenli I, Ozen S, Jayne D. A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts. Rheumatol Int. 2018 Oct;38(10):1833-1840. doi: 10.1007/s00296-018-4122-1. Epub 2018 Aug 11. PMID: 30099592.

#323 2026 Semin Arthritis Rheum

Phenotype-genotype correlation and treatment outcomes in mevalonate kinase deficiency: A large Turkish cohort

Kaplan MM, Ekici Tekin Z, Kılıç Könte E, Balık Z, Aydın T, Çağlayan Ş, Arık SD, Kurt T, Yıldız Ç, Karalı Y, Kışla Ekinci M, Çakan M, Doğantan Ş, Kılbaş G, Bozkaya Yücel B, Tanatar A, Şener S, Esen E, Öner N, Köker O, Demir S, Sağ E, Demir Yiğit Y, Baba Ö, Kaya Akça Ü, Taşkın S, Sunar Yayla EN, Yıldız M, Gezgin Yıldırım D, Paç Kısaarslan A, Kasap Demir B, Kalyoncu M, Gürgöze MK, Yüksel S, Kılıç SŞ, Bora B, Sözeri B, Aktay Ayaz N, Bilginer Y, Kasapçopur Ö, Özen S, Çelikel Acar B. Phenotype-genotype correlation and treatment outcomes in mevalonate kinase deficiency: A large Turkish cohort. Semin Arthritis Rheum. 2026 Jun;78:152963. doi: 10.1016/j.semarthrit.2026.152963. Epub 2026 Mar 7. PMID: 41833237.

#324 2003 Microscopic polyarteritis nodosa (PAN)

Questions

Kalyoncu M, Ozen S, Orhan D, Topaloglu R, Kale G, Bakkaloglu A. Questions. Microscopic polyarteritis nodosa (PAN). Pediatr Nephrol. 2003 Sep;18(9):962-5. doi: 10.1007/s00467-003-1202-5. PMID: 14515856.

#325 2007 Pediatrics

Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement

Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007 Feb;119(2):e474-83. doi: 10.1542/peds.2006-1434. Epub 2007 Jan 22. PMID: 17242135.

#326 2012 Nat Rev Rheumatol

Severity scoring system for paediatric FMF

Kalkan G, Demirkaya E, Ozen S. Severity scoring system for paediatric FMF. Nat Rev Rheumatol. 2012 Oct;8(10):621. doi: 10.1038/nrrheum.2012.54-c1. Epub 2012 Sep 11. PMID: 22964532.

#327 2012 2012 Apr;51(4):743-8

Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Rheumatology (Oxford)

Kalkan G, Demirkaya E, Acikel CH, Polat A, Peru H, Karaoglu A, Sari E, Dursun I, Gok F, Ozen S; FMF Arthritis Vasculitis and Orphan Disease Research in Paediatric Rheumatology (FAVOR). Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Rheumatology (Oxford). 2012 Apr;51(4):743-8. doi: 10.1093/rheumatology/ker421. Epub 2011 Dec 20. PMID: 22190688.

#328 2023 Curr Rheumatol Rep

Possible Role of Dysbiosis of the Gut Microbiome in SLE

Kalayci FNC, Ozen S. Possible Role of Dysbiosis of the Gut Microbiome in SLE. Curr Rheumatol Rep. 2023 Dec;25(12):247-258. doi: 10.1007/s11926-023-01115-8. Epub 2023 Sep 22. PMID: 37737528.

#329 2021 Lupus

WITHDRAWN: Hematological involvement in pediatric systemic lupus erythematosus: A multi- center study

K Akca Ü, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S. WITHDRAWN: Hematological involvement in pediatric systemic lupus erythematosus: A multi- center study. Lupus. 2021 Sep;30(10):NP1-NP8. doi: 10.1177/09612033211014271. Epub 2021 May 6. Retraction in: Lupus. 2021 Sep;30(10):1700. doi: 10.1177/09612033211026424. PMID: 33951967.

#330 2025 Rheumatol Adv Pract

Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action

Jouret M, Aguiar F, Girard-Guyonvarc'h C, Vyzhga Y, Oliveira-Ramos F, Lana CC, Guedri R, Lefevre-Utile A, Hadef D, Angarita JMM, Ozen S, Sahin S, Hashad S, Daghor-Abbaci K, Foell D, Georgin-Lavialle S, Theodoropoulou K; JIR-CLIPS Network. Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action. Rheumatol Adv Pract. 2025 Jul 3;9(3):rkaf073. doi: 10.1093/rap/rkaf073. PMID: 40901639; PMCID: PMC12401577.

#331 2019 2019 Feb 28;17(1):10

Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? Pediatr Rheumatol Online J

Jelusic M, Sestan M, Cimaz R, Ozen S. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? Pediatr Rheumatol Online J. 2019 Feb 28;17(1):10. doi: 10.1186/s12969-019-0311-z. PMID: 30819179; PMCID: PMC6393980.

#332 2003 Pediatr Nephrol

Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever

Işlek I, Simşek T, Baskin E, Simşek B, Küçüködük S, Bedir A, Bakkaloğlu A, Beşbaş N, Topaloğlu R, Ozen S, Saatçi U. Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever. Pediatr Nephrol. 2003 Oct;18(10):1005-8. doi: 10.1007/s00467-003-1227-9. Epub 2003 Jul 23. PMID: 12883976.

#333 2020 Turk J Pediatr

Takayasu arteritis presenting with spontaneous pneumothorax

Hızal M, Demir S, Polat SE, Özen S, Kiper N. Takayasu arteritis presenting with spontaneous pneumothorax. Turk J Pediatr. 2020;62(5):879-883. doi: 10.24953/turkjped.2020.05.024. PMID: 33108095.

#334 2014 J Immunol

Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling

Heymann MC, Winkler S, Luksch H, Flecks S, Franke M, Ruß S, Ozen S, Yilmaz E, Klein C, Kallinich T, Lindemann D, Brenner S, Ganser G, Roesler J, Rösen- Wolff A, Hofmann SR. Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling. J Immunol. 2014 May 1;192(9):4379-85. doi: 10.4049/jimmunol.1203524. Epub 2014 Apr 4. PMID: 24706726.

#335 2011 Arthritis Rheum

Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study

Hasija R, Pistorio A, Ravelli A, Demirkaya E, Khubchandani R, Guseinova D, Malattia C, Canhao H, Harel L, Foell D, Wouters C, De Cunto C, Huemer C, Kimura Y, Mangge H, Minetti C, Nordal EB, Philippet P, Garozzo R, Martini A, Ruperto N; Pediatric Rheumatology International Trials Organization. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. Arthritis Rheum. 2011 Oct;63(10):3142-52. doi: 10.1002/art.30475. PMID: 21647864.

#336 2022 J Clin Immunol

Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein DD, Hsu AP, Holland SM, Krance R, Sasa G, Kumar AR, Müller I, de Sousa MA, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese MP, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks JP, Dokmeci E, Dara J, Lucas CL, Hambleton S, Wilson K, Jolles S, Koc Y, Güngör T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry JA, Meyts I. Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients. J Clin Immunol. 2022 Oct;42(7):1580-1581. doi: 10.1007/s10875-022-01280-y. Erratum for: J Clin Immunol. 2021 Oct;41(7):1633-1647. doi: 10.1007/s10875-021-01098-0. PMID: 35499644; PMCID: PMC9674743.

#337 2021 J Clin Immunol

Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein DD, Hsu AP, Holland SM, Krance R, Sasa G, Kumar AR, Müller I, de Sousa MA, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese MP, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks JP, Dokmeci E, Dara J, Lucas CL, Hambleton S, Wilson K, Jolles S, Koc Y, Güngör T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry JA, Meyts I. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients. J Clin Immunol. 2021 Oct;41(7):1633-1647. doi: 10.1007/s10875-021-01098-0. Epub 2021 Jul 29. Erratum in: J Clin Immunol. 2022 Oct;42(7):1580-1581. doi: 10.1007/s10875-022-01280-y. PMID: 34324127; PMCID: PMC8452581.

#338 2012 Rheumatology (Oxford)

Canakinumab induces remission in a patient with resistant familial Mediterranean fever

Hacihamdioglu DO, Ozen S. Canakinumab induces remission in a patient with resistant familial Mediterranean fever. Rheumatology (Oxford). 2012 Jun;51(6):1041. doi: 10.1093/rheumatology/kes021. Epub 2012 Mar 7. PMID: 22403182.

#339 2021 Front Immunol

Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders

Guzel F, Romano M, Keles E, Piskin D, Ozen S, Poyrazoglu H, Kasapcopur O, Demirkaya E. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders. Front Immunol. 2021 Jun 9;12:666273. doi: 10.3389/fimmu.2021.666273. PMID: 34177904; PMCID: PMC8219981.

#340 2022 Eur J Paediatr Neurol

Neurologic manifestations in children with COVID-19

Gürlevik SL, Günbey C, Ozsurekci Y, Kesici S, Gocmen R, Temucin Ç, Özen S, Cengiz AB, Yalnızoglu D. Neurologic manifestations in children with COVID-19. Eur J Paediatr Neurol. 2022 Jul;39:118-119. doi: 10.1016/j.ejpn.2022.06.004. Epub 2022 Jun 13. PMID: 35781422; PMCID: PMC9190175.

#341 2022 Pediatr Res

The difference of the inflammatory milieu in MIS-C and severe COVID-19

Gurlevik SL, Ozsurekci Y, Sağ E, Derin Oygar P, Kesici S, Akca ÜK, Cuceoglu MK, Basaran O, Göncü S, Karakaya J, Cengiz AB, Özen S. The difference of the inflammatory milieu in MIS-C and severe COVID-19. Pediatr Res. 2022 Dec;92(6):1805-1814. doi: 10.1038/s41390-022-02029-4. Epub 2022 Mar 29. PMID: 35352005; PMCID: PMC8963396.

#342 2025 Clin Rheumatol

Syndrome of undifferentiated recurrent fever (SURF): a multicenter real-world experience from Türkiye

Güngörer V, Ünal D, Çakan M, Ayduran S, Gül Ü, Zora HK, Öner N, Köker O, Uçak K, Şahin N, Demir S, Demirbaş B, Özdel S, Yüksel S, Kilic SS, Bilginer Y, Kasapçopur Ö, Özen S, Çelikel Acar B. Syndrome of undifferentiated recurrent fever (SURF): a multicenter real-world experience from Türkiye. Clin Rheumatol. 2025 Nov;44(11):4601-4614. doi: 10.1007/s10067-025-07682-8. Epub 2025 Sep 18. PMID: 40968336.

#343 2018 J Allergy Clin Immunol

Type I IFN-related NETosis in ataxia telangiectasia and Artemis deficiency

Gul E, Sayar EH, Gungor B, Eroglu FK, Surucu N, Keles S, Guner SN, Findik S, Alpdundar E, Ayanoglu IC, Kayaoglu B, Geckin BN, Sanli HA, Kahraman T, Yakicier C, Muftuoglu M, Oguz B, Cagdas Ayvaz DN, Gursel I, Ozen S, Reisli I, Gursel M. Type I IFN-related NETosis in ataxia telangiectasia and Artemis deficiency. J Allergy Clin Immunol. 2018 Jul;142(1):246-257. doi: 10.1016/j.jaci.2017.10.030. Epub 2017 Nov 16. PMID: 29155101.

#344 2025 Nat Rev Rheumatol

Reply to 'Inborn errors of immunity and AAV: a complex picture'

Gül A, Aksentijevich I, Brogan P, Gattorno M, Grayson PC, Ozen S. Reply to 'Inborn errors of immunity and AAV: a complex picture'. Nat Rev Rheumatol. 2025 Dec;21(12):753. doi: 10.1038/s41584-025-01298-7. PMID: 40926085.

#345 2025 Nat Rev Rheumatol

The pathogenesis, clinical presentations and treatment of monogenic systemic vasculitis

Gül A, Aksentijevich I, Brogan P, Gattorno M, Grayson PC, Ozen S. The pathogenesis, clinical presentations and treatment of monogenic systemic vasculitis. Nat Rev Rheumatol. 2025 Jul;21(7):414-425. doi: 10.1038/s41584-025-01250-9. Epub 2025 May 14. PMID: 40369133.

#346 2017 Pediatr Emerg Care

Unusual Presentations of Childhood Systemic Lupus Erythematosus to the Emergency Department

Gültekingil Keser A, Ertuğrul İ, Tekşam Ö, Konuşkan B, Özkutlu S, Özen S. Unusual Presentations of Childhood Systemic Lupus Erythematosus to the Emergency Department. Pediatr Emerg Care. 2017 Oct;33(10):e100-e102. doi: 10.1097/PEC.0000000000000829. PMID: 27977505.

#347 2024 Mod Rheumatol

A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

Guliyeva V, Demirkan FG, Yiğit RE, Esen E, Bayındır Y, Torun R, Kılbas G, Gezgin Yıldırım D, Otar Yener G, Cakan M, Demir F, Özturk K, Baglan E, Yuksel S, Bakkaloglu SA, Bora Makay B, Paç Kısaarslan A, Oray M, Bilginer Y, Eker Ömeroğlu R, Ozen S, Sozeri B, Aktay Ayaz N. A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey. Mod Rheumatol. 2024 Mar 28;34(3):639-645. doi: 10.1093/mr/road050. PMID: 37243724.

#348 2020 Pediatr Nephrol

A rare cause of steroid-resistant nephrotic syndrome in a child: Answers

Guliyeva L, Tabel Y, Düzova A, Akpolat N, Özen S, Topaloğlu R, Sözeri B. A rare cause of steroid-resistant nephrotic syndrome in a child: Answers. Pediatr Nephrol. 2020 Apr;35(4):621-623. doi: 10.1007/s00467-019-04385-6. Epub 2019 Dec 6. PMID: 31811537.

#349 2020 Pediatr Nephrol

A rare cause of steroid resistant nephrotic syndrome in a child: Questions

Guliyeva L, Tabel Y, Düzova A, Akpolat N, Özen S, Topaloğlu R, Sözeri B. A rare cause of steroid resistant nephrotic syndrome in a child: Questions. Pediatr Nephrol. 2020 Apr;35(4):619-620. doi: 10.1007/s00467-019-04381-w. Epub 2019 Dec 6. PMID: 31811535.

#350 2015 Pediatr Nephrol

Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura)

Gülhan B, Orhan D, Kale G, Besbas N, Özen S. Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura). Pediatr Nephrol. 2015 Aug;30(8):1269-77. doi: 10.1007/s00467-015-3051-4. Epub 2015 Feb 4. PMID: 25648880.

#351 2014 2014 Jul-Aug;32(4 Suppl 84):S160-4

Are MEFV mutations susceptibility factors in enthesitis-related arthritis patients in the eastern Mediterranean? Clin Exp Rheumatol

Gülhan B, Akkuş A, Ozçakar L, Beşbaş N, Ozen S. Are MEFV mutations susceptibility factors in enthesitis-related arthritis patients in the eastern Mediterranean? Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S160-4. Epub 2014 Feb 24. PMID: 24564907.

#352 2013 2013 May-Jun;55(3):315-8

Diagnostic dilemma in autoinflammatory disease in two patients: does the name matter? Turk J Pediatr

Gülhan B, Büyükcam A, Touitou I, Özen S. Diagnostic dilemma in autoinflammatory disease in two patients: does the name matter? Turk J Pediatr. 2013 May-Jun;55(3):315-8. PMID: 24217079.

#353 2012 Turk J Pediatr

Varying clinical features of Turkish Kawasaki disease patients

Gülhan B, Kesici S, Beken S, Cilsal E, Kale G, Alehan D, Kara A, Ozen S. Varying clinical features of Turkish Kawasaki disease patients. Turk J Pediatr. 2012 Jan-Feb;54(1):1-6. PMID: 22397034.

#354 2005 Pediatr Dev Pathol

Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes

Güçer S, Talim B, Aşan E, Korkusuz P, Ozen S, Unal S, Kalkanoğlu SH, Kale G, Cağlar M. Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes. Pediatr Dev Pathol. 2005 Nov-Dec;8(6):710-7. doi: 10.1007/s10024-005-0058-z. Epub 2005 Nov 18. PMID: 16328667.

#355 2017 Ann Rheum Dis

European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative

Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Özen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis. 2017 Dec;76(12):1965-1973. doi: 10.1136/annrheumdis-2017-211898. Epub 2017 Sep 6. PMID: 28877866.

#356 2017 Ann Rheum Dis

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Ozen S, Pilkington C, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis. 2017 Nov;76(11):1788-1796. doi: 10.1136/annrheumdis-2016-210960. Epub 2017 Jun 19. PMID: 28630236.

#357 2017 Ann Rheum Dis

European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative

Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, Kenet G, Koné-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington CA, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert SJ, Wulffraat NM, Ozen S, Brogan P, Kamphuis S, Beresford MW. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis. 2017 Oct;76(10):1637-1641. doi: 10.1136/annrheumdis-2016-211001. Epub 2017 May 4. PMID: 28473426.

#358 2016 Arthritis Rheumatol

Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group; Leon K, Lheritier K, Abrams K. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. Arthritis Rheumatol. 2016 Jan;68(1):218-28. doi: 10.1002/art.39407. PMID: 26314396.

#359 2010 Eur J Pediatr

Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene

Gok F, Crettol LM, Alanay Y, Hacihamdioglu B, Kocaoglu M, Bonafe L, Ozen S. Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene. Eur J Pediatr. 2010 Mar;169(3):363-7. doi: 10.1007/s00431-009-1028-7. Epub 2009 Aug 4. PMID: 19653001.

#360 2008 Rheumatol Int

Pathogenesis-related adhesion molecules in Henoch-Schonlein vasculitis

Gok F, Ugur Y, Ozen S, Dagdeviren A. Pathogenesis-related adhesion molecules in Henoch-Schonlein vasculitis. Rheumatol Int. 2008 Feb;28(4):313-6. doi: 10.1007/s00296-007-0437-z. Epub 2007 Aug 15. PMID: 17701178.

#361 2025 Nature

TGFβ links EBV to multisystem inflammatory syndrome in children

Goetzke CC, Massoud M, Frischbutter S, Guerra GM, Ferreira-Gomes M, Heinrich F, von Stuckrad ASL, Wisniewski S, Licha JR, Bondareva M, Ehlers L, Khaldi-Plassart S, Javouhey E, Pons S, Trouillet-Assant S, Ozsurekci Y, Zhang Y, Poli MC, Discepolo V, Lo Vecchio A, Sahin B, Verboom M, Hallensleben M, Heuhsen AI, Astudillo C, Espinosa Y, Vial Cox MC, Dobbs K, Delmonte OM, Montealegre Sanchez GA, Magliocco M, Barron K, Danielson J, Petrov L, Unterwalder N, Sawitzki B, Matz M, Lehmann K, Gratopp A, von Bernuth H, Burkhardt LM, Wiese N, Peter L, Schmueck-Henneresse M, Amini L, Maurer M, Roehmel JF, Gewurz BE, Yonker LM, Witkowski M, Kruglov A, Mall MA, Su HC, Ozen S, Radbruch A, Belot A, Durek P, Kallinich T, Mashreghi MF. TGFβ links EBV to multisystem inflammatory syndrome in children. Nature. 2025 Apr;640(8059):762-771. doi: 10.1038/s41586-025-08697-6. Epub 2025 Mar 12. PMID: 40074901; PMCID: PMC12003184.

#362 2025 RMD Open

Elevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohort

Girard-Guyonvarc'h C, Rodriguez E, Mueller YM, Caruso A, Katsikis PD, Gabay C; ImmunAID consortium. Elevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohort. RMD Open. 2025 May 7;11(2):e005388. doi: 10.1136/rmdopen-2024-005388. PMID: 40341183; PMCID: PMC12060884.

#363 2020 Arthritis Res Ther

Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee

Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, Huppertz HI, Lovell DJ, Wolfs T, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok F, Maritsi D, Constantin T, Vargova V, Sawhney S, Rygg M, K Oliveira S, Cattalini M, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee. Arthritis Res Ther. 2020 Apr 7;22(1):71. doi: 10.1186/s13075-020-02167-2. PMID: 32264969; PMCID: PMC7136994.

#364 2015 Ann Rheum Dis

Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever

Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, Kallinich T, Ozdogan H, Anton J, Brogan P, Cantarini L, Frenkel J, Galeotti C, Gattorno M, Grateau G, Hofer M, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Simon A, Demirkaya E, Feldman B, Uziel Y, Ozen S. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015 Apr;74(4):635-41. doi: 10.1136/annrheumdis-2014-206844. Epub 2015 Jan 27. PMID: 25628446.

#365 2025 Turk J Med Sci

Transformation of juvenile idiopathic arthritis in adult-oriented rheumatology care

Germe Dağlioğlu ŞA, Balik Z, Özsoy Z, Dalkiliç YE, Batu ED, Başaran Ö, Bilginer Y, Kalyoncu U, Özen S, Apraş Bilgen Ş, Kiliç L. Transformation of juvenile idiopathic arthritis in adult-oriented rheumatology care. Turk J Med Sci. 2025 Oct 19;55(6):1408-1416. doi: 10.55730/1300-0144.6098. PMID: 41509947; PMCID: PMC12779043.

#366 2020 Front Immunol

Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency

Geier CB, Farmer JR, Foldvari Z, Ujhazi B, Steininger J, Sleasman JW, Parikh S, Dilley MA, Pai SY, Henderson L, Hazen M, Neven B, Moshous D, Sharapova SO, Mihailova S, Yankova P, Naumova E, Özen S, Byram K, Fernandez J, Wolf HM, Eibl MM, Notarangelo LD, Calabrese LH, Walter JE. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency. Front Immunol. 2020 Oct 21;11:574738. doi: 10.3389/fimmu.2020.574738. PMID: 33193364; PMCID: PMC7609967.

#367 2019 Ann Rheum Dis

Classification criteria for autoinflammatory recurrent fevers

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO). Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. PMID: 31018962.

#368 2026 Am J Ophthalmol

Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry

Gaggiano C, DE-LA-Torre A, Guerriero S, Tierradentro-Alape R, Ragab G, Forero-Uribe A, Costi S, Dammacco R, Paroli MP, Hegazy MT, Del Giudice E, Sota J, Hinojosa-Azaola A, Breda L, Vitale A, Fonollosa A, Civino A, Gentileschi S, Cattalini M, Mauro A, Caggiano V, Hashad S, Sbalchiero J, Ruscitti P, Chimenti MS, Tarsia M, Giardini HAM, Conforti A, Tharwat S, Carubbi F, Moshrif A, Hernández-Rodríguez J, Fotis L, Bugatti S, Al-Mayouf S, Karamanakos A, Piga M, Minoia F, Maggio MC, Sebastiani GD, Conti G, Barone P, Kawakami-Campos PA, Lopalco G, LA Torre F, Gicchino MF, Ozen S, Batu ED, Frediani B, Cantarini L, Fabiani C. Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry. Am J Ophthalmol. 2026 Feb;282:292-304. doi: 10.1016/j.ajo.2025.11.009. Epub 2025 Nov 14. PMID: 41242592.

#369 2025 Ophthalmol Ther

Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry

Gaggiano C, De-la-Torre A, Cardona-López J, Guerriero S, Ragab G, Paroli MP, Breda L, Del Giudice E, Tarsia M, Sota J, Civino A, Cattalini M, Vitale A, Gentileschi S, Mauro A, Al-Mayouf S, Hashad S, Fonollosa A, Aboul Naga SH, Amin RH, Fotis L, Gicchino MF, Caggiano V, Dammacco R, Maggio MC, Rodríguez-Camelo D, Chimenti MS, Lopez-Bonilla J, Batu ED, Ozen S, Minoia F, Tufan A, Hegazy MT, Babu K, Sbalchiero J, Moshrif A, Barone P, Kawakami-Campos PA, Conforti A, Govoni M, Conti G, Thabet M, La Torre F, Carreño E, Gupta V, Frediani B, Cantarini L, Fabiani C; on behalf the AIDA Network. Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry. Ophthalmol Ther. 2025 Nov;14(11):2877-2894. doi: 10.1007/s40123-025-01237-5. Epub 2025 Sep 23. PMID: 40983853; PMCID: PMC12534201.

#370 2024 Ophthalmol Ther

Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis from the AIDA Network

Gaggiano C, Tufan A, Guerriero S, Ragab G, Sota J, Gentileschi S, Costi S, Almaghlouth IA, Hinojosa-Azaola A, Tharwat S, Sfikakis PP, Lopalco G, Piga M, Conti G, Fragoulis G, Mauro A, Batu ED, Ozen S, Tarsia M, La Torre F, Kawakami- Campos PA, Vitale A, Caggiano V, Kardaş RC, Tosi GM, Frediani B, Avčin T, Hernández-Rodríguez J, Cantarini L, Fabiani C; AIDA Network. Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis from the AIDA Network. Ophthalmol Ther. 2024 Jun;13(6):1479-1498. doi: 10.1007/s40123-024-00916-z. Epub 2024 Mar 30. PMID: 38563868; PMCID: PMC11109053.

#371 2023 Front Med (Lausanne)

A patient-driven registry on Behçet's disease: the AIDA for patients pilot project

Gaggiano C, Del Bianco A, Sota J, Gentileschi S, Ruscitti P, Giacomelli R, Piga M, Crisafulli F, Monti S, Emmi G, De Paulis A, Vitale A, Tarsia M, Caggiano V, Nuzzolese R, Parretti V, Fabiani C, Lopalco G, Maier A, Cattalini M, Rigante D, Govoni M, Li Gobbi F, Guiducci S, Parronchi P, Marino A, Ciccia F, Maggio MC, Aragona E, Bartoloni E, Iagnocco A, Viapiana O, Sebastiani GD, Guerriero S, Insalaco A, Del Giudice E, Conti G, Barone P, Olivieri AN, Brucato A, Carubbi F, Triggianese P, Mauro A, Tosi GM, Fonollosa A, Giardini HAM, Ragab G, Tharwat S, Hernández-Rodríguez J, Sfikakis PP, Laskari K, Karamanakos A, Espinosa G, Shahram F, Direskeneli H, Hinojosa-Azaola A, Opris-Belinski D, AlMaghlouth IA, Hatemi G, Eksin MA, Önen F, Więsik-Szewczyk E, Akkoç N, Tufan A, Şahin A, Erten Ş, Ozen S, Batu ED, Frediani B, Balistreri A, Cantarini L. A patient-driven registry on Behçet's disease: the AIDA for patients pilot project. Front Med (Lausanne). 2023 Jun 16;10:1188021. doi: 10.3389/fmed.2023.1188021. PMID: 37396916; PMCID: PMC10313381.

#372 2017 Ann Rheum Dis

EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases

Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Demirkaya E, Ozen S, Carmona L. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017 Apr;76(4):639-646. doi: 10.1136/annrheumdis-2016-210112. Epub 2016 Nov 1. Erratum in: Ann Rheum Dis. 2018 Jun;77(6):960. doi: 10.1136/annrheumdis-2016-210112corr1. PMID: 27802961.

#373 2019 Kidney Int

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018. PMID: 30665568.

#374 2017 Int J Rheum Dis

Assessment of autonomic functions in children with familial Mediterranean fever by using heart rate variability measurements

Fidanci K, Gulgun M, Demirkaya E, Acikel C, Kilic A, Gok F, Ozen S. Assessment of autonomic functions in children with familial Mediterranean fever by using heart rate variability measurements. Int J Rheum Dis. 2017 Dec;20(12):2086-2092. doi: 10.1111/1756-185X.12401. Epub 2014 May 24. PMID: 24860912.

#375 2014 Clin Exp Rheumatol

The invisible part of the iceberg: qualitative aspects of childhood vasculitis

Fidanci BE, Demirkaya E, Acikel C, Fidanci K, Karaman D, Yildiz D, Konukbay D, Polat A, Basbozkurt G, Topaloglu R, Cimaz R, Ravelli A, Ozen S; FMF Arthritis Vasculitis and Orphan disease Research in Paediatric Rheumatology. The invisible part of the iceberg: qualitative aspects of childhood vasculitis. Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S122-7. Epub 2013 Sep 10. PMID: 24021608.

#376 2016 Vaccine

Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases

Felicetti P, Trotta F, Bonetto C, Santuccio C, Brauchli Pernus Y, Burgner D, Chandler R, Girolomoni G, Hadden RD, Kochhar S, Kucuku M, Monaco G, Ozen S, Pahud B, Phuong L, Bachtiar NS, Teeba A, Top K, Varricchio F, Wise RP, Zanoni G, Živkovic S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases. Vaccine. 2016 Dec 12;34(51):6634-6640. doi: 10.1016/j.vaccine.2015.09.027. Epub 2015 Sep 21. PMID: 26392009.

#377 2019 J Rheumatol

An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor- associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome

Federici S, Vanoni F, Ben-Chetrit E, Cantarini L, Frenkel J, Goldbach- Mansky R, Gul A, Hoffman H, Koné-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Martini A, Obici L, Ozen S, Simon A, Hofer M, Ruperto N, Gattorno M; Eurofever and the Pediatric Rheumatology International Trials Organization (PRINTO). An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor- associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome. J Rheumatol. 2019 Apr;46(4):429-436. doi: 10.3899/jrheum.180056. Epub 2018 Nov 1. PMID: 30385706.

#378 2015 Ann Rheum Dis

Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers

Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, Koné-Paut I, Dewarrat N, Cantarini L, Insalaco A, Uziel Y, Rigante D, Quartier P, Demirkaya E, Herlin T, Meini A, Fabio G, Kallinich T, Martino S, Butbul AY, Olivieri A, Kuemmerle-Deschner J, Neven B, Simon A, Ozdogan H, Touitou I, Frenkel J, Hofer M, Martini A, Ruperto N, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015 May;74(5):799-805. doi: 10.1136/annrheumdis-2014-206580. Epub 2015 Jan 30. PMID: 25637003.

#379 2024 Ann Rheum Dis

EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease

Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Antón J, Belot A, Bracaglia C, Constantin T, Dagna L, Di Bartolo A, Feist E, Foell D, Gattorno M, Georgin- Lavialle S, Giacomelli R, Grom AA, Jamilloux Y, Laskari K, Lazar C, Minoia F, Nigrovic PA, Oliveira Ramos F, Ozen S, Quartier P, Ruscitti P, Sag E, Savic S, Truchetet ME, Vastert SJ, Wilhelmer TC, Wouters C, Carmona L, De Benedetti F. EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease. Ann Rheum Dis. 2024 Nov 14;83(12):1614-1627. doi: 10.1136/ard-2024-225851. PMID: 39317417; PMCID: PMC11672000.

#380 2022 2022 Sep;17(6):1599-1608

Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease? Intern Emerg Med

Farisogullari B, Cuceoglu MK, Oral H, Yardimci GK, Bilginer Y, Ozen S, Karadag O. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease? Intern Emerg Med. 2022 Sep;17(6):1599-1608. doi: 10.1007/s11739-022-02968-0. Epub 2022 Mar 26. PMID: 35347546.

#381 2012 Clin Exp Rheumatol

Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study

Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, La Torre F, Rigante D. Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study. Clin Exp Rheumatol. 2012 Sep-Oct;30(5):799-804. Epub 2012 Oct 17. PMID: 23020938.

#382 2021 Turk J Pediatr

Oral health status in children with familial Mediterranean fever

Esmeray P, Keçeli Tİ, Tekçiçek M, Batu ED, Arıcı ZS, Ünlü HK, Özen S, Bilginer Y. Oral health status in children with familial Mediterranean fever. Turk J Pediatr. 2021;63(3):443-449. doi: 10.24953/turkjped.2021.03.011. PMID: 34254489.

#383 2016 Clin Exp Rheumatol

Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children

Eroglu FK, Kasapcopur O, Beşbaş N, Ozaltin F, Bilginer Y, Barut K, Mensa- Vilaro A, Nakagawa K, Heike T, Nishikomori R, Arostegui J, Ozen S. Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children. Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S115-S120. Epub 2016 May 10. PMID: 27191192.

#384 2015 Rheumatol Int

Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents

Eroglu FK, Beşbaş N, Topaloglu R, Ozen S. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. Rheumatol Int. 2015 Oct;35(10):1733-7. doi: 10.1007/s00296-015-3293-2. Epub 2015 May 23. PMID: 26001859.

#385 2016 Rheumatol Int

What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review

Erer B, Demirkaya E, Ozen S, Kallinich T. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol Int. 2016 Apr;36(4):483-7. doi: 10.1007/s00296-015-3413-z. Epub 2015 Dec 28. PMID: 26712372.

#386 2018 2018 Nov- Dec;36(6 Suppl 115):97-102

Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? Clin Exp Rheumatol

Erden A, Batu ED, Sarı A, Sönmez HE, Armagan B, Demir S, Fırat E, Bilginer Y, Bilgen SA, Karadağ Ö, Kalyoncu U, Kiraz S, Ertenli I, Özen S, Akdogan A. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? Clin Exp Rheumatol. 2018 Nov- Dec;36(6 Suppl 115):97-102. Epub 2018 Nov 12. PMID: 30418112.

#387 2017 Int J Rheum Dis

Comparing polyarteritis nodosa in children and adults: a single center study

Erden A, Batu ED, Sönmez HE, Sarı A, Armagan B, Arıcı ZS, Bilgin E, Kalyoncu U, Karadağ Ö, Bilginer Y, Ertenli AI, Özen S. Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis. 2017 Aug;20(8):1016-1022. doi: 10.1111/1756-185X.13120. Epub 2017 Jun 19. PMID: 28626961.

#388 2014 J Biomater Appl

In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes

Erdemli Ö, Özen S, Keskin D, Usanmaz A, Batu ED, Atilla B, Tezcaner A. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes. J Biomater Appl. 2014 Oct;29(4):524-42. doi: 10.1177/0885328214535958. Epub 2014 May 21. PMID: 24854983.

#389 2026 RMD Open

Clinical course, complications and treatment outcomes in Still's disease: a 10-year single-centre cohort study

Ercan Emreol H, Sag E, Ozcilingir Hakverdi P, Bayındır Y, Cam V, Unal D, Erkan MO, Necipoglu Banak Ö, Dara Kar HD, Basaran O, Bilginer Y, Ozen S. Clinical course, complications and treatment outcomes in Still's disease: a 10-year single-centre cohort study. RMD Open. 2026 May 12;12(2):e006637. doi: 10.1136/rmdopen-2025-006637. PMID: 42120178; PMCID: PMC13182382.

#390 2026 Rheumatology (Oxford)

Clinical and laboratory predictors of diagnostic delay in childhood Takayasu arteritis and PAN: a retrospective cohort study

Ercan Emreol H, Başaran O, Bayındır Y, Cam V, Ünal D, Erkan MO, Banak ÖN, Dara Kar HD, Sag E, Bilginer Y, Özen S. Clinical and laboratory predictors of diagnostic delay in childhood Takayasu arteritis and PAN: a retrospective cohort study. Rheumatology (Oxford). 2026 Feb 4;65(2):keaf661. doi: 10.1093/rheumatology/keaf661. PMID: 41365833.

#391 2026 Rheumatology (Oxford)

Phenotypic subgroups and classification criteria performance in paediatric Behçet's disease: insights on systemic involvement

Ercan Emreol H, Cam V, Sag E, Bayındır Y, Ünal D, Erkan MO, Banak ÖN, Dara Kar HD, Başaran O, Bilginer Y, Ozen S. Phenotypic subgroups and classification criteria performance in paediatric Behçet's disease: insights on systemic involvement. Rheumatology (Oxford). 2026 Feb 4;65(2):keaf637. doi: 10.1093/rheumatology/keaf637. PMID: 41317363.

#392 2025 Pediatr Rheumatol Online J

New avenues in childhood vasculitis

Ercan Emreol H, Yildirim-Toruner C, Jelusic M, Twilt M, Ozen S. New avenues in childhood vasculitis. Pediatr Rheumatol Online J. 2025 Oct 6;23(1):97. doi: 10.1186/s12969-025-01149-5. PMID: 41053800; PMCID: PMC12502369.

#393 2026 Rheumatology (Oxford)

One mutation, divergent journeys: expanding the clinical spectrum of homozygous SAMHD1 deficiency in childhood

Emreol HE, Ünal D, Ayvaz DNC, Bilginer Y, Özen S. One mutation, divergent journeys: expanding the clinical spectrum of homozygous SAMHD1 deficiency in childhood. Rheumatology (Oxford). 2026 Jan 8;65(1):keaf695. doi: 10.1093/rheumatology/keaf695. PMID: 41496005; PMCID: PMC12798528.

#394 2020 Hum Mutat

ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy

Elsea SH, Solyom A, Martin K, Harmatz P, Mitchell J, Lampe C, Grant C, Selim L, Mungan NO, Guelbert N, Magnusson B, Sundberg E, Puri R, Kapoor S, Arslan N, DiRocco M, Zaki M, Ozen S, Mahmoud IG, Ehlert K, Hahn A, Gokcay G, Torcoletti M, Ferreira CR. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. Hum Mutat. 2020 Sep;41(9):1469-1487. doi: 10.1002/humu.24056. Epub 2020 Jun 24. PMID: 32449975.

#395 2015 Nephrol Dial Transplant

Vasculitis in children

Eleftheriou D, Batu ED, Ozen S, Brogan PA. Vasculitis in children. Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i94-103. doi: 10.1093/ndt/gfu393. Epub 2014 Dec 30. PMID: 25550447.

#396 2009 Rheumatology (Oxford)

Biologic therapy in primary systemic vasculitis of the young

Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, Dolezalova P, Ozen S, Pilkington C, Woo P, Klein N, Dillon MJ, Brogan PA. Biologic therapy in primary systemic vasculitis of the young. Rheumatology (Oxford). 2009 Aug;48(8):978-86. doi: 10.1093/rheumatology/kep148. Epub 2009 Jun 17. PMID: 19535611.

#397 2026 Rheumatology (Oxford)

Paediatric neuro-Behçet's disease: multi-centre observational study

Ekici Tekin Z, Polat MC, Bayındır Y, Kaçmaz M, Esen E, Coşkuner T, Kızıldağ Z, Karalı Z, Sunar Yayla EN, Şenol PE, Yıldız M, Şahin N, Kılbaş G, Tekgöz N, Taşkın SN, Öztürk K, Demir S, Çelikel E, Paç Kısaarslan A, Kilic SS, Sözeri B, Bilginer Y, Yüksel S, Bakkaloğlu S, Balat A, Ünsal E, Kasapçopur Ö, Özen S. Paediatric neuro-Behçet's disease: multi-centre observational study. Rheumatology (Oxford). 2026 Apr 6;65(4):keag187. doi: 10.1093/rheumatology/keag187. PMID: 41968830.

#398 2003 Saudi J Kidney Dis Transpl

Vesicoureteral reflux in childhood

Duzova A, Ozen S. Vesicoureteral reflux in childhood. Saudi J Kidney Dis Transpl. 2003 Jul-Sep;14(3):290-5. PMID: 17657100.

#399 2014 Int J Adolesc Med Health

Quality of life measures and psychiatric symptoms in adolescents with systemic lupus erythematosus and familial Mediterranean fever

Düzçeker Y, Kanbur NÖ, Demirkaya E, Derman O, Moorthy LN, Ozen S. Quality of life measures and psychiatric symptoms in adolescents with systemic lupus erythematosus and familial Mediterranean fever. Int J Adolesc Med Health. 2014;26(4):541-9. doi: 10.1515/ijamh-2013-0332. PMID: 24486727.

#400 2022 Lupus

Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience

Duran E, Yıldırım T, Taghiyeva A, Bilgin E, Arıcı M, Sağlam EA, Özen S, Üner M, Erdem Y, Kalyoncu U, Ertenli AI. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience. Lupus. 2022 Aug;31(9):1147-1156. doi: 10.1177/09612033221106305. Epub 2022 Jun 3. PMID: 35658643; PMCID: PMC9277329.

#401 2019 Rheumatology (Oxford)

The European network for care of children with paediatric rheumatic diseases: care across borders

Dolezalova P, Anton J, Avcin T, Beresford MW, Brogan PA, Constantin T, Egert Y, Foeldvari I, Foster HE, Hentgen V, Kone-Paut I, Kuemmerle-Deschner JB, Lahdenne P, Magnusson B, Martini A, McCann L, Minden K, Ozen S, Schoemaker C, Quartier P, Ravelli A, Rumba-Rozenfelde I, Ruperto N, Vastert S, Wouters C, Zulian F, Wulffraat NM. The European network for care of children with paediatric rheumatic diseases: care across borders. Rheumatology (Oxford). 2019 Jul 1;58(7):1188-1195. doi: 10.1093/rheumatology/key439. PMID: 30668879.

#402 2013 Ann Rheum Dis

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)

Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O'Neil KM, Wallace CA, Wilkinson N, Eleftheriou D, Demirkaya E, Böhm M, Krol P, Luqmani RA, Brogan PA. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013 Oct;72(10):1628-33. doi: 10.1136/annrheumdis-2012-202111. Epub 2012 Oct 25. PMID: 23100606.

#403 2024 Health Expect

Health Literacy Levels of Patients With Juvenile Idiopathic Arthritis and Their Parents

Doğan Y, Karaca NB, Buran S, Atabey Gerlegiz EN, Aliyev E, Bayındır Y, Bilginer Y, Ünal E, Özen S. Health Literacy Levels of Patients With Juvenile Idiopathic Arthritis and Their Parents. Health Expect. 2024 Jun;27(3):e14117. doi: 10.1111/hex.14117. PMID: 38879783; PMCID: PMC11180293.

#404 2024 Clin Rheumatol

The Juvenile Arthritis Quality of Life Questionnaire in patients with juvenile idiopathic arthritis: Turkish version, validity, and reliability study

Doğan Y, Karaca NB, Buran S, Tüfekçi O, Atabey Gerlegiz EN, Aliyev E, Bayındır Y, Bilginer Y, Ünal E, Özen S. The Juvenile Arthritis Quality of Life Questionnaire in patients with juvenile idiopathic arthritis: Turkish version, validity, and reliability study. Clin Rheumatol. 2024 Jun;43(6):1999-2008. doi: 10.1007/s10067-024-06962-z. Epub 2024 Apr 15. PMID: 38619726.

#405 2007 Heart Surg Forum

Peripheral gangrene associated with Kawasaki disease and successful management using prostacycline analogue: a case report

Dogan OF, Kara A, Devrim I, Tezer H, Besbas N, Ozen S, Secmeer G, Yorgancioglu C, Boke E. Peripheral gangrene associated with Kawasaki disease and successful management using prostacycline analogue: a case report. Heart Surg Forum. 2007;10(1):E70-2. doi: 10.1532/HSF98.20061151. PMID: 17311768.

#406 2006 Pediatr Nephrol

A new international classification of childhood vasculitis

Dillon MJ, Ozen S. A new international classification of childhood vasculitis. Pediatr Nephrol. 2006 Sep;21(9):1219-22. doi: 10.1007/s00467-006-0181-8. Epub 2006 Jul 4. PMID: 16821024.

#407 2024 Rheumatology (Oxford)

The risk of cardiovascular comorbidity in children with Behçet's disease

Demir S, Duzova A, Karagoz T, Oguz B, Aykan HH, Satirer O, Sag E, Ozen S, Bilginer Y. The risk of cardiovascular comorbidity in children with Behçet's disease. Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI188-SI194. doi: 10.1093/rheumatology/kead505. PMID: 37788103; PMCID: PMC11381679.

#408 2023 Diagnostics (Basel)

Plasma Proteomic Analysis Reveals the Potential Role of Lectin and Alternative Complement Pathways in IgA Vasculitis Pathogenesis

Demir S, Yet I, Sardan Ekiz M, Sag E, Bilginer Y, Celikbicak O, Lay I, Ozen S. Plasma Proteomic Analysis Reveals the Potential Role of Lectin and Alternative Complement Pathways in IgA Vasculitis Pathogenesis. Diagnostics (Basel). 2023 May 12;13(10):1729. doi: 10.3390/diagnostics13101729. PMID: 37238213; PMCID: PMC10217085.

#409 2022 Lupus

The challenges in diagnosing pediatric primary antiphospholipid syndrome

Demir S, Keskin A, Sağ E, Kaya Akca Ü, Atalay E, Cüceoğlu MK, Batu Akal ED, Özen S, Bilginer Y. The challenges in diagnosing pediatric primary antiphospholipid syndrome. Lupus. 2022 Sep;31(10):1269-1275. doi: 10.1177/09612033221108853. Epub 2022 Jun 23. PMID: 35746827.

#410 2022 2022 Mar;42(3):519-527

Spinal involvement in juvenile idiopathic arthritis: what do we miss without imaging? Rheumatol Int

Demir S, Ergen FB, Taydaş O, Sağ E, Bilginer Y, Aydıngöz Ü, Özen S. Spinal involvement in juvenile idiopathic arthritis: what do we miss without imaging? Rheumatol Int. 2022 Mar;42(3):519-527. doi: 10.1007/s00296-021-04890-8. Epub 2021 Jun 11. PMID: 34115188.

#411 2022 Nephrol Dial Transplant

Long-term renal survival of paediatric patients with lupus nephritis

Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R. Long-term renal survival of paediatric patients with lupus nephritis. Nephrol Dial Transplant. 2022 May 25;37(6):1069-1077. doi: 10.1093/ndt/gfab152. PMID: 33826705.

#412 2020 Semin Arthritis Rheum

Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis

Demir S, Kaplan O, Celebier M, Sag E, Bilginer Y, Lay I, Ozen S. Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis. Semin Arthritis Rheum. 2020 Dec;50(6):1238-1244. doi: 10.1016/j.semarthrit.2020.09.006. Epub 2020 Sep 19. PMID: 33065418.

#413 2019 Turk J Pediatr

Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience

Demir S, Sönmez HE, Arslanoğlu-Aydın E, Özen S, Bilginer Y. Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience. Turk J Pediatr. 2019;61(2):180-185. doi: 10.24953/turkjped.2019.02.005. PMID: 31951328.

#414 2020 Clin Exp Rheumatol

Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood

Demir S, Soyer O, Bilginer Y, Sag E, Sahiner UM, Buyuktiryaki B, Sekerel BE, Ozen S. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood. Clin Exp Rheumatol. 2020 May- Jun;38(3):552-557. Epub 2019 Nov 20. PMID: 31820716.

#415 2019 Clin Exp Rheumatol

Paediatric Behçet's disease with sinus venous thrombosis: experience from three centres in Turkey

Demir S, Acari C, Basaran O, Sağ E, Karlı Oğuz K, Bilginer Y, Ünsal SE, Özen S. Paediatric Behçet's disease with sinus venous thrombosis: experience from three centres in Turkey. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):147-151. Epub 2019 Jul 15. PMID: 31376249.

#416 2019 Pediatrics

The Challenge of Treating Pulmonary Vasculitis in Behçet Disease: Two Pediatric Cases

Demir S, Sag E, Kaya Akca U, Hazirolan T, Bilginer Y, Ozen S. The Challenge of Treating Pulmonary Vasculitis in Behçet Disease: Two Pediatric Cases. Pediatrics. 2019 Aug;144(2):e20190162. doi: 10.1542/peds.2019-0162. Epub 2019 Jul 18. PMID: 31320468.

#417 2018 Front Pediatr

Vasculitis in Systemic Autoinflammatory Diseases

Demir S, Sag E, Dedeoglu F, Ozen S. Vasculitis in Systemic Autoinflammatory Diseases. Front Pediatr. 2018 Dec 3;6:377. doi: 10.3389/fped.2018.00377. PMID: 30560109; PMCID: PMC6287042.

#418 2019 Curr Rheumatol Rev

Vasculitis: Decade in Review

Demir S, Sönmez HE, Özen S. Vasculitis: Decade in Review. Curr Rheumatol Rev. 2019;15(1):14-22. doi: 10.2174/1573397114666180726093731. PMID: 30047330.

#419 2026 Pediatr Res

Multisystem Inflammatory Syndrome in Children with tailored therapy and six-month outcome

Demir OO, Aykac K, Cheng AHH, Kesici S, Aykan HH, Bilginer Y, Cengiz AB, Yeung RSM, Ozsurekci Y, Ozen S. Multisystem Inflammatory Syndrome in Children with tailored therapy and six-month outcome. Pediatr Res. 2026 Jan 10. doi: 10.1038/s41390-025-04706-6. Epub ahead of print. PMID: 41519951.

#420 2026 Turk J Pediatr

Impact of rheumatologic diseases on pediatric inflammatory bowel disease

Demirtaş Güner D, Sağ E, Hızarcıoğlu Gülşen H, Balık Z, Saltık Temizel İN, Özen H, Demir H, Özen S. Impact of rheumatologic diseases on pediatric inflammatory bowel disease. Turk J Pediatr. 2026 Apr 30;68(2):288-296. doi: 10.24953/turkjpediatr.2026.6631. PMID: 42172463.

#421 2018 Rheumatol Int

The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

Demirkaya E, Ozen S, Sozeri B, Ayaz NA, Kasapcopur O, Unsal E, Makay BB, Barut K, Fidanci BE, Simsek D, Cakan M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int. 2018 Apr;38(Suppl 1):395-402. doi: 10.1007/s00296-018-3982-8. Epub 2018 Apr 7. PMID: 29637329; PMCID: PMC5893710.

#422 2016 Ann Rheum Dis

Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)

Demirkaya E, Acikel C, Hashkes P, Gattorno M, Gul A, Ozdogan H, Turker T, Karadag O, Livneh A, Ben-Chetrit E, Ozen S; FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR). Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis. 2016 Jun;75(6):1051-6. doi: 10.1136/annrheumdis-2015-208671. Epub 2016 Jan 28. PMID: 26823530.

#423 2016 Rheumatol Int

Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review

Demirkaya E, Erer B, Ozen S, Ben-Chetrit E. Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review. Rheumatol Int. 2016 Mar;36(3):325-31. doi: 10.1007/s00296-015-3408-9. Epub 2015 Dec 19. PMID: 26687683.

#424 2016 J Rheumatol

Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry

Demirkaya E, Saglam C, Turker T, Koné-Paut I, Woo P, Doglio M, Amaryan G, Frenkel J, Uziel Y, Insalaco A, Cantarini L, Hofer M, Boiu S, Duzova A, Modesto C, Bryant A, Rigante D, Papadopoulou-Alataki E, Guillaume-Czitrom S, Kuemmerle- Deschner J, Neven B, Lachmann H, Martini A, Ruperto N, Gattorno M, Ozen S; Paediatric Rheumatology International Trials Organisations (PRINTO); Eurofever Project. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry. J Rheumatol. 2016 Jan;43(1):154-60. doi: 10.3899/jrheum.141249. Epub 2015 Nov 15. PMID: 26568587.

#425 2014 Ann Rheum Dis

Response to: 'The country of residence affects the phenotype of familial Mediterranean fever? Is it real or a selection bias?' by Korkmaz

Demirkaya E, Ozen S. Response to: 'The country of residence affects the phenotype of familial Mediterranean fever? Is it real or a selection bias?' by Korkmaz. Ann Rheum Dis. 2014 Aug;73(8):e53. doi: 10.1136/annrheumdis-2014-205819. Epub 2014 Jun 3. PMID: 24894191.

#426 2012 Clin Exp Rheumatol

Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides

Demirkaya E, Ozen S, Pistorio A, Galasso R, Ravelli A, Hasija R, Baskin E, Dressler F, Fischbach M, Garcìa Consuegra J, Iagaru N, Pasic S, Scarpato S, van Rossum MA, Apaz MT, Barash J, Calcagno G, Gonzalez B, Hoppenreijs E, Ioseliani M, Mazur-Zielinska H, Vougiouka O, Wulffraat N, Luqmani R, Martini A, Ruperto N, Dolezalova P; Paediatric Rheumatology International Trials Organization (PRINTO). Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S162-8. Epub 2012 May 14. PMID: 22640658.

#427 2011 Pediatr Rheumatol Online J

Time to focus on outcome assessment tools for childhood vasculitis

Demirkaya E, Luqmani R, Ayaz NA, Karaoglu A, Ozen S; FMF Arthritis Vasculitis and Orphan Disease Research in Paediatric Rheumatology (FAVOR). Time to focus on outcome assessment tools for childhood vasculitis. Pediatr Rheumatol Online J. 2011 Sep 26;9(1):29. doi: 10.1186/1546-0096-9-29. PMID: 21943296; PMCID: PMC3192748.

#428 2011 Clin Exp Rheumatol

The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association

Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, Erguven M, Poyrazoglu H, Kasapcopur O, Gok F, Akman S, Balat A, Cavkaytar O, Kaya B, Duzova A, Ozaltin F, Topaloglu R, Besbas N, Bakkaloglu A, Arisoy N, Ozdogan H, Bakkaloglu S, Turker T. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):111-6. Epub 2011 Feb 23. PMID: 21269582.

#429 2010 Arthritis Care Res (Hoboken)

Genotoxicity of anti-tumor necrosis factor therapy in patients with juvenile idiopathic arthritis

Demirkaya E, Cok I, Durmaz E, Ulutas OK, Ayaz NA, Besbas N, Ozen S. Genotoxicity of anti-tumor necrosis factor therapy in patients with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):73-7. doi: 10.1002/acr.20016. PMID: 20191493.

#430 2009 Turk J Pediatr

Purpura fulminans as the presenting manifestation in a patient with juvenile SLE

Demirkaya E, Cakmakli HF, Güçer S, Aktay-Ayaz N, Gürgey A, Ozen S. Purpura fulminans as the presenting manifestation in a patient with juvenile SLE. Turk J Pediatr. 2009 Jul-Aug;51(4):378-80. PMID: 19950848.

#431 2009 Arthritis Rheum

Musculoskeletal sonography in juvenile systemic lupus erythematosus

Demirkaya E, Ozçakar L, Türker T, Haghari S, Ayaz NA, Bakkaloglu A, Ozen S. Musculoskeletal sonography in juvenile systemic lupus erythematosus. Arthritis Rheum. 2009 Jan 15;61(1):58-60. doi: 10.1002/art.24090. PMID: 19116978.

#432 2008 Turk J Pediatr

Neuropsychiatric involvement in juvenile systemic lupus erythematosus

Demirkaya E, Bilginer Y, Aktay-Ayaz N, Yalnizoğlu D, Karli-Oğuz K, Işikhan V, Türker T, Topaloğlu R, Beşbaş N, Bakkaloğlu A, Ozen S. Neuropsychiatric involvement in juvenile systemic lupus erythematosus. Turk J Pediatr. 2008 Mar- Apr;50(2):126-31. PMID: 18664075.

#433 2008 Clin Rheumatol

A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients

Demirkaya E, Tunca Y, Gok F, Ozen S, Gul D. A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients. Clin Rheumatol. 2008 Jun;27(6):729-32. doi: 10.1007/s10067-007-0780-1. Epub 2007 Nov 14. PMID: 18000697.

#434 2007 Clin Rheumatol

A patient with hyper-IgD syndrome responding to anti-TNF treatment

Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S. A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol. 2007 Oct;26(10):1757-9. doi: 10.1007/s10067-006-0501-1. Epub 2006 Dec 15. PMID: 17171314.

#435 2026 Arthritis Rheumatol

Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders

De Visscher A, Beliën J, Malengier-Devlies B, Bernaerts E, De Vuyst L, Filtjens J, Ahmadzadeh K, Mitera T, Berghmans N, Laskari K, Jamilloux Y, Regnier P, Saadoun D, Girard-Guyonvarc'h C, Gabay C, Gouwy M, Proost P, Humblet-Baron S, Mueller YM, Erkland SJ, van de Werken HJG, Grashof DGB, Katsikis PD; Immunome Project Consortium for Autoinflammatory Disorders; Wouters C, Matthys P. Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders. Arthritis Rheumatol. 2026 Jul;78(7):1512-1526. doi: 10.1002/art.70008. Epub 2026 Feb 22. PMID: 41363108.

#436 2020 J Clin Invest

Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, Calvo KR, Marrero B, Moir S, Oler AJ, Deng Z, Montealegre Sanchez GA, Ahmed A, Allenspach E, Arabshahi B, Behrens E, Benseler S, Bezrodnik L, Bout-Tabaku S, Brescia AC, Brown D, Burnham JM, Caldirola MS, Carrasco R, Chan AY, Cimaz R, Dancey P, Dare J, DeGuzman M, Dimitriades V, Ferguson I, Ferguson P, Finn L, Gattorno M, Grom AA, Hanson EP, Hashkes PJ, Hedrich CM, Herzog R, Horneff G, Jerath R, Kessler E, Kim H, Kingsbury DJ, Laxer RM, Lee PY, Lee-Kirsch MA, Lewandowski L, Li S, Lilleby V, Mammadova V, Moorthy LN, Nasrullayeva G, O'Neil KM, Onel K, Ozen S, Pan N, Pillet P, Piotto DG, Punaro MG, Reiff A, Reinhardt A, Rider LG, Rivas- Chacon R, Ronis T, Rösen-Wolff A, Roth J, Ruth NM, Rygg M, Schmeling H, Schulert G, Scott C, Seminario G, Shulman A, Sivaraman V, Son MB, Stepanovskiy Y, Stringer E, Taber S, Terreri MT, Tifft C, Torgerson T, Tosi L, Van Royen-Kerkhof A, Wampler Muskardin T, Canna SW, Goldbach-Mansky R. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020 Apr 1;130(4):1669-1682. doi: 10.1172/JCI129301. PMID: 31874111; PMCID: PMC7108905.

#437 2020 Rheumatology (Oxford)

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative

de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. Rheumatology (Oxford). 2020 Apr 1;59(4):919. doi: 10.1093/rheumatology/keaa057. Erratum for: Rheumatology (Oxford). 2019 Apr 1;58(4):656-671. doi: 10.1093/rheumatology/key322. PMID: 32073621.

#438 2019 Rheumatology (Oxford)

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative

de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. Rheumatology (Oxford). 2019 Apr 1;58(4):656-671. doi: 10.1093/rheumatology/key322. Erratum in: Rheumatology (Oxford). 2020 Apr 1;59(4):919. doi: 10.1093/rheumatology/keaa057. PMID: 30535249.

#439 2019 Rheumatology (Oxford)

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative

de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Brogan P, Beresford MW. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. Rheumatology (Oxford). 2019 Apr 1;58(4):672-682. doi: 10.1093/rheumatology/key344. PMID: 30535127.

#440 2018 N Engl J Med

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. N Engl J Med. 2018 May 17;378(20):1908-1919. doi: 10.1056/NEJMoa1706314. PMID: 29768139.

#441 2011 J Rheumatol

An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis

Davì S, Consolaro A, Guseinova D, Pistorio A, Ruperto N, Martini A, Cron RQ, Ravelli A; MAS Study Group. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2011 Apr;38(4):764-8. doi: 10.3899/jrheum.100996. Epub 2011 Feb 1. PMID: 21285158.

#442 2026 J Clin Rheumatol

Baseline Bone Mineral Density Predicts Treatment Switch in Pediatric Chronic Nonbacterial Osteomyelitis: A Real-World Cohort Study

Cuceoglu MK, Canturk M, Batu ED, Yildiz AE, Basaran HO, Bilginer Y, Aydingoz U, Ozon A, Ozen S. Baseline Bone Mineral Density Predicts Treatment Switch in Pediatric Chronic Nonbacterial Osteomyelitis: A Real-World Cohort Study. J Clin Rheumatol. 2026 Feb 23. doi: 10.1097/RHU.0000000000002326. Epub ahead of print. PMID: 41730249.

#443 2021 Pediatr Clin North Am

Pulmonary Manifestations of Systemic Vasculitis in Children

Cuceoglu MK, Ozen S. Pulmonary Manifestations of Systemic Vasculitis in Children. Pediatr Clin North Am. 2021 Feb;68(1):167-176. doi: 10.1016/j.pcl.2020.09.014. PMID: 33228930.

#444 2025 Ann Rheum Dis

Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care

Courel-Ibáñez J, Prieto-Moreno R, Briones-Vozmediano E, Ariza-Vega P, Angevare S, Anton J, Bini I, Clemente D, Correia M, Costello W, De Cock D, Domjan A, Leon L, Marques A, Minden K, Mourão AF, Najm A, Özen S, Pimentel G, Saleem Z, Vetrovsky T, Wulffraat N, Zacarias A, Prior Y, Carmona L, Estévez- López F. Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care. Ann Rheum Dis. 2025 Dec;84(12):2115-2127. doi: 10.1016/j.ard.2025.01.017. Epub 2025 Feb 11. PMID: 39939275.

#445 2024 Ann Rheum Dis

EULAR points to consider for patient education in physical activity and self-management of pain during transitional care

Courel-Ibáñez J, Prieto-Moreno R, Briones-Vozmediano E, Ariza-Vega P, Angevare S, Anton J, Bini I, Clemente D, Correia M, Costello W, De Cock D, Domján A, Leon L, Marques A, Minden K, Mourão AF, Najm A, Ozen S, Pimentel G, Saleem Z, Vetrovsky T, Wulffraat NM, Zacarias Crovato A, Prior Y, Carmona L, Estévez-López F. EULAR points to consider for patient education in physical activity and self-management of pain during transitional care. Ann Rheum Dis. 2024 Nov 11:ard-2024-226448. doi: 10.1136/ard-2024-226448. Epub ahead of print. PMID: 39532311.

#446 2019 Mult Scler Relat Disord

Concurrence of juvenile idiopathic arthritis and primary demyelinating disease in a young child

Coşkun AN, Günbey C, Göçmen R, Turan KE, Sönmez HE, Özen S, Anlar B. Concurrence of juvenile idiopathic arthritis and primary demyelinating disease in a young child. Mult Scler Relat Disord. 2019 Jan;27:20-22. doi: 10.1016/j.msard.2018.10.002. Epub 2018 Oct 3. PMID: 30300848.

#447 2024 Arthritis Rheumatol

Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis

Correia Marques M, Rubin D, Shuldiner EG, Datta M, Schmitz E, Gutierrez Cruz G, Patt A, Bennett E, Grom A, Foell D, Gattorno M, Bohnsack J, Yeung RSM, Prahalad S, Mellins E, Anton J, Len CA, Oliveira S, Woo P, Ozen S, Deng Z, Ombrello MJ; INCHARGE Consortium. Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2024 Oct;76(10):1566-1572. doi: 10.1002/art.42938. Epub 2024 Aug 9. PMID: 38937141; PMCID: PMC12341541.

#448 2008 Kidney Int

Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome

Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, Rangel LJ, Aspinwall R, Niaudet WP, Ozen S, David A, Velinov M, Bergstralh EJ, Bae KT, Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Sampson JR, Dawson BD, Harris PC; CRISP Consortium. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int. 2008 Dec;74(11):1468-79. doi: 10.1038/ki.2008.485. Epub 2008 Sep 24. PMID: 18818683; PMCID: PMC2756756.

#449 2025 2025 May;77(5):521-525

Do We Need Distinct Pediatric Classification Criteria for Rheumatic Diseases That Affect Both Children and Adults? Arthritis Rheumatol

Ciurtin C, Jelusic M, Ozen S. Do We Need Distinct Pediatric Classification Criteria for Rheumatic Diseases That Affect Both Children and Adults? Arthritis Rheumatol. 2025 May;77(5):521-525. doi: 10.1002/art.43058. Epub 2025 Jan 5. PMID: 39542846; PMCID: PMC12039469.

#450 2019 Turk Pediatri Ars

Behçet's disease in children: single-center experience

Çirkinoğlu MS, Demir S, Bilginer Y, Özen S. Behçet's disease in children: single-center experience. Turk Pediatri Ars. 2019 Sep 25;54(3):179-184. doi: 10.14744/TurkPediatriArs.2019.15045. PMID: 31619930; PMCID: PMC6776452.

#451 2009 Proc Natl Acad Sci U S A

Genetic diagnosis by whole exome capture and massively parallel DNA sequencing

Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloğlu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19096-101. doi: 10.1073/pnas.0910672106. Epub 2009 Oct 27. PMID: 19861545; PMCID: PMC2768590.

#452 2016 J Am Acad Dermatol

Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy

Chia J, Eroglu FK, Özen S, Orhan D, Montealegre-Sanchez G, de Jesus AA, Goldbach-Mansky R, Cowen EW. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy. J Am Acad Dermatol. 2016 Jan;74(1):186-9. doi: 10.1016/j.jaad.2015.10.007. Epub 2015 Nov 14. PMID: 26584874; PMCID: PMC4691417.

#453 2022 Arthritis Rheumatol

International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis

Chalhoub NE, Wenderfer SE, Levy DM, Rouster-Stevens K, Aggarwal A, Savani SI, Ruth NM, Arkachaisri T, Qiu T, Merritt A, Onel K, Goilav B, Khubchandani RP, Deng J, Fonseca AR, Ardoin SP, Ciurtin C, Kasapcopur O, Jelusic M, Huber AM, Ozen S, Klein-Gitelman MS, Appenzeller S, Cavalcanti A, Fotis L, Lim SC, Silva RM, Miramontes JR, Rosenwasser NL, Saad-Magalhaes C, Schonenberg-Meinema D, Scott C, Silva CA, Enciso S, Terreri MT, Torres-Jimenez AR, Trachana M, Al- Mayouf SM, Devarajan P, Huang B, Brunner HI; Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Work Group and the Pediatric Rheumatology European Society Lupus Working Party. International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. Arthritis Rheumatol. 2022 Feb;74(2):263-273. doi: 10.1002/art.41930. Epub 2022 Jan 4. PMID: 34279063; PMCID: PMC8766607.

#454 2023 Pediatr Pulmonol

COVID-19-related multiple inflammatory syndrome-C and pulmonary embolism in Aicardi-Goutries syndrome

Çevik NN, Aytekin E, Esenboğa S, Özbek B, Aytaç S, Özen S, Karagöz T, Cagdas D. COVID-19-related multiple inflammatory syndrome-C and pulmonary embolism in Aicardi-Goutries syndrome. Pediatr Pulmonol. 2023 Nov;58(11):3326-3329. doi: 10.1002/ppul.26551. Epub 2023 Jun 23. PMID: 37350359.

#455 2022 Arthritis Rheumatol

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS

Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS. Arthritis Rheumatol. 2022 May;74(5):735-751. doi: 10.1002/art.42087. Epub 2022 Mar 21. PMID: 35315249.

#456 2022 Ann Rheum Dis

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS

Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022 May;81(5):601-613. doi: 10.1136/annrheumdis-2021-221814. Epub 2022 Jan 27. PMID: 35086813; PMCID: PMC9036471.

#457 2013 Turk J Pediatr

Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases

Celebi-Tayfur A, Bilginer Y, Finetti M, Gattorno M, Ozen S. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases. Turk J Pediatr. 2013 Jan- Feb;55(1):78-81. PMID: 23692837.

#458 2017 Minerva Pediatr

Final diagnosis of children and adolescents with musculoskeletal complaints

Cavkaytar O, Düzova A, Tekşam O, Karabulut E, Derman O, Kale G, Ozen S. Final diagnosis of children and adolescents with musculoskeletal complaints. Minerva Pediatr. 2017 Feb;69(1):50-58. doi: 10.23736/S0026-4946.16.04216-X. Epub 2015 Sep 10. PMID: 26365744.

#459 2026 Arthritis Rheumatol

DNA Methylation Profiling Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Patterns Associated With Sex and Disease Activity in Childhood-Onset Lupus

Casares-Marfil D, Kavrul Kayaalp G, Guliyeva V, Akgün Ö, Türkmen Ş, Kılıç Könte E, Şener S, Şahin S, Kasapçopur Ö, Sözeri B, Sözer Tokdemir S, Özen S, Aktay Ayaz N, Sawalha AH. DNA Methylation Profiling Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Patterns Associated With Sex and Disease Activity in Childhood-Onset Lupus. Arthritis Rheumatol. 2026 Jun;78(6):1245-1257. doi: 10.1002/art.70045. Epub 2026 Mar 25. PMID: 41451519.

#460 2025 medRxiv [Preprint]

DNA Methylation Profiling in Childhood-Onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity

Casares-Marfil D, Kavrul Kayaalp G, Guliyeva V, Akgün Ö, Türkmen Ş, Kılıç Könte E, Şener S, Şahin S, Kasapçopur Ö, Sözeri B, Tokdemir SS, Özen S, Aktay Ayaz N, Sawalha AH. DNA Methylation Profiling in Childhood-Onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity. medRxiv [Preprint]. 2025 Oct 2:2025.09.30.25337006. doi: 10.1101/2025.09.30.25337006. Update in: Arthritis Rheumatol. 2026 Jun;78(6):1245-1257. doi: 10.1002/art.70045. PMID: 41256171; PMCID: PMC12622076.

#461 2022 Rheumatology (Oxford)

Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis

Carmona EG, García-Giménez JA, López-Mejías R, Khor CC, Lee JK, Taskiran E, Ozen S, Hocevar A, Liu L, Gorenjak M, Potočnik U, Kiryluk K, Ortego-Centeno N, Cid MC, Hernández-Rodríguez J, Castañeda S, González-Gay MA, Burgner D, Martín J, Márquez A; Spanish IgA Vasculitis Consortium;* International Kawasaki Disease Genetics Consortium. Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis. Rheumatology (Oxford). 2022 Mar 2;61(3):1204-1210. doi: 10.1093/rheumatology/keab443. PMID: 33993232; PMCID: PMC10687354.

#462 2024 J Autoimmun

The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C

Caorsi R, Consolaro A, Speziani C, Sozeri B, Ulu K, Faugier-Fuentes E, Menchaca-Aguayo H, Ozen S, Sener S, Akhter Rahman S, Imnul Islam M, Haerynck F, Simonini G, Mastri MV, Avcin T, Sršen S, de Albuquerque Pedrosa Fernandes T, Stanevicha V, Vojinovic J, Sobh A, Fingerhutova S, Minxova L, Gagro A, Rodrigues Fonseca A, Pandya D, Varbanova B, Sánchez-Manubens J, Ganeva M, Montin D, Boyarchuk O, Minghini A, Bracaglia C, Brogan P, Candotti F, Cattalini M, Meyts I, Minoia F, Taddio A, Wouters C, De Benedetti F, Bovis F, Ravelli A, Ruperto N, Gattorno M; HyperPED-COVID study group; ERN-RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases); PReS (Pediatric Rheumatology European Society); ESID (European Society for Immunodeficiencies); ISSAID (International Society of Systemic Auto-Inflammatory Diseases) and the; **Paediatric Rheumatology International Trials Organisation (PRINTO); Bilginer Y, Laila K, Islam MM, Meertens B, Hoste L, Dehoorne J, Schelstraete P, Vandekerckhove K, Willems J, Matthijs I, Filocamo E Gisella Beatrice Beretta G, Magalhaes CS, Chubata O, Ricci F, Vukovic A, Temelkova K, Avramovic MZ, Emersic N, Bizjak M, Vesel T, Rodrigues MF, Gasparello de Almeida R, Lukjanovica K, Elnagdy MH, Soliman A, Terifajova E, Brejchova I, Magner M, Myrup C, Vougiouka O, Jelusic M, La Torre F, Rigante D, Maggio MC, Verdoni L, Rubio-Perez N, Cornejo GV, Villarreal Trevino AV, Brito I, Oliveira-Ramos F, Alexeeva E, Chasnyk V, Arkachaisri T, Boyko Y, Vyzhga Y, Samsonenko S. The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C. J Autoimmun. 2024 Jul;147:103265. doi: 10.1016/j.jaut.2024.103265. Epub 2024 Jun 4. PMID: 38838452.

#463 2010 Turk J Pediatr

Toll-like receptors 2 and 4 cell surface expression reflects endotoxin tolerance in Henoch-Schönlein purpura

Canpinar H, Ozaltin F, Bilginer Y, Bakkaloğlu A, Ozen S. Toll-like receptors 2 and 4 cell surface expression reflects endotoxin tolerance in Henoch-Schönlein purpura. Turk J Pediatr. 2010 Jan-Feb;52(1):22-7. PMID: 20402063.

#464 2026 Rheumatology (Oxford)

Before calling it FMF: MEFV variants of uncertain significance in autoinflammatory disease

Cam V, Cingoz E, Ercan Emreol H, Unal D, Bayindir Y, Aliyev E, Erkan MO, Banak ON, Dara Kar HD, Basaran O, Bilginer Y, Sag E, Ozen S. Before calling it FMF: MEFV variants of uncertain significance in autoinflammatory disease. Rheumatology (Oxford). 2026 Jun 3;65(6):keag252. doi: 10.1093/rheumatology/keag252. PMID: 42135612; PMCID: PMC13244793.

#465 2026 BMJ Paediatr Open

Multicentre cohort study on the course of paediatric familial Mediterranean fever in the aftermath of the 2023 earthquake

Cam V, Yalcin SS, Batu ED, Kacmaz HM, Kocamaz NG, Günal Ö, Kayhan E, Bozkaya B, Taşkın S, Gungorer V, Kılıç Konte E, Pirim G, Ünal D, Ozdel S, Koker O, Pac Kısaarslan A, Kisla Ekinci RM, Dogantan Ş, Demir S, Ozturk K, Adıgüzel Dundar H, Basaran O, Balat A, Sozeri B, Kasapcopur O, Bilginer Y, Ozen S. Multicentre cohort study on the course of paediatric familial Mediterranean fever in the aftermath of the 2023 earthquake. BMJ Paediatr Open. 2026 May 4;10(1):e003818. doi: 10.1136/bmjpo-2025-003818. PMID: 42082277; PMCID: PMC13141018.

#466 2026 J Rheumatol

How Physicians Manage Colchicine-Resistant Familial Mediterranean Fever: Insights From a Multinational Survey in High-Prevalence Countries

Cam V, Unal D, Sag E, Satirer O, La Bella S, Basaran O, Bilginer Y, Uziel Y, Gattorno M, Ozen S. How Physicians Manage Colchicine-Resistant Familial Mediterranean Fever: Insights From a Multinational Survey in High-Prevalence Countries. J Rheumatol. 2026 May 1;53(5):556-561. doi: 10.3899/jrheum.2025-0804. PMID: 41539729.

#467 2026 Rheumatology (Oxford)

Treatment responses and relapse predictors in paediatric CNO: insights from a referral centre

Cam V, Cingoz E, Bayindir Y, Unal D, Ercan Emreol H, Erkan MO, Necipoglu O, Dara Kar HD, Sag E, Basaran O, Bilginer Y, Ozen S. Treatment responses and relapse predictors in paediatric CNO: insights from a referral centre. Rheumatology (Oxford). 2026 Jun 3;65(6):keaf645. doi: 10.1093/rheumatology/keaf645. PMID: 41335422.

#468 2025 Rheumatology (Oxford)

Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study

Cam V, Unal D, Sag E, Bayindir Y, Aliyev E, Emreol HE, Erkan MO, Necipoglu Banak O, Dara Kar HD, Basaran O, Bilginer Y, Ozen S. Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study. Rheumatology (Oxford). 2025 Nov 1;64(11):5726-5732. doi: 10.1093/rheumatology/keaf340. PMID: 40512183; PMCID: PMC12596059.

#469 2025 Rheumatology (Oxford)

Long-term follow-up after discontinuation of anti-IL1 treatment in colchicine-resistant familial Mediterranean fever

Cam V, Bayindir Y, Bilginer Y, Ozen S. Long-term follow-up after discontinuation of anti-IL1 treatment in colchicine-resistant familial Mediterranean fever. Rheumatology (Oxford). 2025 Jun 1;64(6):4064. doi: 10.1093/rheumatology/keaf154. PMID: 40100746; PMCID: PMC12107058.

#470 2025 Rheumatology (Oxford)

A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin

Cam V, Sag E, Bilginer Y, Ozen S. A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin. Rheumatology (Oxford). 2025 Apr 1;64(4):2315-2316. doi: 10.1093/rheumatology/keae637. PMID: 39579141; PMCID: PMC11962887.

#471 2024 Arch Rheumatol

New and future perspectives in familial Mediterranean fever and other autoinflammatory diseases

Çam V, Ercan Emreol H, Ozen S. New and future perspectives in familial Mediterranean fever and other autoinflammatory diseases. Arch Rheumatol. 2024 Aug 26;39(3):331-338. doi: 10.46497/ArchRheumatol.2024.10911. PMID: 39507834; PMCID: PMC11537678.

#472 2026 Rheumatology (Oxford)

Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry

Calabrese L, D'Onghia M, Cartocci A, Hinojosa-Azaola A, Torres-Ruiz J, Lopalco G, Sbalchiero J, Caggiano V, Giardini HAM, Almaghlouth IA, Ruscitti P, Di Cola I, Sfikakis PP, Laskari K, Sfriso P, Dagna L, Campochiaro C, Tufan A, Kucuk H, Kardas RC, Erden A, Ragab G, Hegazy MT, Laymouna AH, Navarini L, Berardicurti O, Ciccia F, Iacono D, Riccio F, Fotis L, Direskeneli H, Makowska J, Iagnocco A, Conforti A, Rigante D, Thabet M, Iannone F, Domanico D, Govoni M, Maggio MC, Del Giudice E, La Torre F, Batu ED, Ozen S, Gaggiano C, Martín-Nares E, Guaracha-Basañez GA, Karamanakos A, Lo Gullo A, Monosi B, Bartoloni E, Hernández-Rodríguez J, Gómez-Caverzaschi V, Emmi G, Erten S, Carubbi F, Gicchino MF, De Paulis A, Conti G, Ogunjimi B, Wiesik-Szewczyk E, Nowakowska-Płaza A, Viapiana O, Sarzi-Puttini P, Tharwat S, Crisafulli F, Parronchi P, Gidaro A, De Stefano L, Breda L, La Barbera L, Guggino G, Balistreri A, Fabiani C, Rubegni P, Frediani B, Giacomelli R, Cantarini L, Vitale A; International AIDA (AutoInflammatory Diseases Alliance) Network and the Autoinflammatory Diseases Working Group of the Italian Society of Rheumatology (SIR). Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry. Rheumatology (Oxford). 2026 Jan 8;65(1):keaf512. doi: 10.1093/rheumatology/keaf512. PMID: 41025504; PMCID: PMC12862393.

#473 2008 J Rheumatol

Takayasu arteritis in children

Cakar N, Yalcinkaya F, Duzova A, Caliskan S, Sirin A, Oner A, Baskin E, Bek K, Soylu A, Fitoz S, Bayazit AK, Bircan Z, Ozen S, Uncu N, Ekim M. Takayasu arteritis in children. J Rheumatol. 2008 May;35(5):913-9. Epub 2008 Mar 15. PMID: 18381778.

#474 2021 J Allergy Clin Immunol Pract

Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the Literature

Cagdas D, Halacli SO, Tan C, Esenboga S, Karaatmaca B, Cetinkaya PG, Balcı- Hayta B, Ayhan A, Uner A, Orhan D, Boztug K, Ozen S, Topaloglu R, Sanal O, Tezcan I. Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the Literature. J Allergy Clin Immunol Pract. 2021 Oct;9(10):3752-3766.e4. doi: 10.1016/j.jaip.2021.05.032. Epub 2021 Jun 17. PMID: 34146746.

#475 2020 Mol Immunol

Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect

Çağdaş D, Sürücü N, Tan Ç, Kayaoğlu B, Özgül RK, Akkaya-Ulum YZ, Aydınoğlu AT, Aytaç S, Gümrük F, Balci-Hayta B, Balci-Peynircioğlu B, Özen S, Gürsel M, Tezcan İ. Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect. Mol Immunol. 2020 May;121:28-37. doi: 10.1016/j.molimm.2020.02.014. Epub 2020 Mar 6. PMID: 32151906.

#476 2005 Pediatr Nephrol

Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature

Cagdas DN, Gucer S, Kale G, Duzova A, Ozen S. Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature. Pediatr Nephrol. 2005 Sep;20(9):1352-4. doi: 10.1007/s00467-005-1991-9. Epub 2005 Jun 22. PMID: 15971069.

#477 2020 Semin Arthritis Rheum

Characteristics of pediatric Behçet's disease in Turkey and Israel: A cross-sectional cohort comparison

Butbul Aviel Y, Batu ED, Sözeri B, Aktay Ayaz N, Baba L, Amarilyo G, Şimşek S, Harel L, Karadag SG, Bilginer Y, Özen S. Characteristics of pediatric Behçet's disease in Turkey and Israel: A cross-sectional cohort comparison. Semin Arthritis Rheum. 2020 Jun;50(3):515-520. doi: 10.1016/j.semarthrit.2020.01.013. Epub 2020 Feb 4. PMID: 32113838.

#478 2025 J Autoimmun

Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study

Bustaffa M, Bella S, Bayindir Y, Amaryan G, Gallizzi R, Papadopoulou- Alataki E, Fabio G, Assalia N, Amarilyo G, Bakkaloglu S, Jesenak M, Breda L, Anton J, Legger E, Alessio M, Simonini G, Rigante D, Obici L, Kuemmerle-Deschner J, Kasapcopur O, Insalaco A, Glerup M, Frenkel J, Brunner J, Horneff G, Sánchez- Manubens J, Cantarini L, Spagnolo A, Alataki S, Carrabba M, Belder N, Porreca A, Caorsi R, Ruperto N, Gattorno M, Ozen S; Eurofever Registry. Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study. J Autoimmun. 2025 May;153:103421. doi: 10.1016/j.jaut.2025.103421. Epub 2025 Apr 18. PMID: 40252570.

#479 2023 Semin Arthritis Rheum

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort

Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, Carrabba M, Aviel YB, Cantarini L, Alessio M, Anton J, Obici L, Gok F, Batu ED, Moreno E, Brogan P, Trachana M, Simonini G, Rigante D, Uziel Y, Insalaco A, Maggio MC, Ruperto N, Gattorno M, Semerano LR. Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort. Semin Arthritis Rheum. 2023 Feb;58:152123. doi: 10.1016/j.semarthrit.2022.152123. Epub 2022 Nov 18. Erratum for: Semin Arthritis Rheum. 2022 Feb;52:151957. doi: 10.1016/j.semarthrit.2022.151957. PMID: 36404149.

#480 2022 Semin Arthritis Rheum

The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort

Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, Carrabba M, Aviel YB, Cantarini L, Alessio M, Anton J, Obici L, Gok F, Batu ED, Moreno E, Brogan P, Trachana M, Simonini G, Rigante D, Uziel Y, Insalaco A, Maggio MC, Ruperto N, Gattorno M, Semerano LR. The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort. Semin Arthritis Rheum. 2022 Feb;52:151957. doi: 10.1016/j.semarthrit.2022.151957. Epub 2022 Jan 10. Erratum in: Semin Arthritis Rheum. 2023 Feb;58:152123. doi: 10.1016/j.semarthrit.2022.152123. PMID: 35042149.

#481 2019 J Neuroradiol

Deficiency of adenosine deaminase 2; special focus on central nervous system imaging

Bulut E, Erden A, Karadag O, Oguz KK, Ozen S. Deficiency of adenosine deaminase 2; special focus on central nervous system imaging. J Neuroradiol. 2019 May;46(3):193-198. doi: 10.1016/j.neurad.2018.05.002. Epub 2018 Jun 18. PMID: 29913178.

#482 2026 Arthritis Rheumatol

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo- Controlled Withdrawal Trial

Brunner HI, Alexeeva E, Bandeira M, Carrasco R, Chaitow J, Chiraseveenuprapund P, Ting TV, Erguven M, Gottlieb B, Oliveira SK, Patel PN, Ozen S, Saad Magalhaes C, Penadés IC, Gruben D, Germino R, Posner HB, Stockert L, Martini A, Lovell DJ, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo- Controlled Withdrawal Trial. Arthritis Rheumatol. 2026 Mar;78(3):752-762. doi: 10.1002/art.43428. Epub 2025 Dec 19. PMID: 41169192; PMCID: PMC12991914.

#483 2023 Ann Rheum Dis

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

Brunner HI, Foeldvari I, Alexeeva E, Ayaz NA, Calvo Penades I, Kasapcopur O, Chasnyk VG, Hufnagel M, Żuber Z, Schulert G, Ozen S, Rakhimyanova A, Ramanan A, Scott C, Sozeri B, Zholobova E, Martin R, Zhu X, Whelan S, Pricop L, Martini A, Lovell D, Ruperto N; Paediatric Rheumatology INternational Trials Organization (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. Ann Rheum Dis. 2023 Jan;82(1):154-160. doi: 10.1136/ard-2022-222849. Epub 2022 Aug 12. PMID: 35961761; PMCID: PMC9811076.

#484 2021 Arthritis Rheumatol

Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial

Brogan PA, Arch B, Hickey H, Anton J, Iglesias E, Baildam E, Mahmood K, Cleary G, Moraitis E, Papadopoulou C, Beresford MW, Riley P, Demir S, Ozen S, Culeddu G, Hughes DA, Dolezalova P, Hampson LV, Whitehead J, Jayne D, Ruperto N, Tudur-Smith C, Eleftheriou D. Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial. Arthritis Rheumatol. 2021 Sep;73(9):1673-1682. doi: 10.1002/art.41730. Epub 2021 Jul 31. PMID: 33760371.

#485 2016 Vaccine

Vasculitis as an adverse event following immunization - Systematic literature review

Bonetto C, Trotta F, Felicetti P, Alarcón GS, Santuccio C, Bachtiar NS, Brauchli Pernus Y, Chandler R, Girolomoni G, Hadden RD, Kucuku M, Ozen S, Pahud B, Top K, Varricchio F, Wise RP, Zanoni G, Živković S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group. Vasculitis as an adverse event following immunization - Systematic literature review. Vaccine. 2016 Dec 12;34(51):6641-6651. doi: 10.1016/j.vaccine.2015.09.026. Epub 2015 Sep 21. PMID: 26398442.

#486 2021 2021 Mar-Apr;39 Suppl 129(2):32-38

Is Takayasu's arteritis more severe in children? Clin Exp Rheumatol

Bolek EC, Kaya Akca U, Sari A, Sag E, Demir S, Kilic L, Sener YZ, Aykan HH, Kaya EB, Bilginer Y, Akdogan A, Kiraz S, Karadag O, Ozen S. Is Takayasu's arteritis more severe in children? Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):32-38. doi: 10.55563/clinexprheumatol/kr357t. Epub 2020 Sep 16. PMID: 32940211.

#487 2014 Pediatr Rheumatol Online J

Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis)

Bohm M, Gonzalez Fernandez MI, Ozen S, Pistorio A, Dolezalova P, Brogan P, Barbano G, Sengler C, Klein-Gitelman M, Quartier P, Fasth A, Herlin T, Terreri MT, Nielsen S, van Rossum MA, Avcin T, Castell ER, Foeldvari I, Foell D, Kondi A, Koné-Paut I, Kuester RM, Michels H, Wulffraat N, Amer HB, Malattia C, Martini A, Ruperto N. Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis). Pediatr Rheumatol Online J. 2014 May 26;12:18. doi: 10.1186/1546-0096-12-18. PMID: 24891844; PMCID: PMC4041043.

#488 2019 Rheumatol Int

Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia

Bilgin E, Dizdar Ö, Güven DC, Ceylan S, Aybi Ö, Fırlatan B, Kardaş RC, Yıldırım T, Hayran MK, Kalyoncu U, Özen S. Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia. Rheumatol Int. 2019 Jun;39(6):1045-1051. doi: 10.1007/s00296-019-04311-x. Epub 2019 Apr 25. PMID: 31025139.

#489 2022 Curr Opin Pediatr

Polyarteritis nodosa

Bilginer Y, Ozen S. Polyarteritis nodosa. Curr Opin Pediatr. 2022 Apr 1;34(2):229-233. doi: 10.1097/MOP.0000000000001106. PMID: 35081554.

#490 2011 Pediatr Nephrol

Renal amyloidosis in children

Bilginer Y, Akpolat T, Ozen S. Renal amyloidosis in children. Pediatr Nephrol. 2011 Aug;26(8):1215-27. doi: 10.1007/s00467-011-1797-x. Epub 2011 Mar 1. PMID: 21360109; PMCID: PMC3119800.

#491 2010 Clin Rheumatol

Low cortisol levels in active juvenile idiopathic arthritis

Bilginer Y, Topaloglu R, Alikasifoglu A, Kara N, Besbas N, Ozen S, Bakkaloglu A. Low cortisol levels in active juvenile idiopathic arthritis. Clin Rheumatol. 2010 Mar;29(3):309-14. doi: 10.1007/s10067-009-1326-5. Epub 2009 Dec 15. PMID: 20013015.

#492 2010 Clin Rheumatol

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease

Bilginer Y, Ayaz NA, Ozen S. Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease. Clin Rheumatol. 2010 Feb;29(2):209-10. doi: 10.1007/s10067-009-1279-8. Epub 2009 Sep 23. PMID: 19774408.

#493 2008 Rheumatol Int

Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis

Bilginer Y, Ozaltin F, Basaran C, Duzova A, Besbas N, Topaloglu R, Ozen S, Bakkaloglu A. Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int. 2008 Oct;28(12):1211-6. doi: 10.1007/s00296-008-0605-9. Epub 2008 May 24. PMID: 18500463.

#494 2007 common carotid artery

Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs

Bilginer Y, Ozaltin F, Basaran C, Aki TF, Karabulut E, Duzova A, Besbas N, Topaloglu R, Ozen S, Bakkaloglu M, Bakkaloglu A. Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery. Pediatr Transplant. 2007 Dec;11(8):888-94. doi: 10.1111/j.1399-3046.2007.00760.x. PMID: 17976124.

#495 2025 BMC Ophthalmol

Clinical characteristics and long-term outcomes of Vogt-Koyanagi-Harada disease in pediatric age group

Bezci Aygun F, Akgoz Koyuncuoglu M, Kadayıfcılar S, Ozen S. Clinical characteristics and long-term outcomes of Vogt-Koyanagi-Harada disease in pediatric age group. BMC Ophthalmol. 2025 Sep 26;25(1):509. doi: 10.1186/s12886-025-04334-y. PMID: 41013312; PMCID: PMC12476036.

#496 2004 Pediatr Nephrol

Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis

Besbas N, Ozaltin F, Catal F, Ozen S, Topaloglu R, Bakkaloglu A. Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis. Pediatr Nephrol. 2004 Aug;19(8):864-8. doi: 10.1007/s00467-004-1522-0. Epub 2004 Jun 17. PMID: 15206029.

#497 2003 Pediatr Nephrol

Successful renal transplantation in a child with ANCA-associated microscopic polyangiitis

Besbas N, Ozaltin F, Tinaztepe K, Güçer S, Ozen S, Bakkaloglu M, Bakkaloglu A. Successful renal transplantation in a child with ANCA-associated microscopic polyangiitis. Pediatr Nephrol. 2003 Jul;18(7):696-9. doi: 10.1007/s00467-003-1114-4. Epub 2003 May 13. PMID: 12743792.

#498 2018 Ann Rheum Dis

Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

Ben-Chetrit E, Gattorno M, Gul A, Kastner DL, Lachmann HJ, Touitou I, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis. 2018 Nov;77(11):1558-1565. doi: 10.1136/annrheumdis-2017-212515. Epub 2018 Aug 12. PMID: 30100561.

#499 2017 Ann Rheum Dis

Consensus-based recommendations for the management of juvenile dermatomyositis

Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, van der Net J, Vastert S, Wedderburn LR, Wulffraat N, McCann LJ, van Royen-Kerkhof A. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017 Feb;76(2):329-340. doi: 10.1136/annrheumdis-2016-209247. Epub 2016 Aug 11. PMID: 27515057; PMCID: PMC5284351.

#500 2019 Pediatr Res

Toward the elimination of bias in Pediatric Research

Bearer C, Agostoni C, Anand KJS, Ambalavanan N, Bhandari V, Bliss JM, Bloomfield F, Bonifacio SL, Buhimschi I, Cilio MR, Coppes M, Czinn SJ, El- Khuffash A, Embleton N, Felderhoff-Müser U, Ferriero DM, Florin T, Fuentes- Afflick E, Gardner W, Gospe SM Jr, Gunn A, Gressens P, Guissani D, Haiden N, Hauptman M, Kim KS, Klebanoff M, Lachman P, Lanphear B, Ozen S, Roehr C, Roland D, Rosenblum N, Schwarz M, Staiano A, Stroustrup A, Valente EM, Wilson-Costello D, Wynn J, Molloy E. Toward the elimination of bias in Pediatric Research. Pediatr Res. 2019 Dec;86(6):680-681. doi: 10.1038/s41390-019-0583-5. Epub 2019 Sep 18. PMID: 31533126.

#501 2020 Pediatr Rheumatol Online J

Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency

Baytaroğlu A, Kadayifçilar S, Ağin A, Deliktaş Ö, Demir S, Bilginer Y, Karakaya J, Özen S, Eldem B. Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency. Pediatr Rheumatol Online J. 2020 Apr 3;18(1):29. doi: 10.1186/s12969-020-0417-3. PMID: 32245490; PMCID: PMC7118843.

#502 2007 J Nephrol

Effect of early corticosteroid therapy on development of Henoch- Schönlein nephritis

Bayrakci US, Topaloglu R, Soylemezoglu O, Kalyoncu M, Ozen S, Besbas N, Bakkaloglu A. Effect of early corticosteroid therapy on development of Henoch- Schönlein nephritis. J Nephrol. 2007 Jul-Aug;20(4):406-9. PMID: 17879205.

#503 2026 Pediatr Rheumatol Online J

Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders

Bayindir Y, Satirer Ö, Cam V, Turkmen S, Sozeri B, Kuemmerle-Deschner JB, Ozen S. Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders. Pediatr Rheumatol Online J. 2026 Apr 11;24(1):21. doi: 10.1186/s12969-026-01214-7. PMID: 41965684; PMCID: PMC13072506.

#504 2025 RMD Open

Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis

Bayindir Y, Grayson PC, Gribbons KB, Demir S, Audemard-Verger A, Ponte C, Robson JC, Suppiah R, Bes C, Bulat B, Yildirim F, Karadag O, Luqmani RA, Watts RA, Merkel PA, Ozen S. Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis. RMD Open. 2025 Jul 21;11(3):e005728. doi: 10.1136/rmdopen-2025-005728. PMID: 40695543; PMCID: PMC12281324.

#505 2025 Rheumatology (Oxford)

Highlights from the breakout session: vasculitis in paediatric rheumatology

Bayindir Y, Jelusic M, Ozen S. Highlights from the breakout session: vasculitis in paediatric rheumatology. Rheumatology (Oxford). 2025 Mar 1;64(Supplement_1):i131-i133. doi: 10.1093/rheumatology/keae406. PMID: 40071400.

#506 2024 Turk Arch Pediatr

Vasculitis in Children

Bayındır Y, Başaran Ö, Bilginer Y, Özen S. Vasculitis in Children. Turk Arch Pediatr. 2024 Nov 1;59(6):517-526. doi: 10.5152/TurkArchPediatr.2024.24181. PMID: 39540696; PMCID: PMC11562156.

#507 2023 Arthritis Rheumatol

Reply

Batu ED; Pediatric Rheumatology European Society (PReS) Vasculitis Working Party; Sener S, Özen S. Reply. Arthritis Rheumatol. 2023 Dec;75(12):2266. doi: 10.1002/art.42647. Epub 2023 Oct 4. PMID: 37441769.

#508 2023 Arthritis Rheumatol

The Characteristics of Patients With COVID-19-Associated Pediatric Vasculitis: An International, Multicenter Study

Batu ED, Sener S, Ozomay Baykal G, Arslanoglu Aydin E, Özdel S, Gagro A, Esen E, Heshin-Bekenstein M, Akpınar Tekgöz N, Demirkan FG, Ozturk K, Vougiouka O, Sonmez HE, Maggio MC, Kaya Akca U, Jelusic M, Pac Kısaarslan A, Acar B, Aktay Ayaz N, Sözeri B, Özen S; Pediatric Rheumatology European Society (PReS) Vasculitis Working Party. The Characteristics of Patients With COVID-19-Associated Pediatric Vasculitis: An International, Multicenter Study. Arthritis Rheumatol. 2023 Apr;75(4):499-506. doi: 10.1002/art.42411. Epub 2023 Jan 23. PMID: 36457245; PMCID: PMC9877558.

#509 2022 Rheumatol Int

Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study

Batu ED, Kaya Akca U, Basaran O, Bilginer Y, Özen S. Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study. Rheumatol Int. 2022 Jul;42(7):1207-1211. doi: 10.1007/s00296-021-05084-y. Epub 2022 Jan 7. PMID: 34994815.

#510 2022 2022 Jan;42(1):71-80

Galectin-3: a new biomarker for differentiating periodic fever, adenitis, pharyngitis, aphthous stomatitis (PFAPA) syndrome from familial Mediterranean fever? Rheumatol Int

Batu ED, Vezir E, Öğüş E, Özbaş Demirel Ö, Akpınar G, Demir S, Özen S. Galectin-3: a new biomarker for differentiating periodic fever, adenitis, pharyngitis, aphthous stomatitis (PFAPA) syndrome from familial Mediterranean fever? Rheumatol Int. 2022 Jan;42(1):71-80. doi: 10.1007/s00296-021-04827-1. Epub 2021 Mar 11. PMID: 33709179.

#511 2021 J Rheumatol

The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus

Batu ED, Akca UK, Kısaarslan AP, Sağ E, Demir F, Demir S, Çiçek SÖ, Poyrazoglu H, Sozeri B, Bilginer Y, Ozen S. The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus. J Rheumatol. 2021 Jun;48(6):907-914. doi: 10.3899/jrheum.200871. Epub 2020 Nov 15. PMID: 33191281.

#512 2016 Arthritis Care Res (Hoboken)

Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas

Batu ED, Kara Eroğlu F, Tsoukas P, Hausmann JS, Bilginer Y, Kenna MA, Licameli GR, Fuhlbrigge RC, Özen S, Dedeoğlu F. Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1859-1865. doi: 10.1002/acr.22901. PMID: 27059542.

#513 2025 Biomarkers

A diagnostic algorithm to evaluate elevated C-reactive protein levels in juvenile systemic lupus erythematosus

Batu ED, Sener S, Atamyildiz Ucar S, Balik Z, Kavrul Kayaalp G, Cam V, Aliyev E, Bayindir Y, Basaran O, Aktay Ayaz N, Sozeri B, Bilginer Y, Ozen S. A diagnostic algorithm to evaluate elevated C-reactive protein levels in juvenile systemic lupus erythematosus. Biomarkers. 2025 Jul;30(5):380-385. doi: 10.1080/1354750X.2025.2556159. Epub 2025 Sep 4. PMID: 40888355.

#514 2024 Adv Exp Med Biol

Other Immunomodulatory Treatment for Cytokine Storm Syndromes

Batu ED, Ozen S. Other Immunomodulatory Treatment for Cytokine Storm Syndromes. Adv Exp Med Biol. 2024;1448:601-609. doi: 10.1007/978-3-031-59815-9_40. PMID: 39117842.

#515 2024 Neuromuscul Disord

Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents

Batu ED, Şener S, Haliloğlu G, Talim B, Şener B, Şahiner ÜM, Bilginer Y, Orhan D, Aydıngöz Ü, Özen S. Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents. Neuromuscul Disord. 2024 Jul;40:7-15. doi: 10.1016/j.nmd.2024.05.008. Epub 2024 May 17. PMID: 38805897.

#516 2025 Rheumatology (Oxford)

A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks

Batu ED, Bayindir Y, Sener S, Balik Z, Aliyev E, Kasap Cuceoglu M, Basaran O, Bilginer Y, Ozen S. A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks. Rheumatology (Oxford). 2025 Mar 1;64(3):1341-1346. doi: 10.1093/rheumatology/keae256. PMID: 38710490; PMCID: PMC11879335.

#517 2025 Rheumatology (Oxford)

Transitioning from pediatric to adult-oriented healthcare in rheumatology: the pediatric side of the coin

Batu ED, Balik Z, Sener S, Aliyev E, Bayindir Y, Cam V, Kasap Cuceoglu M, Kaya Akca U, Kilic L, Basaran O, Bilginer Y, Apras Bilgen S, Ozen S. Transitioning from pediatric to adult-oriented healthcare in rheumatology: the pediatric side of the coin. Rheumatology (Oxford). 2025 Mar 1;64(3):1003-1009. doi: 10.1093/rheumatology/keae254. PMID: 38710478; PMCID: PMC11879301.

#518 2024 2024 Jan;43(1):415-421

Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis? Clin Rheumatol

Batu ED, Sener S, Balık Z, Bayındır Y, Cam V, Kasap Cuceoglu M, Uysal O, Aliyev E, Basaran Ö, Bilginer Y, Özen S. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis? Clin Rheumatol. 2024 Jan;43(1):415-421. doi: 10.1007/s10067-023-06828-w. Epub 2023 Nov 28. PMID: 38012469.

#519 2023 BioDrugs

Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data

Batu ED, Sener S, Cam V, Aktay Ayaz N, Ozen S. Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data. BioDrugs. 2023 Nov;37(6):813-828. doi: 10.1007/s40259-023-00613-6. Epub 2023 Jun 29. PMID: 37382804.

#520 2024 Rheumatology (Oxford)

A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry

Batu ED, Şener S, Arslanoglu Aydin E, Aliyev E, Bagrul İ, Türkmen Ş, Akgün Ö, Balık Z, Tanatar A, Bayındır Y, Kızıldağ Z, Torun R, Günalp A, Coşkuner T, İşgüder R, Aydın T, Haşlak F, Kasap Cüceoğlu M, Esen E, Akçay U, Başaran Ö, Pac Kısaarslan A, Akal F, Yüce D, Özdel S, Bülbül M, Bilginer Y, Aktay Ayaz N, Sözeri B, Kasapçopur Ö, Ünsal E, Özen S. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry. Rheumatology (Oxford). 2024 Mar 1;63(3):791-797. doi: 10.1093/rheumatology/kead242. PMID: 37228026; PMCID: PMC10907807.

#521 2023 Rheumatol Int

Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study

Batu ED, Günalp A, Şahin S, Özdel S, Kızıldağ Z, Pac Kısaarslan A, Bağrul İ, Kasap Cuceoglu M, Tanatar A, Sonmez HE, Sag E, Demir S, Çelikel E, Cağlayan S, Çelikel Acar B, Sözeri B, Aktay Ayaz N, Bilginer Y, Poyrazoğlu MH, Ünsal E, Kasapçopur Ö, Özen S. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study. Rheumatol Int. 2023 Aug;43(8):1485-1495. doi: 10.1007/s00296-023-05300-x. Epub 2023 Mar 12. PMID: 36906866.

#522 2022 Semin Arthritis Rheum

Reply on: COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis

Batu ED, Sener S, Ozen S. Reply on: COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis. Semin Arthritis Rheum. 2022 Dec;57:152091. doi: 10.1016/j.semarthrit.2022.152091. Epub 2022 Sep 8. PMID: 36150318; PMCID: PMC9454153.

#523 2022 Semin Arthritis Rheum

COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis

Batu ED, Sener S, Ozen S. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis. Semin Arthritis Rheum. 2022 Aug;55:152047. doi: 10.1016/j.semarthrit.2022.152047. Epub 2022 Jun 9. PMID: 35709649; PMCID: PMC9183245.

#524 2022 Curr Rheumatol Rep

Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene

Batu ED, Basaran O, Bilginer Y, Ozen S. Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene. Curr Rheumatol Rep. 2022 Jun;24(6):206-212. doi: 10.1007/s11926-022-01073-7. Epub 2022 Apr 18. PMID: 35435612.

#525 2022 Semin Arthritis Rheum

Macrophage activation syndrome in pediatric Sjögren's syndrome

Batu ED, Demir S, Bilginer Y, Ozen S. Macrophage activation syndrome in pediatric Sjögren's syndrome. Semin Arthritis Rheum. 2022 Apr;53:151977. doi: 10.1016/j.semarthrit.2022.151977. Epub 2022 Feb 9. PMID: 35182962.

#526 2023 Ann Rheum Dis

Correspondence on 'Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus'

Batu ED, Kaya Akca U, Basaran O, Bilginer Y, Ozen S. Correspondence on 'Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus'. Ann Rheum Dis. 2023 Jun;82(6):e144. doi: 10.1136/annrheumdis-2021-220246. Epub 2021 Apr 2. PMID: 33811035.

#527 2020 Semin Arthritis Rheum

How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross- sectional, online survey

Batu ED, Lamot L, Sag E, Ozen S, Uziel Y. How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross- sectional, online survey. Semin Arthritis Rheum. 2020 Dec;50(6):1262-1268. doi: 10.1016/j.semarthrit.2020.09.008. Epub 2020 Sep 28. PMID: 33065421; PMCID: PMC7833192.

#528 2020 Rheumatology (Oxford)

Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus

Batu ED, Ozen S. Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus. Rheumatology (Oxford). 2020 Dec 1;59(12):e155. doi: 10.1093/rheumatology/keaa562. PMID: 32974675.

#529 2020 Rheumatol Int

Implications of COVID-19 in pediatric rheumatology

Batu ED, Özen S. Implications of COVID-19 in pediatric rheumatology. Rheumatol Int. 2020 Aug;40(8):1193-1213. doi: 10.1007/s00296-020-04612-6. Epub 2020 Jun 4. PMID: 32500409; PMCID: PMC7270517.

#530 2020 Curr Rheumatol Rev

Measuring Vasculitis with Numbers: Outcome Scores

Batu ED, Ozen S. Measuring Vasculitis with Numbers: Outcome Scores. Curr Rheumatol Rev. 2020;16(1):21-28. doi: 10.2174/1573397115666191126093927. PMID: 31804163.

#531 2018 Turk J Pediatr

A patient heterozygous for R92Q mutation with periodic fever and aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome-like phenotype

Batu ED, Sönmez HE, Bilginer Y, Özen S. A patient heterozygous for R92Q mutation with periodic fever and aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome-like phenotype. Turk J Pediatr. 2018;60(6):726-728. doi: 10.24953/turkjped.2018.06.014. PMID: 31365210.

#532 2018 J Rheumatol

Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus

Batu ED, Koşukcu C, Taşkıran E, Sahin S, Akman S, Sözeri B, Ünsal E, Bilginer Y, Kasapcopur O, Alikaşifoğlu M, Ozen S. Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus. J Rheumatol. 2018 Dec;45(12):1671-1679. doi: 10.3899/jrheum.171358. Epub 2018 Jul 15. PMID: 30008451.

#533 2017 J Clin Rheumatol

Acceptability and Practicality of the Turkish Translation of Pediatric Gait Arm Legs and Spine in Turkish Children

Batu ED, Keniş Coşkun Ö, Sönmez HE, Karali D, Arslanoğlu Aydin E, Bilginer Y, Karadağ Saygi E, Özen S. Acceptability and Practicality of the Turkish Translation of Pediatric Gait Arm Legs and Spine in Turkish Children. J Clin Rheumatol. 2017 Dec;23(8):421-424. doi: 10.1097/RHU.0000000000000586. PMID: 28926470.

#534 2017 Clin Exp Rheumatol

The performance of different classification criteria in paediatric Behçet's disease

Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S. The performance of different classification criteria in paediatric Behçet's disease. Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):119-123. Epub 2017 Apr 5. PMID: 28406761.

#535 2017 Semin Arthritis Rheum

Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature

Batu ED, Sönmez HE, Hazırolan T, Özaltın F, Bilginer Y, Özen S. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature. Semin Arthritis Rheum. 2017 Feb;46(4):529-535. doi: 10.1016/j.semarthrit.2016.07.012. Epub 2016 Jul 26. PMID: 27515155.

#536 2015 J Rheumatol

A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations

Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, Özen S. A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations. J Rheumatol. 2015 Aug;42(8):1532-4. doi: 10.3899/jrheum.150024. PMID: 26233953.

#537 2015 Joint Bone Spine

Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO)

Batu ED, Ergen FB, Gulhan B, Topaloglu R, Aydingoz U, Ozen S. Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO). Joint Bone Spine. 2015 Dec;82(6):471-3. doi: 10.1016/j.jbspin.2014.11.010. Epub 2015 Jul 14. PMID: 26184538.

#538 2015 Clin Exp Rheumatol

Immunoglobulin G4-related orbital disease: report of two pediatric cases

Batu ED, Arici ZS, Orhan D, Kiratli H, Özen S. Immunoglobulin G4-related orbital disease: report of two pediatric cases. Clin Exp Rheumatol. 2015 May- Jun;33(3):409-410. Epub 2015 Apr 16. PMID: 25897575.

#539 2015 2015 Sep;30(9):1425-32

Vasculitis: do we know more to classify better? Pediatr Nephrol

Batu ED, Ozen S. Vasculitis: do we know more to classify better? Pediatr Nephrol. 2015 Sep;30(9):1425-32. doi: 10.1007/s00467-014-3015-0. Epub 2014 Dec 6. PMID: 25480731.

#540 2012 Curr Rheumatol Rep

Pediatric vasculitis

Batu ED, Ozen S. Pediatric vasculitis. Curr Rheumatol Rep. 2012 Apr;14(2):121-9. doi: 10.1007/s11926-011-0232-4. PMID: 22231274.

#541 2010 Ann Rheum Dis

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L, Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA, Mahr A, McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C, Savage C, Scott DG, Segelmark M, Specks U, Sunderköetter C, Suzuki K, Tesar V, Wiik A, Yazici H, Luqmani R. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis. 2010 Oct;69(10):1744-50. doi: 10.1136/ard.2009.119032. Epub 2010 May 6. PMID: 20448283.

#542 2010 Pediatr Nephrol

The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis

Baskin E, Ozen S, Cakar N, Bayrakci US, Demirkaya E, Bakkaloglu A. The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis. Pediatr Nephrol. 2010 Jan;25(1):111-7. doi: 10.1007/s00467-009-1291-x. Epub 2009 Sep 1. PMID: 19727839.

#543 2004 Int Urol Nephrol

Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism

Baskin E, Ozen S, Karçaaltincaba M, Besbas N, Saatci U, Düzova A, Agras PI, Haliloglu M, Bakkaloglu A. Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism. Int Urol Nephrol. 2004;36(1):113-8. doi: 10.1023/b:urol.0000032691.62102.1d. PMID: 15338687.

#544 2004 Turk J Pediatr

Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children

Baskin E, Beşbaş N, Saatçi U, Hasçelik G, Topaloğlu R, Ozen S, Bakkaloğlu A. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children. Turk J Pediatr. 2004 Jan-Mar;46(1):28-31. PMID: 15074371.

#545 2003 Eur J Pediatr

Urinary glycosaminoglycans in the course of familial Mediterranean fever

Baskin E, Saatçi U, Ciliv G, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S. Urinary glycosaminoglycans in the course of familial Mediterranean fever. Eur J Pediatr. 2003 May;162(5):305-8. doi: 10.1007/s00431-003-1173-3. Epub 2003 Mar 4. PMID: 12692710.

#546 2002 Pediatr Nephrol

Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients

Baskin E, Bakkaloglu A, Besbas N, Hascelik G, Saatci U, Gök F, Ozen S. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients. Pediatr Nephrol. 2002 Nov;17(11):917-9. doi: 10.1007/s00467-002-0969-0. Epub 2002 Oct 16. PMID: 12432434.

#547 2026 Turk J Pediatr

Chronic nonbacterial osteomyelitis: current perspectives in pediatric practice

Başaran Ö, Yıldız AE, Bilginer Y, Özen S. Chronic nonbacterial osteomyelitis: current perspectives in pediatric practice. Turk J Pediatr. 2026 Feb 27;68(1):1-17. doi: 10.24953/turkjpediatr.2026.7367. PMID: 41871553.

#548 2026 Mod Rheumatol

Evaluation of 334 Pediatric CNO Cases: A Multicenter Cohort Study Defining Clusters

Başaran Ö, Bayındır Y, Demir S, Yildiz AE, Aliyev E, Ulu K, Kayhan E, Haşlak F, Akgün Ö, Aydın EA, İsgüder R, Tekin ZE, Köse H, Baba Ö, Karaçayır N, Ayduran S, Ay EG, Akça ÜK, Dündar HA, Cüceoğlu MK, Çağlayan Ş, Bülbül AY, Varol ŞE, Batu ED, Bora B, Sönmez HE, Öztürk K, Gürgöze MK, Yüksel S, Kalyoncu M, Bakkaloğlu SA, Kilic SS, Çakan M, Ekinci RMK, Ünsal E, Özdel S, Acar BÇ, Ayaz NA, Kasapçopur Ö, Kısaarslan AP, Sözeri B, Bilginer Y, Özen S. Evaluation of 334 Pediatric CNO Cases: A Multicenter Cohort Study Defining Clusters. Mod Rheumatol. 2026 Feb 28:roag019. doi: 10.1093/mr/roag019. Epub ahead of print. PMID: 41761772.

#549 2026 Pediatr Res

Retinal clues to subclinical inflammation in familial Mediterranean fever

Başaran Ö, Ozen S. Retinal clues to subclinical inflammation in familial Mediterranean fever. Pediatr Res. 2026 Feb;99(3):851-852. doi: 10.1038/s41390-025-04541-9. Epub 2025 Oct 21. PMID: 41120725.

#550 2025 Pediatr Rheumatol Online J

Lack of HLH in FMF

Basaran O, Sag E, Aydın EA, Aydın B, Tasdemir NK, Celikel E, Bayındır Y, Özdel S, Bilginer Y, Grom AA, Ozen S. Lack of HLH in FMF. Pediatr Rheumatol Online J. 2025 Feb 8;23(1):14. doi: 10.1186/s12969-025-01064-9. PMID: 39923056; PMCID: PMC11807302.

#551 2023 Children (Basel)

The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study

Basaran O, Batu ED, Kaya Akca U, Atalay E, Kasap Cuceoglu M, Sener S, Balık Z, Karabulut E, Kesici S, Karagoz T, Ozsurekci Y, Bilginer Y, Cengiz AB, Ozen S. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study. Children (Basel). 2023 Jun 11;10(6):1045. doi: 10.3390/children10061045. PMID: 37371276; PMCID: PMC10296827.

#552 2022 Turk Arch Pediatr

Rare Autoinflammatory Diseases

Başaran Ö, Bilginer Y, Özen S. Rare Autoinflammatory Diseases. Turk Arch Pediatr. 2022 Jan;57(1):18-25. doi: 10.5152/TurkArchPediatr.2022.21303. PMID: 35110074; PMCID: PMC8867516.

#553 2025 Turk J Med Sci

Erratum to " Telemedicine in pediatric rheumatology: the video pediatric gait, arms, legs, and spine (v-pGALS) examination" [Turkish Journal of Medical Sciences 54 (5) 2024 963-969 ]

Balik Z, Şener S, Bayindir Y, Kasap Cüceoğlu M, Aliyev E, Başaran Ö, Bilginer Y, Özen S, Batu ED. Erratum to " Telemedicine in pediatric rheumatology: the video pediatric gait, arms, legs, and spine (v-pGALS) examination" [Turkish Journal of Medical Sciences 54 (5) 2024 963-969 ]. Turk J Med Sci. 2025 Mar 1;55(1):348. doi: 10.55730/1300-0144.5976. Erratum for: Turk J Med Sci. 2024 Jul 02;54(5):963-969. doi: 10.55730/1300-0144.5874. PMID: 40104318; PMCID: PMC11913511.

#554 2024 Turk J Med Sci

Telemedicine in pediatric rheumatology: the video pediatric gait, arms, legs, and spine (v-pGALS) examination

Balik Z, Şener S, Bayindir Y, Kasap Cüceoğlu M, Aliyev E, Başaran Ö, Bilginer Y, Özen S, Batu ED. Telemedicine in pediatric rheumatology: the video pediatric gait, arms, legs, and spine (v-pGALS) examination. Turk J Med Sci. 2024 Jul 2;54(5):963-969. doi: 10.55730/1300-0144.5874. Erratum in: Turk J Med Sci. 2025 Mar 1;55(1):348. doi: 10.55730/1300-0144.5976. PMID: 39473760; PMCID: PMC11518324.

#555 2025 Rheumatology (Oxford)

Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project

Baldo F, Erkens RGA, Mizuta M, Rogani G, Lucioni F, Bracaglia C, Foell D, Gattorno M, Jelusic M, Anton J, Brogan P, Canna S, Chandrakasan S, Cron RQ, De Benedetti F, Grom A, Heshin-Bekenstein M, Horne A, Khubchandani R, Ozen S, Quartier P, Ravelli A, Shimizu M, Schulert G, Scott C, Sinha R, Ruperto N, Swart JF, Vastert S, Minoia F; PReS MAS/sJIA Working Party and Paediatric Rheumatology International Trial Organization. Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology (Oxford). 2025 Jan 1;64(1):32-44. doi: 10.1093/rheumatology/keae391. PMID: 39058514; PMCID: PMC11701305.

#556 2002 Nephrol Dial Transplant

MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study

Balci B, Tinaztepe K, Yilmaz E, Guçer S, Ozen S, Topaloğlu R, Beşbaş N, Ozguç M, Bakkaloğlu A. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dial Transplant. 2002 Nov;17(11):1921-3. doi: 10.1093/ndt/17.11.1921. PMID: 12401847.

#557 2020 Rheumatology (Oxford)

Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients

Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö, Kalyoncu U, Bilginer Y, Yılmaz E, Özen S. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford). 2020 Jun 1;59(6):1372-1380. doi: 10.1093/rheumatology/kez410. PMID: 31598713.

#558 2018 Clin Exp Rheumatol

Potential role of pyrin, the protein mutated in familial Mediterranean fever, during inflammatory cell migration

Balci-Peynircioglu B, Akkaya-Ulum YZ, Avci E, Batu ED, Purali N, Ozen S, Yilmaz E. Potential role of pyrin, the protein mutated in familial Mediterranean fever, during inflammatory cell migration. Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):116-124. Epub 2018 Dec 12. PMID: 30582517.

#559 2008 Exp Biol Med (Maywood)

Expression of ASC in renal tissues of familial mediterranean fever patients with amyloidosis: postulating a role for ASC in AA type amyloid deposition

Balci-Peynircioglu B, Waite AL, Schaner P, Taskiran ZE, Richards N, Orhan D, Gucer S, Ozen S, Gumucio D, Yilmaz E. Expression of ASC in renal tissues of familial mediterranean fever patients with amyloidosis: postulating a role for ASC in AA type amyloid deposition. Exp Biol Med (Maywood). 2008 Nov;233(11):1324-33. doi: 10.3181/0803-RM-106. Epub 2008 Sep 12. PMID: 18791131.

#560 2009 Acta Paediatr

Ulcerative colitis associated with Takayasu's arteritis in a child

Balamtekin N, Gürakan F, Ozen S, Oguz B, Talim B. Ulcerative colitis associated with Takayasu's arteritis in a child. Acta Paediatr. 2009 Aug;98(8):1368-71. doi: 10.1111/j.1651-2227.2009.01330.x. Epub 2009 May 7. PMID: 19432836.

#561 2004 J Rheumatol

Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population

Bakkaloglu A, Duzova A, Ozen S, Balci B, Besbas N, Topaloglu R, Ozaltin F, Yilmaz E. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population. J Rheumatol. 2004 Jun;31(6):1139-42. PMID: 15170927.

#562 2025 Lupus Sci Med

Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes

Baba O, Kısaoğlu H, Unal D, Gul U, Basaran Ö, Sahin S, Kasapcopur O, Ozen S, Kalyoncu M. Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes. Lupus Sci Med. 2025 May 27;12(1):e001415. doi: 10.1136/lupus-2024-001415. PMID: 40436422; PMCID: PMC12121582.

#563 2016 Rheumatol Int

Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus

Aytaç S, Batu ED, Ünal Ş, Bilginer Y, Çetin M, Tuncer M, Gümrük F, Özen S. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int. 2016 Oct;36(10):1421-9. doi: 10.1007/s00296-016-3545-9. Epub 2016 Aug 10. PMID: 27510530.

#564 2012 Turk J Pediatr

Takayasu arteritis in a 4-year-old girl: case report and brief overview of the pediatric literature

Aypar E, Celebi-Tayfur A, Keser M, Odabaş D, Ozaltin F, Paksoy Y, Ozen S. Takayasu arteritis in a 4-year-old girl: case report and brief overview of the pediatric literature. Turk J Pediatr. 2012 Sep-Oct;54(5):536-9. PMID: 23427521.

#565 2003 J Rheumatol

Th1 polarization in familial Mediterranean fever

Aypar E, Ozen S, Okur H, Kutluk T, Besbas N, Bakkaloglu A. Th1 polarization in familial Mediterranean fever. J Rheumatol. 2003 Sep;30(9):2011-3. PMID: 12966607.

#566 2023 Turk J Pediatr

Spontaneous hyphema in juvenile idiopathic arthritis uveitis

Aygun FB, Kadayıfçılar S, Özen S. Spontaneous hyphema in juvenile idiopathic arthritis uveitis. Turk J Pediatr. 2023;65(1):161-164. doi: 10.24953/turkjped.2022.55. PMID: 36866998.

#567 2017 J Rheumatol

Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise

Aydin SZ, Direskeneli H, Merkel PA; International Delphi on Disease Activity Assessment in Large-vessel Vasculitis. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise. J Rheumatol. 2017 Dec;44(12):1928-1932. doi: 10.3899/jrheum.161269. Epub 2017 Sep 1. PMID: 28864648; PMCID: PMC6690481.

#568 2026 Semin Arthritis Rheum

Evaluation of disease severity and treatment responses in patients with enthesitis-related arthritis

Aydin S, Balik Z, Batu ED, Bayindir Y, Unal D, Ercan Emreol H, Basaran O, Bilginer Y, Ozen S. Evaluation of disease severity and treatment responses in patients with enthesitis-related arthritis. Semin Arthritis Rheum. 2026 Jun;78:152956. doi: 10.1016/j.semarthrit.2026.152956. Epub 2026 Mar 4. PMID: 41825256.

#569 2007 Pediatr Hematol Oncol

Extranodal type T/NK-cell lymphoma with an atypical clinical presentation

Aydin GB, Akyuz C, Talim B, Evans SE, Sahin S, Sari N, Tabanlioglu D, Ozen S, Cağlar M, Büyükpamukçu M. Extranodal type T/NK-cell lymphoma with an atypical clinical presentation. Pediatr Hematol Oncol. 2007 Jun;24(4):291-9. doi: 10.1080/08880010701441112. PMID: 17613872.

#570 2024 Eur Radiol

Preferential involvement of the pelvis and hips along with active sacroiliitis in chronic nonbacterial osteomyelitis: MRI of 97 patients from a single tertiary referral center

Aydıngöz Ü, Yıldız AE, Ayaz E, Batu ED, Özen S. Preferential involvement of the pelvis and hips along with active sacroiliitis in chronic nonbacterial osteomyelitis: MRI of 97 patients from a single tertiary referral center. Eur Radiol. 2024 Aug;34(8):4979-4987. doi: 10.1007/s00330-023-10558-7. Epub 2024 Jan 5. PMID: 38180529.

#571 2015 Turk J Pediatr

Systems-level analysis of genome wide association study results for a pilot juvenile idiopathic arthritis family study

Aydın-Son Y, Batu ED, Demirkaya E, Bilginer Y, Kasapçopur Ö, Ünsal E, Alikaşifoglu M, Özen S. Systems-level analysis of genome wide association study results for a pilot juvenile idiopathic arthritis family study. Turk J Pediatr. 2015 Jul-Aug;57(4):324-33. PMID: 27186693.

#572 2010 Clin Rheumatol

Preventing tuberculosis in children receiving anti-TNF treatment

Ayaz NA, Demirkaya E, Bilginer Y, Ozçelik U, Cobanoğlu N, Kiper N, Besbas N, Bakkaloğlu A, Ozen S. Preventing tuberculosis in children receiving anti-TNF treatment. Clin Rheumatol. 2010 Apr;29(4):389-92. doi: 10.1007/s10067-009-1334-5. PMID: 20084445.

#573 2024 Int J Rheum Dis

Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world data

Ayan G, Basaran O, Firlatan B, Kilic L, Bilginer Y, Alikasifoglu M, Karadag O, Ozen S. Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world data. Int J Rheum Dis. 2024 Nov;27(11):e15377. doi: 10.1111/1756-185X.15377. PMID: 39558610.

#574 2026 Clin Rheumatol

Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry

Ata EB, Kılıç L, Fırlatan Yazgan B, Kart Bayram SG, Ekici M, Ünaldı E, Kuştaş AA, Bulat B, Karadağ Ö, Akdoğan A, Apraş Bilgen Ş, Kiraz S, Ertenli İ, Bilginer Y, Özen S, Kalyoncu U. Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry. Clin Rheumatol. 2026 Feb;45(2):781-789. doi: 10.1007/s10067-026-07938-x. Epub 2026 Jan 14. PMID: 41533222; PMCID: PMC12858487.

#575 2023 Rheumatology (Oxford)

A new tool supporting the diagnosis of childhood-onset Behçet's disease: venous wall thickness

Atalay E, Oguz B, Sener S, Ozcan HN, Sag E, Kaya Akca U, Kasap Cuceoglu M, Balik Z, Karakaya J, Karadag O, Basaran O, Batu ED, Bilginer Y, Ozen S. A new tool supporting the diagnosis of childhood-onset Behçet's disease: venous wall thickness. Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI181-SI188. doi: 10.1093/rheumatology/keac314. PMID: 35640152.

#576 2018 Arthritis Rheumatol

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis

Arthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rösen-Wolff A, Minden K, Szymanski AM; INCHARGE Consortium; Thomson W, Kastner DL, Woo P, Ombrello MJ. IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2018 Aug;70(8):1319-1330. doi: 10.1002/art.40498. Epub 2018 Jun 28. PMID: 29609200; PMCID: PMC6105455.

#577 2026 Eur J Radiol

Predictive role of muscle MRI in juvenile dermatomyositis: A tertiary center experience

Arslan S, Yildiz AE, Bayindir Y, Sag E, Bilginer Y, Ozen S, Haliloglu G. Predictive role of muscle MRI in juvenile dermatomyositis: A tertiary center experience. Eur J Radiol. 2026 Feb;195:112599. doi: 10.1016/j.ejrad.2025.112599. Epub 2025 Dec 3. PMID: 41353970.

#578 2019 J Med Case Rep

Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature

Arslanoglu Aydin E, Demir S, Aydin O, Bilginer Y, Ozen S. Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature. J Med Case Rep. 2019 Nov 25;13(1):344. doi: 10.1186/s13256-019-2284-4. PMID: 31760956; PMCID: PMC6876070.

#579 2019 Rheumatol Int

The factors affecting the disease course in Kawasaki disease

Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S. The factors affecting the disease course in Kawasaki disease. Rheumatol Int. 2019 Aug;39(8):1343-1349. doi: 10.1007/s00296-019-04336-2. Epub 2019 May 28. PMID: 31139951.

#580 2015 Curr Rheumatol Rep

Reviewing the recommendations for lupus in children

Arıcı ZS, Batu ED, Ozen S. Reviewing the recommendations for lupus in children. Curr Rheumatol Rep. 2015 Mar;17(3):17. doi: 10.1007/s11926-014-0489-5. PMID: 25761924.

#581 2009 Turk J Pediatr

Treatment of severe Henoch-Schönlein nephritis: justifying more immunosuppression

Altugan FS, Ozen S, Aktay-Ayaz N, Güçer S, Topaloğlu R, Düzova A, Ozaltin F, Beşbaş N. Treatment of severe Henoch-Schönlein nephritis: justifying more immunosuppression. Turk J Pediatr. 2009 Nov-Dec;51(6):551-5. PMID: 20196388.

#582 2026 J Clin Rheumatol

Closed Loop Computer-based Artificial Intelligence Model "Maverik" to Help Diagnose and Differential Diagnoses of Childhood Onset Chronic Nonbacterial Osteomyelitis: Pilot Study

Aliyev E, Ugur Y, Yildiz AE, Bayindir Y, Cam V, Unal D, Emreol HE, Sag E, Basaran O, Bilginer Y, Ozen S. Closed Loop Computer-based Artificial Intelligence Model "Maverik" to Help Diagnose and Differential Diagnoses of Childhood Onset Chronic Nonbacterial Osteomyelitis: Pilot Study. J Clin Rheumatol. 2026 Mar 1;32(2):39-46. doi: 10.1097/RHU.0000000000002311. Epub 2025 Dec 26. PMID: 41451463.

#583 2025 Sci Rep

Closed circuit artificial ıntelligence model named morgaf for childhood onset systemic lupus erythematosus diagnosis

Aliyev E, Ugur Y, Cam V, Bayindir Y, Unal D, Balik Z, Sener S, Bilginer Y, Ozen S. Closed circuit artificial ıntelligence model named morgaf for childhood onset systemic lupus erythematosus diagnosis. Sci Rep. 2025 Jul 1;15(1):20868. doi: 10.1038/s41598-025-92964-z. PMID: 40595005; PMCID: PMC12214585.

#584 2025 Rheumatology (Oxford)

A challenging case of limb autoamputation

Aliyev E, Celep I, Cam V, Ozen S, Sag E. A challenging case of limb autoamputation. Rheumatology (Oxford). 2025 Jun 1;64(6):4070-4071. doi: 10.1093/rheumatology/keaf044. PMID: 39873713.

#585 2025 J Psychosom Res

Assessing cognitive functions in non- neuropsychiatric childhood systemic lupus erythematosus: Cross-sectional study

Aliyev E, Aliyev ESA, Demir S, Kirseven MY, Celik C, Erkus OK, Esen HTC, Kultur EC, Anlar B, Ozen S, Bilginer Y. Assessing cognitive functions in non- neuropsychiatric childhood systemic lupus erythematosus: Cross-sectional study. J Psychosom Res. 2025 Feb;189:112027. doi: 10.1016/j.jpsychores.2024.112027. Epub 2024 Dec 31. PMID: 39746278.

#586 2026 Rheumatology (Oxford)

Premenstrual syndrome and inflammatory activity in adolescent familial Mediterranean fever

Aliyeva N, Ünal D, Kızılkan MP, Başaran Ö, Bilginer Y, Özen S, Akgül S. Premenstrual syndrome and inflammatory activity in adolescent familial Mediterranean fever. Rheumatology (Oxford). 2026 Apr 6;65(4):keag169. doi: 10.1093/rheumatology/keag169. PMID: 41936095; PMCID: PMC13105844.

#587 2018 Lupus Sci Med

Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus

AlE'ed A, Aydin POA, Al Mutairi N, AlSaleem A, Sonmez HE, Henrickson M, Huggins JL, Ozen S, Al-Mayouf SM, Brunner HI. Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus. Lupus Sci Med. 2018 Nov 17;5(1):e000275. doi: 10.1136/lupus-2018-000275. PMID: 30538816; PMCID: PMC6257379.

#588 2004 Clin Dysmorphol

Noonan syndrome and systemic lupus erythematosus: presentation in childhood

Alanay Y, Balcı S, Ozen S. Noonan syndrome and systemic lupus erythematosus: presentation in childhood. Clin Dysmorphol. 2004 Jul;13(3):161-163. doi: 10.1097/01.mcd.0000127467.04018.6d. PMID: 15194952.

#589 2025 Turk J Haematol

Extreme Phenotypic Variation in Siblings with Identical Homozygous Mutations Causing ADA2 Deficiency: A Case Series

Aksu MD, Özen S, Aksu T, Gürel A, Çetinkaya A, Ünal Ş. Extreme Phenotypic Variation in Siblings with Identical Homozygous Mutations Causing ADA2 Deficiency: A Case Series. Turk J Haematol. 2025 Feb 28;42(1):61-64. doi: 10.4274/tjh.galenos.2025.2024.0373. Epub 2025 Jan 7. PMID: 39764790; PMCID: PMC11869147.

#590 2010 2010 Aug;169(8):971-4

Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better? Eur J Pediatr

Akse-Onal V, Sağ E, Ozen S, Bakkaloglu A, Cakar N, Besbas N, Gucer S. Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better? Eur J Pediatr. 2010 Aug;169(8):971-4. doi: 10.1007/s00431-010-1158-y. Epub 2010 Feb 24. PMID: 20179967.

#591 2012 Gene

Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients

Akpolat T, Özkaya O, Özen S. Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene. 2012 Jan 15;492(1):285-9. doi: 10.1016/j.gene.2011.10.012. Epub 2011 Oct 13. PMID: 22037353.

#592 2004 Rheumatol Int

Familial Mediterranean fever and glomerulonephritis and review of the literature

Akpolat T, Akpolat I, Karagoz F, Yilmaz E, Kandemir B, Ozen S. Familial Mediterranean fever and glomerulonephritis and review of the literature. Rheumatol Int. 2004 Jan;24(1):43-5. doi: 10.1007/s00296-003-0329-9. Epub 2003 Jun 27. PMID: 12835915.

#593 2002 Semin Arthritis Rheum

Renal Behçet's disease: a cumulative analysis

Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S. Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum. 2002 Apr;31(5):317-37. doi: 10.1053/sarh.2002.31721. PMID: 11965596.

#594 2021 Sci Rep

Familial Mediterranean fever-related miR-197-3p targets IL1R1 gene and modulates inflammation in monocytes and synovial fibroblasts

Akkaya-Ulum YZ, Akbaba TH, Tavukcuoglu Z, Chae JJ, Yilmaz E, Ozen S, Balci- Peynircioglu B. Familial Mediterranean fever-related miR-197-3p targets IL1R1 gene and modulates inflammation in monocytes and synovial fibroblasts. Sci Rep. 2021 Jan 12;11(1):685. doi: 10.1038/s41598-020-80097-4. PMID: 33436947; PMCID: PMC7803773.

#595 2017 Clin Exp Rheumatol

Alteration of the microRNA expression profile in familial Mediterranean fever patients

Akkaya-Ulum YZ, Balci-Peynircioglu B, Karadag O, Eroglu FK, Kalyoncu U, Kiraz S, Ertenli AI, Özen S, Yilmaz E. Alteration of the microRNA expression profile in familial Mediterranean fever patients. Clin Exp Rheumatol. 2017 Nov- Dec;35 Suppl 108(6):90-94. Epub 2017 Nov 27. PMID: 29224588.

#596 2026 Rheumatology (Oxford)

Biological therapies in paediatric Behçet's disease: results of an international collaborative study by the PRES Vasculitis Working Party

Akgün Ö, Demirkan FG, Koné-Paut I, Coşkuner T, Çam V, Polat MC, Esen E, Conti EA, Şahin N, Baba Ö, Kılbaş G, Kocamaz NG, Taşkın SN, Rigante D, Jelusic M, Horne A, Öztürk K, Özdel S, Köker O, Yüksel S, Kalyoncu M, Sönmez HE, Filocamo G, Paç Kısaarslan A, Mastrolia MV, Acar BÇ, Benazzouz D, Batu ED, Sözeri B, Saadoun D, Özen S, Aktay Ayaz N. Biological therapies in paediatric Behçet's disease: results of an international collaborative study by the PRES Vasculitis Working Party. Rheumatology (Oxford). 2026 Mar 5;65(3):keaf404. doi: 10.1093/rheumatology/keaf404. PMID: 40748718; PMCID: PMC13016814.

#597 2019 Am J Med Genet A

ADA2 deficiency in a patient with Noonan syndrome- like disorder with loose anagen hair: The co-occurrence of two rare syndromes

Akgun-Dogan O, Simsek-Kiper PO, Taskiran E, Lissewski C, Brinkmann J, Schanze D, Göçmen R, Cagdas D, Bilginer Y, Utine GE, Zenker M, Ozen S, Tezcan İ, Alikasifoglu M, Boduroğlu K. ADA2 deficiency in a patient with Noonan syndrome- like disorder with loose anagen hair: The co-occurrence of two rare syndromes. Am J Med Genet A. 2019 Dec;179(12):2474-2480. doi: 10.1002/ajmg.a.61363. Epub 2019 Oct 4. PMID: 31584751.

#598 2021 Lupus

Hematological involvement in pediatric systemic lupus erythematosus: A multi- center study

Akca ÜK, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S. Hematological involvement in pediatric systemic lupus erythematosus: A multi- center study. Lupus. 2021 Oct;30(12):1983-1990. doi: 10.1177/09612033211038824. Epub 2021 Aug 28. PMID: 34459313.

#599 2020 Rheumatol Int

Kawasaki-like disease in children with COVID-19

Akca UK, Kesici S, Ozsurekci Y, Aykan HH, Batu ED, Atalay E, Demir S, Sag E, Vuralli D, Bayrakci B, Bilginer Y, Ozen S. Kawasaki-like disease in children with COVID-19. Rheumatol Int. 2020 Dec;40(12):2105-2115. doi: 10.1007/s00296-020-04701-6. Epub 2020 Sep 16. PMID: 32936318; PMCID: PMC7492688.

#600 2023 J Mol Med (Berl)

Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients

Akbaba TH, Akkaya-Ulum YZ, Batu ED, Penco F, Wittkowski H, Kant B, van Gijn ME, Foell D, Gattorno M, Ozen S, Balci-Peynircioglu B. Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients. J Mol Med (Berl). 2023 Jun;101(6):757-766. doi: 10.1007/s00109-023-02327-2. Epub 2023 May 22. PMID: 37212859.

#601 2021 Clin Exp Rheumatol

Inflammation-related differentially expressed common miRNAs in systemic autoinflammatory disorders patients can regulate the clinical course

Akbaba TH, Akkaya-Ulum YZ, Tavukcuoglu Z, Bilginer Y, Ozen S, Balci- Peynircioglu B. Inflammation-related differentially expressed common miRNAs in systemic autoinflammatory disorders patients can regulate the clinical course. Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):109-117. doi: 10.55563/clinexprheumatol/t67tvc. Epub 2021 Jul 6. PMID: 34251308.

#602 2022 Pediatr Res

The pyrin inflammasome aggravates inflammatory cell migration in patients with familial Mediterranean fever

Akbaba TH, Akkaya-Ulum YZ, Demir S, Ozen S, Balci-Peynircioglu B. The pyrin inflammasome aggravates inflammatory cell migration in patients with familial Mediterranean fever. Pediatr Res. 2022 May;91(6):1399-1404. doi: 10.1038/s41390-021-01559-7. Epub 2021 May 7. PMID: 33963299.

#603 2020 Mol Biol Rep

Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients

Akbaba TH, Ustabas G, Kasap-Cuceloglu M, Ozen S, Balci-Peynircioglu B. Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients. Mol Biol Rep. 2020 Nov;47(11):9005-9011. doi: 10.1007/s11033-020-05957-8. Epub 2020 Nov 7. PMID: 33161498.

#604 2020 Curr Rheumatol Rep

Epigenetics for Clinicians from the Perspective of Pediatric Rheumatic Diseases

Akbaba TH, Sag E, Balci-Peynircioglu B, Ozen S. Epigenetics for Clinicians from the Perspective of Pediatric Rheumatic Diseases. Curr Rheumatol Rep. 2020 Jul 11;22(8):46. doi: 10.1007/s11926-020-00912-9. PMID: 32654092.

#605 2025 Immunol Res

Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literature

Akarsu A, Sonmez G, Schiefer AI, Ozcan HN, Üner M, Esenboga S, Duzova A, Oberndorfer F, Ozen S, Ayvaz M, Özçelik U, Cagdas D. Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literature. Immunol Res. 2025 Oct 27;73(1):150. doi: 10.1007/s12026-025-09711-9. PMID: 41139764.

#606 2026 J Hum Immun

Human TBK1 deficiency: An expanded spectrum from autoinflammation to viral encephalitis

Akalu Y, Taft J, Berger T, Rostásy K, Dafsari HS, Schönrade H, Cüceoğlu MK, Özen S, Faye A, Melki I, Dobroz I, Boespflug-Tanguy O, Kiykim A, Sahin S, Tahir Turanli E, Akca ÜK, van Laar JAM, van Pelt PA, Hollink IHIM, Pimpale Chavan P, Khubchandani R, Aksentijevich I, Bogunovic D. Human TBK1 deficiency: An expanded spectrum from autoinflammation to viral encephalitis. J Hum Immun. 2026 Feb 10;2(2):e20250245. doi: 10.70962/jhi.20250245. PMID: 41675198; PMCID: PMC12888840.

#607 2022 Rheumatol Int

Correction to: Assessment of systemic and ocular inflammation in juvenile idiopathic arthritis via choroidal vascularity index

Ağın A, Kadayıfçılar S, Baytaroğlu A, Deliktaş Ö, Demir S, Sağ E, Bilginer Y, Karakaya J, Özen S, Eldem B. Correction to: Assessment of systemic and ocular inflammation in juvenile idiopathic arthritis via choroidal vascularity index. Rheumatol Int. 2022 Jul;42(7):1197. doi: 10.1007/s00296-021-05048-2. Erratum for: Rheumatol Int. 2022 Jul;42(7):1187-1196. doi: 10.1007/s00296-021-05023-x. PMID: 34757433.

#608 2022 Rheumatol Int

Assessment of systemic and ocular inflammation in juvenile idiopathic arthritis via choroidal vascularity index

Ağın A, Kadayıfçılar S, Baytaroğlu A, Deliktaş Ö, Demir S, Sağ E, Bilginer Y, Karakaya J, Özen S, Eldem B. Assessment of systemic and ocular inflammation in juvenile idiopathic arthritis via choroidal vascularity index. Rheumatol Int. 2022 Jul;42(7):1187-1196. doi: 10.1007/s00296-021-05023-x. Epub 2021 Oct 11. Erratum in: Rheumatol Int. 2022 Jul;42(7):1197. doi: 10.1007/s00296-021-05048-2. PMID: 34633494.

#609 2018 Ann Rheum Dis

A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Aeschlimann FA, Batu ED, Canna SW, Go E, Gül A, Hoffmann P, Leavis HL, Ozen S, Schwartz DM, Stone DL, van Royen-Kerkof A, Kastner DL, Aksentijevich I, Laxer RM. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018 May;77(5):728-735. doi: 10.1136/annrheumdis-2017-212403. Epub 2018 Jan 9. PMID: 29317407.

#610 2026 Eur J Pediatr

Tuberculosis infection in BCG vaccinated children and adolescents with rheumatological diseases treated by tumor necrosis factor-α inhibitors

Ademhan Tural D, Doğru D, Özsezen B, Karaman A, Sunman B, Nayir Büyükşahin H, Güzelkaş İ, Alboğa D, Erdal MA, Emiralioğlu Ordukaya N, Bilginer Y, Yalçın E, Özçelik U, Özen S, Kiper N. Tuberculosis infection in BCG vaccinated children and adolescents with rheumatological diseases treated by tumor necrosis factor-α inhibitors. Eur J Pediatr. 2026 May 15;185(6):399. doi: 10.1007/s00431-026-07028-9. PMID: 42141213; PMCID: PMC13179172.

#611 2021 Respir Med

Clinical spectrum of children with interstitial pneumonia with autoimmune features

Ademhan Tural D, Emiralioglu N, Ozsezen B, Sunman B, Nayir Buyuksahin H, Guzelkas I, Oguz B, Bilginer Y, Orhan D, Yalcin E, Dogru D, Ozcelik U, Ozen S, Kiper N. Clinical spectrum of children with interstitial pneumonia with autoimmune features. Respir Med. 2021 Oct;187:106566. doi: 10.1016/j.rmed.2021.106566. Epub 2021 Aug 12. PMID: 34416614.

#612 2023 Clin Oral Investig

Evaluation of periodontal status and cytokine response in children with familial Mediterranean fever or systemic juvenile idiopathic arthritis

Acar B, Demir S, Özşin-Özler C, Tan Ç, Özbek B, Yaz İ, Karabulut E, Batu ED, Tezcan İ, Nohutcu RM, Özen S, Berker E. Evaluation of periodontal status and cytokine response in children with familial Mediterranean fever or systemic juvenile idiopathic arthritis. Clin Oral Investig. 2023 Mar;27(3):1159-1166. doi: 10.1007/s00784-022-04730-4. Epub 2022 Oct 5. PMID: 36197547.